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Due to their unique physicochemical properties, iron oxide nanoparticles (ION) have 
great potential for several biomedical applications, particularly those focused on nervous system. 
ION surface can be coated to improve their properties and biocompatibility. Still, coating may 
affect toxicity, making it imperative knowing the potential risk associated to nervous system 
exposure. The aim of this Thesis was to assess the potential cytotoxicity and genotoxicity induced 
by differently coated ION on human neurons (SH-SY5Y) and astrocytes (A172), under a range 
of doses, two treatment times and presence/absence of serum in the cell culture media. Cellular 
uptake of ION and iron ion release from the ION surface were also determined. In general, silica-
coated ION (S-ION) showed less cytotoxicity and slightly lower genotoxic effects than oleic acid-
coated ION (O-ION), not related to double strand breaks (DSB) or chromosome alterations. 
Furthermore, A172 astrocytes proved to be more sensitive than SH-SY5Y neurons to the toxic 
effect of both ION. In addition, primary DNA damage observed in both cell types only included 
DSB in astrocytes. This work increases the knowledge on the impact of ION on human health in 
general, and specifically on nervous system cells. 
Resumen 
Debido a sus propiedades fisicoquímicas únicas, las nanopartículas de óxido de hierro 
(ION) tienen un gran potencial para varias aplicaciones biomédicas, particularmente aquellas 
enfocadas en el sistema nervioso. La superficie de ION se puede revestir para mejorar sus 
propiedades y biocompatibilidad. Aun así, el recubrimiento puede afectar a su toxicidad, por lo 
que es imperativo conocer el riesgo potencial asociado a la exposición del sistema nervioso. El 
objetivo de esta Tesis fue evaluar la posible citotoxicidad y genotoxicidad inducida por ION con 
diferentes recubrimientos en neuronas humanas (SH-SY5Y) y astrocitos (A172), en un rango de 
dosis, dos tiempos de tratamiento y presencia/ausencia de suero en los medios de cultivo celular. 
También se determinó la captación celular de las ION y la liberación de iones de hierro desde su 
superficie. En general, las ION recubiertas de sílice (S-ION) mostraron menos citotoxicidad y 
efectos genotóxicos ligeramente menores que las ION recubierto con ácido oleico (O-ION), no 
relacionado con roturas de cadena doble (DSB) o alteraciones cromosómicas. Además, los 
astrocitos A172 demostraron ser más sensibles que las neuronas SH-SY5Y al efecto tóxico de 
ambas ION. Además, el daño primario del ADN observado en ambos tipos de células solo incluía 
DSB en los astrocitos. Este trabajo aumenta el conocimiento sobre el impacto de ION en la salud 
humana en general, y específicamente en las células del sistema nervioso. 
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Resumo 
Debido ás súas propiedades físicoquímicas únicas, as nanopartículas de óxido de ferro 
(ION) teñen gran potencial para diversas aplicacións biomédicas, en particular as que se centran 
no sistema nervioso. A superficie das ION pode revestirse para mellorar as súas propiedades e a 
súa biocompatibilidade. Aínda así, o revestimento pode afectar a toxicidade, por iso, é imperativo 
coñecer os riscos potenciais asociados coa exposición do sistema nervioso. O obxectivo desta 
Tese foi o de avaliar a posible citotoxicidade e genotoxicidade inducida polas ION con diferentes 
revestimentos en neuronas humanas (SH-SY5Y) e astrocitos (A172), nun intervalo de doses, dous 
tempos de tratamento e en presenza/ausencia de soro nos medios de cultura celular. A captación 
celular das ION e a liberación de ións de ferro a partir da súa superficie, tamén foron 
determinadas. En xeral, as ION revestidas de sílice (S-ION) amosaron menos citotoxicidade e 
efectos genotóxicos lixeiramente máis baixos que as ION revestidas con ácido oleico (O-ION), 
sen relación con roturas de cadea dobre (DSB) ou alteracións cromosómicas. Ademáis, os 
astrocitos A172 amosaron ser máis sensibles que as neuronas SH-SY5Y ó efecto tóxico de ambas 
ION. Ademáis, o dano primario no ADN observado en ambos tipos celulares só incluía DSB nos 
astrocitos. Este traballo aumenta o coñecemento sobre o impacto das ION na saúde humana en 
xeral, e específicamente nas células do sistema nervioso. 
 
Extended summary 
Extended summary in Spanish - Resumen amplio 
La nanotecnología puede definirse como la investigación, diseño y manipulación de la 
materia en dimensiones de aproximadamente 1 a 100nm. En esta pequeña escala surgen nuevas 
propiedades físicas, químicas y biológicas diferentes a las de los materiales de mayor tamaño con 
la misma composición química, como consecuencia de la elevada proporción superficie/volumen.  
La nanotecnología es un área en rápida expansión con perspectivas muy prometedoras; 
actualmente son 3037 los productos de consumo inventariados que contienen nanomateriales. Con 
el aumento de las aplicaciones de los nanomateriales, especialmente con fines biomédicos, 
también han aumentado las inquietudes con respecto a la aparición de efectos sobre la salud 
asociados a la exposición. Esto ha dado lugar a un creciente debate público sobre la toxicidad y 
el impacto ambiental de los nanomateriales, ya que sus nuevas propiedades pueden ocasionar 
cambios en la interacción con los componentes celulares y aparición de efectos adversos 
inesperados.  
Entre todos los nanomateriales, las nanopartículas de óxido de hierro (ION de iron oxide 
nanoparticles) despiertan un interés particular principalmente en el campo biomédico, debido a 
sus características fisicoquímicas especiales, su aparente biocompatibilidad, y porque exhiben 
una forma única de magnetismo llamada superparamagnetismo. Las aplicaciones más 
prometedoras de las ION son como agente de contraste en imágenes de resonancia magnética, la 
administración dirigida de fármacos, terapia génica y reparación de tejidos, y el tratamiento de 
tumores por hipertermia. En concreto, las ION han demostrado en la última década ser muy útiles 
para una serie de aplicaciones relacionadas principalmente con el diagnóstico y tratamiento de 
enfermedades del sistema nervioso central (SNC), tales como el Parkinson, el Alzheimer, la 
esclerosis múltiple, neoplasias del sistema nervioso o enfermedades neurodegenerativas visuales. 
Las ION generalmente están compuestas por un núcleo cristalino que puede presentar 
múltiples estructuras cristalográficas, entre las cuales la magnetita, la maghemita y la hematita 
son las más comúnmente utilizadas debido a su polimorfismo. Específicamente, la magnetita es 
la ION más frecuente en biomedicina, ya que su magnetización es más alta. Un problema común 
asociado con las ION es su inestabilidad intrínseca durante largos períodos de tiempo, ya que 
tienden a formar aglomerados, son altamente reactivas químicamente y se oxidan con facilidad, 
lo que generalmente produce pérdida de magnetismo y capacidad de dispersión. Para minimizar 
estos efectos, la superficie de las ION puede modificarse recubriéndolas con diferentes materiales, 
para estabilizarlas en medios fisiológicos, aumentar su biocompatibilidad, modificar la eficiencia 
de captación celular, y potenciar sus propiedades en aplicaciones biomédicas, aunque también 
puede alterar su toxicidad. Por otro lado, el gran potencial de las ION se debe principalmente a 
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sus propiedades físicas y químicas únicas, que muestran una dependencia compleja de varios 
factores como su forma, tamaño, estructura, composición y reactividad superficial, 
ausencia/presencia de recubrimiento y estabilidad química (e.g., solubilidad y 
aglomeración/agregación). La carga superficial de las nanopartículas tiene también gran 
importancia en la producción de efectos biológicos, ya que es un factor principal en la 
determinación de las características de dispersión y también influye en la adsorción de iones y 
biomoléculas, en especial proteínas (corona biomolecular), que pueden cambiar la manera en la 
que las células interaccionan con las nanopartículas. 
Se ha demostrado que las ION tienen capacidad para atravesar la barrera 
hematoencefálica (BHE), pudiendo así acceder al SNC. Aunque la translocación de las ION al 
cerebro ha sido estudiada bajo diferentes condiciones experimentales, aún no está claro si son 
generalmente seguras o deben usarse con prudencia. La falta de evaluaciones toxicológicas 
completas y estandarizadas hace difícil la interpretación de los resultados obtenidos hasta el 
momento, sobre todo en el caso de la neurotoxicidad. Esto se debe, al menos en parte, a que los 
resultados disponibles sobre los posibles efectos tóxicos de las ION en el SNC son escasos y 
contradictorios, y no siempre son comparables ya que están influenciados por diversos factores, 
como el tipo de ION y sus características fisicoquímicas, el tipo de célula analizada o las 
condiciones experimentales evaluadas. Se hace necesaria, por tanto, la evaluación de los efectos 
tóxicos que las ION puedan ocasionar en las células del sistema nervioso humano.  
Para garantizar la seguridad del uso diagnóstico o terapéutico de las ION, éstas no deben 
ser tóxicas para las células en concentraciones adecuadas para la orientación magnética u otras 
aplicaciones biomédicas. Sin embargo, se ha demostrado en varios estudios in vitro e in vivo que 
las ION, desnudas o recubiertas con diferentes sustancias, pueden inducir efectos adversos, 
incluso a dosis bajas, como la disminución de la viabilidad celular, alteraciones del citoesqueleto, 
liberación de iones de hierro, inducción de estrés oxidativo o disfunción mitocondrial, entre otros. 
Además, sus posibles efectos sobre otras funciones celulares diferentes, sobre el material genético 
o sobre la capacidad de reparación del ADN no pueden tampoco ser descartados ya que apenas 
han sido abordados hasta la fecha en células nerviosas humanas.  
Sobre esta base, el objetivo principal de este trabajo fue evaluar la posible citotoxicidad 
y genotoxicidad inducida en células neuronales y gliales (astrocitos) por exposición a ION con 
diferentes recubrimientos. En concreto, se analizó la citotoxicidad asociada con la exposición a 
las ION, en términos de alteraciones en la integridad de la membrana (mediante el ensayo de 
liberación de lactato deshidrogenasa [LDH]) o en el ciclo celular, y la inducción de la muerte 
celular (apoptosis y necrosis); se examinaron además los efectos genotóxicos relacionados con el 
tratamiento con las ION, analizando la inducción de daño primario en el ADN (por el ensayo del 
Extended summary 
cometa), de roturas de cadena doble (ensayo γH2AX) y de alteraciones cromosómicas (test de 
micronúcleos [MN]); y, por último, se evaluaron las modificaciones en los procesos de reparación 
del ADN causados por las ION (por el ensayo de competencia de reparación).  
Cada uno de estos ensayos se realizó en células neuronales SH-SY5Y y células gliales 
A172 (astrocitos), testando dos tipos de ION – recubiertas con sílice (S-ION) y con ácido oleico 
(O-ION), cuyas características físico-químicas habían sido determinadas con anterioridad – en un 
rango de condiciones experimentales que incluyeron dosis de 10 a 200µg/ml para neuronas, y de 
5 a 100µg/ml para astrocitos, dos tiempos de tratamiento (3 y 24h), y presencia o ausencia de 
suero en los medios de cultivo celular. Las concentraciones y tiempos de exposición se eligieron 
en base a resultados de viabilidad celular obtenidos previamente en nuestro laboratorio. Las 
condiciones experimentales seleccionadas para el estudio fueron aquellas que inducían una 
disminución máxima en la viabilidad de ambos tipos celulares del 30%, evitando así la posible 
influencia de la disminución excesiva de la viabilidad en los resultados de los diferentes 
parámetros evaluados.  
Antes de analizar los posibles efectos tóxicos de las nanopartículas, se verificó la efectiva 
internalización de las ION en las células nerviosas a través de citometría de flujo y microscopía 
electrónica de transmisión. Además, se evaluó por espectroscopia de absorción atómica de llama 
la concentración de iones de hierro liberados en los medios de cultivo celular empleados.  
En las secciones de Resultados y Discusión de la presente memoria se analizan y 
comparan los resultados experimentales obtenidos subdividiéndolos en función del tipo celular y 
la ION testada.  
Células SH-SY5Y tratadas con S-ION 
En el análisis de la liberación de iones de hierro a partir de las suspensiones de S-ION en 
medio de cultivo SH-SY5Y se detectaron bajas concentraciones de hierro en medio libre de suero, 
mientras que la liberación de iones fue notable en presencia de suero (medio completo), 
aumentando en general con el tiempo y la concentración de las S-ION. Por otra parte, los datos 
obtenidos confirmaron que las células SH-SY5Y captaron las S-ION de forma efectiva, siendo 
mayor la captación en ausencia de suero.  
A pesar de que la evaluación de la integridad de la membrana celular, mediante el ensayo 
de liberación de LDH, mostró resultados negativos en todas las condiciones ensayadas, los 
resultados de la evaluación de los efectos citotóxicos mostraron un aumento de células en la fase 
S del ciclo celular, y/o disminución de células en la fase G2/M, para tratamientos de 24h en ambos 
medios de cultivo a la dosis más alta probada. Además, el único aumento significativo observado 
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en la tasa de apoptosis fue para las concentraciones más elevadas de S-ION tras los tratamientos 
de 24h en ambos medios analizados. Por otra parte, el análisis de la muerte celular por necrosis 
(y/o apoptosis tardía), y el análisis de la integridad de membrana no mostraron alteraciones en las 
células SH-SY5Y expuestas a S-ION en ninguna de las condiciones ensayadas.  
Respecto a los ensayos de genotoxicidad, no se observaron aumentos significativos en los 
niveles de γH2AX, ni de formación de MN en las células SH-SY5Y expuestas a las S-ION. Sin 
embargo, los resultados del ensayo del cometa mostraron un incremento en el daño primario en 
el ADN dependiente de la dosis y del tiempo en medio completo, paralela a las cantidades 
importantes de iones de hierro liberados de las nanopartículas en ese medio. Los iones de hierro 
son capaces de interactuar con el ADN entre las bases, y causar roturas de cadena sencilla (SSB) 
y modificación oxidativa de las bases. Analizando conjuntamente todos los resultados de 
genotoxicidad, el tipo de daño en el ADN inducido por las S-ION en células neuronales 
probablemente no esté relacionado con roturas de cadena doble (DSB), sino principalmente con 
lesiones fácilmente reparables (sitios sensibles al álcali y SSB). 
En resumen, a pesar de ser efectivamente internalizadas por las células neuronales, las S-
ION presentaron una citotoxicidad en general baja, obteniéndose resultados positivos únicamente 
en algunos ensayos a las concentraciones más altas y/o al tiempo de exposición más prolongado. 
Las evaluaciones de genotoxicidad en medio sin suero fueron negativas para todas las condiciones 
analizadas, mientras que en medio con suero se observó un aumento dependiente de la dosis y del 
tiempo en el daño en el ADN, no relacionado con la producción de DSB o la pérdida cromosómica 
(de acuerdo con los resultados del ensayo γH2AX y el test de MN). Las diferencias observadas 
en los tres ensayos de genotoxicidad aplicados, con respecto a su sensibilidad para detectar 
diferentes tipos de daño genético, confirman la necesidad de usarlos en combinación, ya que se 
complementan entre sí. La internalización de las nanopartículas por las células, la citotoxicidad y 
los efectos sobre la reparación del ADN fueron más pronunciados en ausencia de suero. Por el 
contrario, la liberación de iones de hierro y el daño primario del ADN sólo se observaron en el 
medio completo. La formación de una corona de proteínas en presencia de suero probablemente 
juegue un papel importante en estas diferencias.  
Células SH-SY5Y tratadas con O-ION 
La liberación de iones de hierro desde la superficie de las O-ION en medio completo se 
mostró dependiente de la dosis, mientras que las O-ION suspendidas en medio sin suero fueron 
muy estables en todas las condiciones evaluadas. Los resultados de captación celular obtenidos 
muestran que las células SH-SY5Y pueden internalizar de manera eficiente estas nanopartículas 
Extended summary 
en todas las condiciones experimentales probadas, independientemente de la composición del 
medio. 
En cuanto a la citotoxicidad, los datos obtenidos sugirieron que las proteínas del suero 
interaccionan con el recubrimiento de ácido oleico ejerciendo un cierto efecto protector y 
disminuyendo ligeramente la inducción de citotoxicidad. La ausencia de liberación significativa 
de LDH por las células neuronales sugiere que las O-ION, en general, no alteran la integridad de 
la membrana celular a concentraciones bajas y medias. Por otra parte, las O-ION alteran la 
progresión normal del ciclo celular de SH-SY5Y, de forma particularmente notable después de 
24h de tratamiento en medio sin suero, induciendo un aumento significativo dependiente de la 
dosis en la fase G0/G1 junto con una clara disminución en la región G2/M, sugiriendo la detención 
del ciclo celular previo a la mitosis. Además, los resultados del análisis de muerte celular 
mostraron incrementos significativos en las tasas de apoptosis en ambos medios. Sin embargo, 
las O-ION no produjeron necrosis en ninguna de las condiciones evaluadas, lo que sugiere que 
inducen la muerte celular principalmente a través de la vía apoptótica. 
En general, la presencia de suero tuvo una influencia ligera sobre la genotoxicidad 
inducida por las O-ION y los efectos sobre la capacidad de reparación. Los resultados del ensayo 
del cometa mostraron que las O-ION indujeron daño primario del ADN en las células expuestas, 
no relacionado con la inducción de DSB en ninguna condición probada. Además, sólo se 
detectaron aumentos significativos en la frecuencia de MN en células SH-SY5Y después de 24h 
de exposición a las dosis más altas de O-ION en medio sin suero, sugiriendo que el daño primario 
del ADN detectado en el ensayo del cometa sólo se fijó como alteraciones cromosómicas en estas 
condiciones. El ensayo de competencia de reparación del ADN mostró un efecto similar de las O-
ION en ambos medios testados, consistente en alteraciones en la capacidad de reparación cuando 
las células se trataron antes o durante la incubación con H2O2, pero no cuando el tratamiento se 
realizó durante el periodo de reparación. 
En conclusión, los resultados obtenidos en células neuronales mostraron que las O-ION 
presentan una citotoxicidad moderada a altas concentraciones, relacionada con el deterioro de la 
membrana celular, la disrupción del ciclo celular y la inducción de muerte celular, especialmente 
marcada en el medio sin suero. Por el contrario, la liberación de iones de hierro sólo se observó 
en medio completo, lo que indica que la citotoxicidad observada no está relacionada con la 
presencia de estos iones en el medio. Sin embargo, los efectos genotóxicos de las O-ION se 
limitaron a la inducción de daño primario en el ADN, no relacionado con DSB y fácilmente 
reparable, y además este daño no se fijó en las células en la mayoría de las condiciones. 
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Células A172 tratadas con S-ION 
Mientras que las S-ION suspendidas en medio sin suero fueron muy estables en todas las 
condiciones probadas, las suspensiones de estas nanopartículas en medio completo mostraron un 
aumento en la liberación de iones de hierro dependiente de la concentración, particularmente 
notable en el tiempo de exposición más prolongado. Los datos de la captación celular de 
nanopartículas revelaron la presencia de las S-ION internalizadas en astrocitos A172 en todas las 
condiciones probadas, independientemente de la composición del medio o del tiempo de 
exposición. Además, se observó que las S-ION se acumulaban en vesículas intracelulares, lo que 
sugiere una entrada por endocitosis de las mismas.  
Las S-ION no alteraron la integridad de la membrana plasmática en las condiciones 
evaluadas en este estudio, como lo demuestran los resultados negativos revelados en la evaluación 
de liberación de LDH. Los resultados obtenidos del análisis del ciclo celular mostraron 
importantes alteraciones inducidas por las S-ION dependientes de la dosis, particularmente 
marcadas en los tratamientos de 24h, en los que el ciclo celular de las células A172 resultó 
significativamente alterado en todas las condiciones probadas. Estos efectos incluyeron 
principalmente alteraciones en las fases G0/G1 y S, reflejando una posible parada mitótica. Los 
resultados de muerte celular mostraron la inducción de apoptosis y necrosis limitadas a las dosis 
más altas de S-ION y al tiempo de exposición más prolongado en medio completo. Sin embargo, 
en medio libre de suero se observaron aumentos significativos de las tasas de apoptosis 
dependientes de la dosis en ambos tiempos de exposición, al igual que aumentos significativos 
dependientes de la dosis de células necróticas únicamente en el tratamiento de 3h. 
Por otra parte, las S-ION no indujeron incrementos significativos de γH2AX en los 
astrocitos A172, excepto en las concentraciones más altas después de 24h de tratamiento. 
Teniendo en cuenta los resultados obtenidos en la liberación de iones de hierro de las 
nanopartículas, el aumento detectado parece ser más probablemente debido al efecto indirecto de 
los iones de hierro, que a las propiedades genotóxicas de las S-ION. Los resultados del ensayo 
del cometa mostraron que las S-ION inducen daño primario en el ADN sólo a las concentraciones 
más altas después de un corto período de exposición, pero a partir de dosis más bajas, de una 
manera dependiente de la dosis, después de 24h de tratamiento. No se observó inducción de MN 
en ninguna de las condiciones probadas, lo que indica, por un lado, que las S-ION no inducen 
efectos aneugénicos en los astrocitos, y por otro, que estas células fueron capaces de reparar el 
daño primario del ADN producido inicialmente por la exposición (revelado por la respuesta 
positiva del ensayo del cometa), evitando así su fijación como alteraciones cromosómicas (MN). 
Por último, las S-ION no interfirieron en la capacidad de reparación de los astrocitos A172, en 
ninguna condición probada, indicativo de una reparación eficiente en presencia de S-ION. 
Extended summary 
En resumen, los resultados mostraron que la ausencia de suero en el medio tiene cierta 
influencia sobre la citotoxicidad de las S-ION en células A172, lo que resulta en efectos celulares 
más pronunciados (ciclo celular, apoptosis y necrosis). Sin embargo, en general no se encontraron 
diferencias notables debidas a la composición del medio en la inducción de genotoxicidad o 
alteraciones en la reparación del ADN, que se limitó a la producción de daño primario fácilmente 
reparable.  
Células A172 tratadas con O-ION 
Los resultados de la cuantificación de los iones de hierro liberados de la superficie de O-
ION mostraron liberación de iones dependiente de la dosis y el tiempo en medio completo, 
mientras que en medio libre de suero resultaron muy estables. Los resultados de captación de 
nanopartículas demostraron la internalización efectiva de las O-ION por las células A172, 
independientemente de la dosis, la composición del medio o el tiempo de exposición.  
Los resultados mostraron que las O-ION exhiben una citotoxicidad moderada en 
astrocitos. Mientras que la exposición a las O-ION no comprometió la integridad de la membrana 
de las células A172, el análisis de la distribución del ciclo celular mostró una parada significativa 
del mismo, dependiente de la dosis, en la fase S en todas las condiciones probadas, lo que indica 
que las O-ION alteran claramente la progresión normal de su ciclo celular. Asimismo, se 
observaron aumentos significativos en las tasas de apoptosis tras la exposición a O-ION, junto 
con un aumento ligero pero significativo en las tasas de necrosis cuando los tratamientos se 
realizaron en medio completo, pero no en medio sin suero. 
Las pruebas de genotoxicidad demostraron la inducción de daño primario en el ADN de 
astrocitos dependiente de la dosis de O-ION, particularmente en presencia de suero en el medio. 
Además, se detectaron ligeros incrementos significativos en los niveles de γH2AX. No obstante, 
no se observó inducción de MN por exposición a las O-ION. 
En resumen, los resultados obtenidos mostraron que las O-ION presentan citotoxicidad 
moderada en astrocitos, relacionada con la detención de la proliferación y la muerte celular 
(principalmente por vía apoptótica), y causan efectos genotóxicos, principalmente daño primario 
del ADN que no se fija como alteraciones cromosómicas. Estos efectos no estuvieron influidos 
por la presencia de suero en el medio. Por el contrario, la notable liberación de iones de hierro 
únicamente el medio completo indica que la citotoxicidad y genotoxicidad detectadas no fueron 
causadas por la disrupción de la homeostasis del hierro. Por último, no se obtuvieron alteraciones 
en los procesos de reparación del ADN en presencia de las O-ION. 
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A la luz de todos los resultados obtenidos en el presente trabajo, el recubrimiento de sílice 
parece ser menos tóxico y más biocompatible que el de ácido oleico para las líneas celulares 
nerviosas empleadas. En general, las S-ION mostraron menos citotoxicidad que las O-ION. 
Además, las S-ION exhibieron efectos genotóxicos de intensidad ligeramente inferior que las O-
ION en ambas líneas celulares, no relacionados con la inducción de DSB y no fijados en las 
células SH-SY5Y o A172 después de la división celular. Una posible explicación puede ser que 
ocurra una transferencia más rápida de las O-ION internalizadas al compartimiento lisosómico y 
que se produzca una mayor tasa de disolución del recubrimiento de ácido oleico al pH ácido del 
lisosoma, lo que podrían generar mayores cantidades de iones de hierro disponibles, y causar 
mayor daño celular. Además, las O-ION presentan alta tendencia a formar aglomerados de 
pequeño tamaño, especialmente en medio sin suero, probablemente debido a la ausencia de 
interacciones superficiales con las proteínas séricas del medio biológico (corona de proteína), lo 
que modifica su tamaño hidrodinámico y estabilidad. Este hecho podría influir en gran medida en 
la interacción biológica de las O-ION con sus dianas celulares y en su mayor efecto tóxico 
respecto al recubrimiento de sílice. 
Por otra parte, en cuanto a la comparación entre las células utilizadas, los astrocitos A172 
demostraron ser más vulnerables que las neuronas al efecto tóxico de S-ION y O-ION. Aunque 
en ambos tipos celulares se han observado efectos citotóxicos después de la exposición a ambas 
ION, estos efectos fueron en general mayores en los astrocitos que en las neuronas. Además, los 
dos tipos celulares presentaron daño primario en el ADN tras la exposición a las ION, pero 
únicamente en el caso de las células A172 se relacionó con la producción de DSB, un tipo más 
grave de daño genético. No obstante, en ambos casos este daño parece que fue reparado, ya que 
no condujo a su fijación en forma de alteraciones cromosómicas en la mayoría de condiciones. 
La fase del ciclo celular en la que se encuentran ambos tipos celulares en el momento del 
tratamiento puede provocar la expresión de diferentes biomoléculas e influir en la respuesta a 
estímulos exógenos, tales como la exposición a las ION. Además, las diferentes características de 
los tipos de células involucradas en la fisiología del sistema nervioso pueden determinar una 
respuesta diversa ante los xenobióticos. 
En suma, los resultados obtenidos en esta Tesis contribuyen a aumentar el conocimiento 
sobre el impacto de las ION en la salud en general, y específicamente en las células del sistema 
nervioso humano. Dado que las ION tienen un gran potencial en el diagnóstico y tratamiento de 
diversos trastornos del SNC en un futuro próximo, un conocimiento profundo sobre su potencial 
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an increase in forward scatter (FSC) and side scatter (SSC); c) nanoparticle internalization by the 
cell, leading to an increase in SSC only; d) FSC/SSC dot plot from FCM analysis with cells no 
exposed to ION; e) FSC/SSC dot plot from FCM analysis showing a high proportion of cells with 
internalized nanoparticles (R2). 
Figure I.12. In normal cells, phosphatidylserines (purple membrane phospholipids) are held on 
the inner layer of the cell membrane, so annexin V does not attach to the cells. During early 
apoptosis, the phosphatidilserines are exposed on the outer layer, where they attach to the FITC-
labeled Annexin V and stain the cell surface green. During late apoptosis, propidium iodide (PI) 
enters the cell and stains the contents red (from 
https://www.nacalai.co.jp/global/download/pdf/AnnexinV-FITC.pdf). 
Figure I.13. Fluorescence microscopy image of cell nucleoids after comet assay: A) not damaged 
nucleoid, B) mildly damaged nucleoid, C) highly damaged nucleoid. 
Figure I.14. Representation of H2AX phosphorylation as a response to double strand breaks 
(DSB). ATM, ataxia telangiectasia mutated (modified from Hoeller and Dikic, 2009). 
Figure I.15. Representation of MN formation in cells undergoing nuclear division (from Fenech 
et al., 2011). 
Figure IV.1: Analysis of iron ions released from S-ION in (A) complete cell culture medium and 
(B) serum-free cell culture medium. Bars represent the mean ± standard error.  
Figure IV.2: Neuronal cell uptake of S-ION prepared in complete and serum-free medium. Bars 
represent the mean ± standard error. **P<0.01, significant difference with regard to the 
corresponding negative control. 
Figure IV.3: Results of membrane integrity assessment in SH-SY5Y cells exposed to S-ION in 
complete and serum-free medium. Bars represent the mean ± standard error. PC: positive control 
(1% Triton X-100). **P<0.01, significant difference regarding the corresponding negative 
control. 
Figure IV.4: Analysis of SH-SY5Y cell cycle after 3 and 24h of treatment with S-ION prepared 
in complete and serum-free medium. Bars represent the mean ± standard error. PC: positive 
control (1.5μM MMC). **P<0.01, significant difference with regard to the corresponding 
negative control. 
Figure IV.5: Apoptosis (% of cells in the subG1 region of cell cycle distribution) in neuronal cells 
treated with S-ION prepared in complete and serum-free medium. Bars represent the mean ± 
standard error. PC: positive control (1.5μM MMC). *P<0.05, significant difference with regard 
to the corresponding negative control. 
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Figure IV.6: Apoptosis cell rates (%) after exposure of neuronal cells to S-ION for 3 and 24h 
prepared in complete and serum-free medium. Bars represent the mean ± standard error. PC: 
positive control (10μM Campt). *P<0.05, **P<0.01, significant difference regarding the 
corresponding negative control. 
Figure IV.7: Necrosis cell rates (%) after exposure of neuronal cells to S-ION for 3 and 24h 
prepared in complete and serum-free medium. Bars represent the mean ± standard error. PC: 
positive control (10μM Campt). *P<0.05, **P<0.01, significant difference regarding the 
corresponding negative control. 
Figure IV.8: Phosphorylation of H2AX histone after treatment of neuronal cells with S-ION 
prepared in complete and serum-free medium. Bars represent the mean ± standard error. PC: 
positive control (1μg/ml BLM). **P<0.01, significant difference with regard to the corresponding 
negative control. 
Figure IV.9: MN induction in neuronal cells after treatment with S-ION prepared in complete 
and serum-free medium. Bars represent the mean ± standard error. PC: positive control (1.5μM 
MMC). *P<0.05, significant difference with regard to the corresponding negative control. 
Figure IV.10: Results of interference testing between S-ION (200µg/ml) and comet assay 
methodology in complete and serum-free medium. Bars represent the mean ± standard error. 
Figure IV.11: DNA damage induction in neuronal cells after treatment with S-ION prepared in 
complete and serum-free medium. Bars represent the mean ± standard error. PC: positive control 
(100μM H2O2). *P<0.05, **P<0.01, significant difference with regard to the corresponding 
negative control. 
Figure IV.12: Effects of S-ION on repair of H2O2-induced DNA damage in neuronal cells. 
Incubation with 50µg/ml S-ION was carried out either before 100µg/ml H2O2 treatment (phase 
A), simultaneously (phase B), or during the repair period (phase C). Bars represent the mean ± 
standard error. *P<0.05, **P<0.01, significant difference with regard to the same treatment 
before repair, #P<0.05, significant differences with regard to the negative control. 
Figure IV.13: Analysis of iron ion release from O-ION in complete and serum-free cell culture 
medium. Bars represent mean ± standard error. 
Figure IV.14: SH-SY5Y cellular uptake of O-ION in complete and serum-free medium. Bars 
represent mean ± standard error. **P<0.01, significant differences with regard to the 
corresponding negative control. 
Figure IV.15: Results of membrane integrity assessment (LDH assay) in neuronal cells exposed 
to O-ION in complete and serum-free medium. Bars represent mean ± standard error. PC: positive 
control (1% Triton X-100). *P<0.05, **P<0.01, significant differences compared to the 
corresponding negative control. 
Figure IV.16: Analysis of SH-SY5Y cell cycle after treatment with O-ION for 3h in complete 
(upper left) and serum-free medium (upper right), or for 24h in complete (lower left) and serum-
free medium (lower right). Bars represent mean ± standard error. PC: positive control (1.5μM 
MMC). *P<0.05, **P<0.01, significant differences with regard to the corresponding negative 
control. 
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Figure IV.17: Late apoptosis (cells in the subG1 region of cell cycle distribution) assessment in 
neural cells treated with O-ION in complete and serum-free medium. Bars represent mean ± 
standard error. *P<0.05, **P<0.01, significant differences compared to the corresponding 
negative control. 
Figure IV.18: Apoptosis induction by exposure of SH-SY5Y cells to O-ION in complete and 
serum-free medium. Bars represent the mean ± standard error. PC: positive control (10μM 
Campt). *P<0.05, **P<0.01, significant difference with regard to the corresponding negative 
control. 
Figure IV.19: Necrosis induction after exposure of SH-SY5Y neurons to O-ION in complete and 
serum-free medium. Bars represent mean ± standard error. PC: positive control (10μM Campt). 
**P<0.01, significant difference with regard to the corresponding negative control 
Figure IV.20: H2AX histone phosphorylation after treatment of neuronal cells with O-ION in 
complete and serum-free medium. Bars represent mean ± standard error. PC: positive control 
(1μg/ml BLM). **P<0.01, significantly different from the corresponding negative control. 
Figure IV.21: Micronuclei rates in SH-SY5Y neurons exposed to O-ION in complete and serum-
free medium. Bars represent mean ± standard error. PC: positive control (1.5μM MMC). *P<0.05, 
**P<0.01, significant differences with respect to the corresponding negative control. 
Figure IV.22: Results of interference testing between O-ION (10-200μg/ml) and comet assay 
methodology in complete and serum-free cell culture medium. Bars represent mean ± standard 
error. *P<0.05, significant difference with regard to the corresponding control. 
Figure IV.23: Primary DNA damage in SH-SY5Y cells treated with O-ION in complete and 
serum-free medium. Data corresponding to treatment with 200μg/ml in serum-free medium are 
not shown due to interference of the nanoparticles with the comet methodology. Bars represent 
mean ± standard error. PC: positive control (100μM H2O2). *P<0.05, **P<0.01, significant 
differences with regard to the corresponding negative control. 
Figure IV.24: Effects of O-ION on repair of H2O2-induced DNA damage in neurons in complete 
and serum-free medium. Incubation with 50µg/ml O-ION was conducted independently prior to 
exposure to 100µM H2O2 (for 3 or 24 h, phase A), simultaneously with H2O2 (phase B), or during 
the repair period (phase C). Bars represent mean ± standard error. *P<0.05, **P<0.01, significant 
differences with regard to the same treatment before repair. ##P<0.01, significant differences with 
regard to the negative control. 
Figure IV.25: Analysis of iron ion release from S-ION in complete and serum-free cell culture 
medium. Bars represent mean ± standard error. 
Figure IV.26: Transmission electron micrographs of A172 cells incubated with 100µg/ml of S-
ION for 3h in complete (a) and serum-free (b) medium and after 24h of exposure in complete (c) 
medium showing nanoparticle internalization (arrows indicate S-ION agglomerates) in opposition 
to control cells (d). All bars (down left side) are 0.5μm long. 
Figure IV.27: Results of membrane integrity assessment (LDH assay) in A172 cells exposed to 
S-ION in complete and serum-free medium. Bars represent mean ± standard error. PC: positive 
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control (1% Triton X-100). **P<0.01, significant differences compared to the corresponding 
negative control. 
Figure IV.28: Analysis of A172 cell cycle after treatment with S-ION for 3h in complete (upper 
left) and serum-free medium (upper right), or for 24h in complete (lower left) and serum-free 
medium (lower right). Bars represent mean ± standard error. PC: positive control (1.5μM MMC). 
*P<0.05, **P<0.01, significant differences regarding the corresponding negative control. 
Figure IV.29: Late apoptosis (cells in the subG1 region of cell cycle distribution) assessment in 
glial cells treated with S-ION in complete and serum-free medium. Bars represent mean ± 
standard error. *P<0.05, **P<0.01, significant differences compared to the negative control. 
Figure IV.30: Apoptosis induction by exposure of A172 cells to S-ION for 3 and 24h in complete 
and serum-free medium. Bars represent the mean ± standard error. PC: positive control (10μM 
Campt). *P<0.05, **P<0.01, significant difference with regard to the negative control. 
Figure IV.31: Necrosis induction after exposure of A172 astrocytes to S-ION for 3 and 24h in 
complete and serum-free medium. Bars represent mean ± standard error. PC: positive control 
(10μM Campt). *P<0.05, **P<0.01, significant difference with regard to the negative control. 
Figure IV.32: H2AX histone phosphorylation after treatment of glial cells with S-ION in 
complete and serum-free medium. Bars represent mean ± standard error. PC: positive control 
(1μg/ml BLM). *P<0.05, **P<0.01, significantly different from the negative control. 
Figure IV.33: Micronuclei rates in A172 astrocytes after treatment with S-ION in complete and 
serum-free medium. Bars represent mean ± standard error. PC: positive control (15μM MMC). 
**P<0.01, significant differences with respect to the negative control. 
Figure IV.34: Results of interference testing between S-ION (100μg/ml) and comet assay 
methodology in complete and serum-free cell culture medium. Bars represent mean ± standard 
error.  
Figure IV.35: Primary DNA damage in A172 cells after treatment with S-ION in complete and 
serum-free medium. Bars represent mean ± standard error. PC: positive control (100μM H2O2). 
*P<0.05, **P<0.01, significant differences with regard to the corresponding negative control. 
Figure IV.36: Effects of S-ION on repair of H2O2-induced DNA damage in astrocytes in 
complete and serum-free medium. Incubation with 50µg/ml S-ION was performed independently 
prior to exposure to 200µM H2O2 (phase A, for 3 or 24h), simultaneously with H2O2 (phase B), 
or during the repair period (phase C). Bars represent mean ± standard error. *P<0.05, **P<0.01, 
significant difference with regard to the same treatment before repair. 
Figure IV.37: Analysis of iron ion release from O-ION in complete and serum-free cell culture 
medium. Bars represent mean ± standard error. 
Figure IV.38: Transmission electron micrographs of A172 cells incubated with 100µg/mL of O-
ION in complete medium for 3h (a) and 24h (b), and in serum-free medium for 3h (c) and 24h 
(d), showing nanoparticle internalization. Bar sizes are 0.2μm in (a) and (b), and 1μm in (c) and 
(d). 
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Figure IV.39: Results of membrane integrity assessment (LDH assay) in A172 cells exposed to 
O-ION in complete and serum-free medium. Bars represent mean ± standard error. PC: positive 
control (1% Triton X-100). *P<0.05, significant differences compared to the corresponding 
negative control. 
Figure IV.40: Analysis of A172 cell cycle after treatment with O-ION for 3h in complete (upper 
left) and serum-free medium (upper right), or for 24h in complete (lower left) and serum-free 
medium (lower right). Bars represent mean ± standard error. PC: positive control (1.5μM MMC). 
*P<0.05, **P<0.01, significant differences with regard to the corresponding negative control. 
Figure IV.41: Late apoptosis (cells in the subG1 region of cell cycle distribution) assessment in 
A172 cells treated with O-ION in complete and serum-free medium. Bars represent mean ± 
standard error. **P<0.01, significant differences compared to the corresponding negative control. 
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free medium. Bars represent the mean ± standard error. PC: positive control (10μM Campt). 
*P<0.05, **P<0.01, significant difference with regard to the corresponding negative control. 
Figure IV.43: Necrosis induction after exposure of A172 astrocytes to O-ION in complete and 
serum-free medium. Bars represent mean ± standard error. PC: positive control (10μM Campt). 
*P<0.05, **P<0.01, significant difference with regard to the corresponding negative control. 
Figure IV.44: H2AX histone phosphorylation after treatment of A172 cells with O-ION in 
complete and serum-free medium. Bars represent mean ± standard error. PC: positive control 
(1µg/ml BLM). *P<0.05, **P<0.01, significantly different from the corresponding negative 
control. 
Figure IV.45: Micronuclei rates in A172 cells exposed to O-ION in complete and serum-free 
medium. Bars represent mean ± standard error. PC: positive control (15µM MMC). **P<0.01, 
significant differences with respect to the corresponding negative control. 
Figure IV.46: Results of interference testing between O-ION (100μg/ml) and comet assay 
methodology in complete and serum-free cell culture medium. Bars represent mean ± standard 
error. 
Figure IV.47: Primary DNA damage in A172 cells treated with O-ION in complete and serum-
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Figure IV.48: Effects of O-ION on repair of H2O2-induced DNA damage in A172 cells in 
complete and serum-free medium. Incubation with 50µg/ml O-ION was conducted independently 
prior to exposure to 200µM H2O2 (for 3 or 24h, phase A), simultaneously with H2O2 (phase B), 
or during the repair period (phase C). Bars represent mean ± standard error. *P<0.05, **P<0.01, 
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1. NANOTECHNOLOGY AND NANOMATERIALS 
Nanotechnology is the understanding and control of matter at dimensions of roughly 1-
100nm, where unique phenomena enable novel applications. A nanometer is 10-9 of a meter; a 
sheet of paper is about 100,000nm thick. Encompassing nanoscale science, engineering and 
technology, nanotechnology involves imaging, measuring, modelling, and manipulating matter at 
this length scale. At this level, the physical, chemical and biological properties of materials differ 
in fundamental and valuable ways from both the properties of individual atoms and molecules or 
bulk matter. Nanotechnology is directed toward understanding and creating improved materials, 
devices and systems that exploit these new properties. An engineered nanomaterial may then be 
defined as any intentionally produced material that has a characteristic size from 1 to 100nm in at 
least one dimension. Because of this very small size and the resultant high surface to volume ratio, 
nanomaterials exhibit properties that are different from larger-sized materials of the same 
chemical composition (Landsiedel et al., 2012). The unique properties of nanotechnology 
originate from:  
• Small dimensions, enabling high speed and high functional density (nanoelectronics, 
lab-on-chip), small and lightweight devices and sensors (smart dust), high sensitivity 
(sensors, nanowires) and special surface effects. 
• Very large surface area, providing reinforcement and catalytic effects; quantum effects, 
such as highly efficient optical fluorescent quantum dots. 
• New molecular structures, with new material properties: high strength nanotubes, 
nanofibers and nanocomposites.  
Nanotechnology is a rapidly expanding area which has highly promising prospects for 
turning fundamental research into successful innovations, currently reaching 3037 inventoried 
consumer products containing nanomaterials (http://nanodb.dk/, consulted on September 4th, 
2018). Not only to boost the competitiveness of our industry but also to create new products that 
make positive changes in the lives of our citizens, be it in medicine, environment, electronics or 
any other field, nanosciences and nanotechnologies open up new avenues of research and lead to 
new, useful, and sometimes unexpected applications (Simonis and Schilthuizen, 2006). 
Nanotechnology has taken advantage of most of the new properties and so has expanded into 
various domains from industrial applications (e.g., which may lead to stronger and lighter building 
materials) and biomedical uses (e.g., as new tools for the diagnosis and treatment of diseases) to 
commercially available consumer products including transparent sunscreens, stain resistant 
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clothing, self-cleaning glass, paints, sport equipment, etc. (Figure I.1) (Buzea et al., 2007; Card 
et al., 2008; Amstad et al., 2011; Vance et al., 2015; Long et al., 2015; Bobo et al., 2016). 
Figure I.1. Distribution of nanotechnology products into the major categories of the 
commercial marketplace (data source from www.nanodb.dk/; August 2018). 
 
The development of nanotechnology has resulted in a growing public debate on the 
toxicity and environmental impact of nanomaterials. The reduction in size provides greater 
bioavailability as compared to the bulk material, leading to enhanced absorption of nanoparticles 
in biological systems (Das et al., 2009). Living organisms are made of cells that usually range 10 
to 100nm. However, cellular parts are much smaller, and proteins are even smaller with a typical 
range of just 5 to 50nm (Figure I.2). These size differences enable the potential use of 
nanoparticles as very small probes to directly observe cellular machinery without too much 
interference (Taton, 2002; Salata, 2004); however, nanomaterials can also interact with cellular 
components and induce toxic effects. Indeed, particle toxicology suggests that, for toxic particles 
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Figure I.2. Nanoscale integration of nanoparticles and biomolecules (from Saallah 
and Lenggoro, 2018). Schematic representation of a scale bar to visualize the range 
of nanomaterials and nanosystems as compared with biological components. 
 
With the increased applications of nanotechnology products, especially for biomedical 
purposes, concerns regarding the onset of unexpected adverse health effects following exposure 
have been also raised. Understanding of toxicological profiles of engineered nanomaterials is 
necessary in order to ensure that these materials are safe for use and are developed responsibly, 
with optimization of benefits and minimization of risks. Nevertheless, development and 
production of engineered nanomaterials are increasing faster than generation of toxicological 
information (Figure I.3). This lack of information on possible adverse effects of nanomaterials 
has been taken into consideration by many organizations worldwide such as the US 
Environmental Protection Agency (EPA), the World Health Organization (WHO), the US 
National Institute for Occupational Safety and Health (NIOSH), the European Commission (EC) 
and the Organization for Economic Co-operation and Development (OECD). Official documents 
have been prepared by these organizations addressing the need of dedicated research on 
appropriate methodological assays for assessing engineered nanomaterial toxicity (Colognato et 
al., 2012).  
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Figure I.3. Toxicological and hazard profile for humans of consumer products 
containing engineered nanomaterials present in marketplace (data source from 
www.nanodb.dk/; August 2018). 
 
Consequently, starting in the early 2000s, concerns about the potential human and 
environmental health effects of nanomaterials were being expressed by many scientists, 
regulators, and non-governmental agencies. Indeed, as a proof of the growing interest on this 
topic, the number of scientific articles published on ‘nanotoxicity’ or ‘nanotoxicology’ increased 
progressively in the last decade (around 2550 until August 2018, according to PubMed database); 
before 2008 it was almost negligible (Figure I.4). 
 
Figure I.4. Number of publications from PubMed database on ‘nanotoxicity’ or 
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2. IRON OXIDE NANOPARTICLES 
Among all engineered nanomaterials, magnetic nanoparticles – made of iron, cobalt, or 
nickel oxides – arouse a particular interest in biomedical field mainly due to their special 
physicochemical features, including their proven biocompatibility and their magnetic properties 
that allow them to be manipulated by an external magnetic field gradient (Gupta and Gupta, 2005). 
Particularly, nanoparticles made of a ferro or ferromagnetic material, i.e., iron oxide nanoparticles 
(ION), can exhibit a unique form of magnetism called superparamagnetism, which appears when 
the ION size is below a critical value – depending on the material, but typically around 10-20nm 
– and when the temperature is above the so-called blocking temperature (Lu et al., 2010). This 
feature, together with their high colloidal stability, and their unique biochemical and catalytic 
properties makes them very attractive for a broad range of technical and biomedical uses (Shah 
et al., 2013; Wu et al., 2015; Gkagkanasiou et al., 2016; Blanco-Andujar et al., 2016). 
From an industrial perspective, ION are frequently used in building materials, as pigments 
– which are low cost, colorfast, nontoxic and capable of imparting different colors – and as a food 
additive, which fortifies foods without altering their color or taste (Dissanayake et al., 2015). 
However, the most promising uses of ION are in the biomedicine field. Among others, they have 
applications in magnetic resonance imaging, targeted drug delivery, tumor location and treatment, 
gene therapy, and tissue repair (reviewed in Revia and Zhang, 2016). These biomedical uses, 
which require that nanoparticles are directly introduced in the human body, give rise to concerns 
regarding the potential toxic effects that may be associated with ION exposure. Indeed, clinical 
use of several ION as contrast agents for imaging were already approved by the US Food and 
Drug Administration since 1996 (US FDA) (Reimer and Balzer, 2003; Lu et al., 2007a; Maier-
Hauff et al., 2011; Sharma et al., 2014). Therefore, due to the current and promising biomedical 
uses of ION involving the direct contact with different tissues and organs, studies addressing their 
potential toxicity are especially relevant. Specifically, in the last decade, ION have shown highly 
useful for a number of applications mainly related to diagnosis, drug delivery, and imaging of the 
central nervous system (CNS) for neurovascular, neurooncological or neuroinflammatory 
processes and diseases (Huber, 2005; Kanwar et al., 2012; Ittrich et al., 2013).  
ION are usually made of a crystalline core and a surface coating. Even though technically 
speaking particles larger than 50nm (size of core/shell) ION are classified as superparamagnetic 
iron oxides (SPIO), and particles smaller than 50nm are ultra-small superparamagnetic iron 
oxides (USPIO) (Estelrich et al., 2015), the term ION is usually employed in the literature to 
designate both of them. Likewise, in this memory ION will be used to refer to both types of 
magnetic nanoparticles. ION may present multiple crystallographic structures that include: 
magnetite (Fe3O4), maghemite (γ-Fe2O3), hematite (α-Fe2O3), wüstite (FeO), ε-Fe2O3, and β-
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Fe2O3, among which magnetite, maghemite and hematite are the most commonly used due to their 
polymorphism involving temperature-induced phase transition (Dissanayake et al., 2015). The 
crystalline core of ION, made of ferri- (Fe3+) or ferro- (Fe2+) magnetic material, is generally 
synthesized through protocols with controlled precipitation of iron oxides in organic solution (Wu 
et al., 2013a), or in aqueous solution by adding a base (Mohapatra and Anand, 2010). And, 
specifically, ION manufactured for biomedical purposes, both diagnostics and therapeutics, are 
typically formed by a core of magnetite or maghemite. This crystalline core is usually surface 
modified. Surface modification prevents particle agglomeration, provides biocompatibility, and 
modifies cellular uptake efficiency of ION (Mahmoudi et al., 2009b; Zhu et al., 2012; Mahdavi 
et al., 2013; Wu et al., 2015). 
2.1. Surface modification of iron oxide nanoparticles 
 A common problem associated with nanoparticles is their intrinsic instability over long 
periods of time, since they tend to form agglomerates to reduce the energy associated with the 
high surface area to volume ratio. Moreover, naked nanoparticles introduced into the body can be 
easily trapped by the immune system as foreign materials, which means that they cannot reach 
their desired target (Santhosh and Ulrih, 2013). Furthermore, naked metallic nanoparticles are 
highly chemically active, and are easily oxidized in air, generally resulting in loss of magnetism 
and dispensability (Lu et al., 2007b). In order to minimize these effects, the surface of 
commercially available nanoparticles may be modified by coating with different materials 
including: natural (gelatine, dextran, chitosan, pullulan, etc.) or synthetic (polyethylene glycol 
[PEG], polyacrylic acid, polyvinyl alcohol, etc.) polymeric coatings, inorganic molecules (silica, 
gold, silver, platinum, palladium, iron, carbon, etc.) and numerous biological molecules 
(polypeptides, proteins, antibodies, biotin, etc.) (reviewed in Gupta and Gupta, 2005 and Santhosh 
and Ulrih, 2013). Surface modification often serves multiple purposes (Kim et al., 2012). On one 
hand, it stabilizes nanoparticles in an environment of slightly alkaline pH or high salt 
concentrations. For example, ION coated with silica, which achieves the isoelectric point at pH 
of 2 to 3, are negatively charged at blood pH, helping to avoid aggregate formation in body fluids 
(McBain et al., 2008). On the other hand, surface modification allows biomolecule binding 
favoring surface attachments between ION and antibodies, peptides, hormones or drugs 
(Sadeghiani et al., 2005). The polymer coating significantly increases their overall size, which 
may also be used to modify the toxicokinetic behavior of the particles, since it may limit their 
absorption, tissue distribution, and excretion (Wang et al., 2001; Bjørnerud and Johansson, 2004). 
Moreover, the use of coatings by forming monolayers on the nanoparticle surface, such as stable 
gold or silica shell structures, allows for the application of core materials that would be toxic 
otherwise. 
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Therefore, the iron oxide core is usually covered with a biocompatible coating. While the 
iron oxide core is responsible for the magnetic properties of ION, the ligand coat is essential to 
stabilize ION in physiological media. The choice of coating is mainly determined by the desired 
application concerning functionalization, stability or size, since every material has advantages 
and drawbacks (Petters et al., 2014b). Some of the most commonly used coatings for ION are 
silica, largely used for bioimaging and biosensing purposes (Alwi et al., 2012); oleic acid, suitable 
for lipid-soluble and non-ionic coatings required for applications directed to the brain (Dilnawaz 
and Sahoo, 2015), polyethylene glycol, with good compatibility, favorable chemical properties, 
and solubility (Yu et al., 2012); carboxydextran, used for cell labelling since it provides stability 
and increases intravascular retention time of nanoparticles (Tong et al., 2011); and polyethylene 
imine, used as gene/drug delivery vehicle due to its high cellular uptake (Xia et al., 2009b; Duan 
et al., 2014). Together with this primary coating, targeting efficiency of ION can be further 
improved by employing conjugation biomarkers on their surface such as peptides, antibodies or 
small molecules (Figuerola et al., 2010; Jin et al., 2014). Thus, ION coating has frequently been 
modified with fluorescent dyes for imaging, targeting molecules (Agemy et al., 2011; Kumar et 
al., 2012), drugs or nucleic acids (Krötz et al., 2003; Kumar et al., 2010; Choi et al., 2015).  
The potential of the surface coatings that enable special probing and/or monitoring of 
local physical mechanistic changes at a length scale may greatly assist in improving disease 
detection, monitoring, and treatment (Sun et al., 2008). For this purpose, ION are required to be 
magnetically targeted to a tissue/organ in order to benefit a therapeutic or diagnostic application. 
Moreover, in a study using a number of cell lines it was demonstrated that cellular uptake 
efficiency of ION is dependent on surface coating of the nanoparticles, irrespective of the cell 
line used (Zhu et al., 2012). Hence, a strategy to adjust the cellular uptake efficiency and precision 
of ION is to modify their surface coating. 
Nevertheless, besides providing generally increased biocompatibility and enhancing ION 
properties to be used in biomedical applications, surface coating may also alter ION toxicity 
(reviewed in Singh et al., 2010). Therefore, it is important to carefully monitor the influence of 
surface modifications (chemical nature of coating, presence of functional groups, and net size) on 
ION toxicity, since this great variety of coatings leads to many diverse types of ION with different 
potential action mechanisms and toxic patterns. The use of ION in biomedical research is 
progressively gaining importance, leading to the rapid development of novel ION types. 
Therefore, consequently, a growing number of toxicological studies have now been carried out 
with a great variety of ION, cell types, incubation conditions, etc. However, it is still unclear 
whether ION are generally safe or should be used prudently. 
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2.2. Physicochemical characteristics of ION 
 
Nanoparticle toxicity can be attributed to nonspecific interactions with biological 
structures due to their physical properties (e.g., size and shape) and biopersistence, or to specific 
interactions with biomolecules through their surface properties (e.g., surface chemistry and 
reactivity) (Nel et al., 2009). As mentioned before, the reason for ION to have a great potential 
for industrial and biomedical applications is mainly because of their unique physical and chemical 
properties (Nel, 2006), displaying a complex dependence upon several factors such as their shape, 
size, surface structure, absence/presence of surface coating, and chemical stability (e.g., solubility 
and aggregation) (Sakulkhu et al., 2014; Sutariya et al., 2016). These potential uses of ION have 
raised concerns regarding their impact on biological response in living organisms and the 
environment at large (Pettitt and Lead, 2013). Therefore, it is highly difficult to correlate the 
biological response observed (overall potential toxicity) with their intricate physicochemical 
characteristics. Hence, carrying out an exhaustive physicochemical characterization for a proper 
interpretation of the potential ION toxic effects is crucial (Podila and Brown, 2013).  
The nanometric size is one of the main physicochemical features that make nanoparticles 
different from same bulk material. Decreases in size open the potential for crossing the various 
biological barriers within the body [e.g., blood-brain barrier], since the mobility, potential 
transport across cellular membranes, and availability of the nanoparticles in the biological 
environment increase (De Jong and Borm, 2008). Also, as a direct consequence, while the size of 
a nanoparticle decreases, its surface area increases (Figure I.5), which determines the potential 
number of reactive groups on the particle surface and therefore it is strongly possible that 
biological activity might increase. This may be one of the reasons why ION are generally 
considered more toxic than larger particles of the same material (Fröhlich et al., 2012). 
Furthermore, as particle size decreases concomitant changes in other physicochemical parameters 
such as crystalline form or oxidation state may be responsible for altered toxicity. Also, for soluble 
nanoparticles, where the ions themselves could be toxic (e.g. Fe2+/Fe3+), increased toxicity may 
result from an increase in particle dissolution with decreasing size and increasing specific surface 
area (Pettitt and Lead, 2013). Therefore, size seems to be an important indicator of potential ION 
toxicity, as different particle sizes have fundamentally different modes-of-action which alter their 
toxicity, persistence and bioavailability, or are responsible for size-dependent changes in other 
physicochemical characteristics. Theoretically, particle size is likely to contribute to cytotoxicity, 
since smaller nanoparticles have a larger specific surface area and thus more available surface 
area to interact with cellular components such as nucleic acids, proteins, fatty acids, and 
carbohydrates (Pettitt and Lead, 2013). The smaller size also likely enhances their ability to cross 
membranes, enter the cell, and causing cellular damage (Huang et al., 2017).  




Figure I.5. The decrease in particle size means a high increase in surface area for 
the same quantity of material, (from 
www.bbc.co.uk/staticarchive/1ba786c30a635037b6a1fc3d8a992d477c68bbc9.jpg) 
 
Nano-scale materials are known to have various shapes and structures such as spherical, 
oval, cubic, prism, helical, needle-like, tubes, platelets, etc. (Colognato et al., 2012). The shape 
of nanomaterials may have effects on the kinetics of deposition and cellular uptake mechanisms 
(Lai, 2015). Particularly, ION usually present spherical shapes, which was reported to be taken 
up by cells 500% more efficiently than rod-shaped particles of similar size (Verma and Stellacci, 
2010). As in the case of size, particles may also have a ‘shape distribution’, depending on the 
state of dispersion of the nanoparticle system, and interactions with the different moieties of the 
surrounding medium that may contribute to the behavior and biological responses of ION. This 
important factor derived from surface properties of nanoparticles and refers to the relative number 
of single particles in a suspending medium in comparison to agglomerates/aggregates (Powers et 
al., 2006). These agglomerates/aggregates may be formed directly from attractive interparticle 
forces (e.g., Van der Waals and hydrophobic interactions) or through the binding of molecules in 
the surroundings (e.g., polymers, proteins, polysaccharides) (Powers et al., 2007). The smaller 
the nanoparticle, the stronger the interparticle forces that attract them. Thus, they might 
agglomerate/aggregate into vastly different shapes and sizes, which may also profoundly change 
the dynamics and properties of the resultant potential hazards (Maynard et al., 2011; Shin et al., 
2015). 
There is a wide variety of methods for determining nanoparticle size, size distributions, 
and hydrodynamic size, including dynamic light scattering (DLS), differential mobility analysis, 
time of flight mass spectroscopy, transmission electron microscopy (TEM), and surface area 
measurements, among many others. Microscopy is one of the most powerful techniques and is 
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often relied on exclusively to provide valuable information regarding size, shape, and morphology 
(Powers et al., 2007).  
Surface characteristics affect how nanoparticles react with other biological entities in 
solution through attractive and repulsive electrochemical forces. In particular, hydrophobicity, 
surface charge, and charge distribution have been demonstrated to influence nanoparticle fate and 
behavior in an organism (Teske and Detweiler, 2015). Most nanoparticles are poorly soluble and 
persistent to interaction with biological systems. However, dissolution of some nanoparticles 
occurs in culture medium or biological fluids, and cellular uptake, subcellular localization, and 
toxic effects can be affected by their solubility (Lai, 2015). For instance, dissolved and non-
dissolved nanoparticles have been shown to have different cellular uptake pathways and 
cytotoxicity due to their differing ability in releasing the toxic ions (Xia et al., 2009a). Under 
aqueous conditions, ION nanoparticles dissolution can induce higher cytotoxicity and apoptosis 
in mammalian cells than non-dissolved ION due to the release of ions and the production of 
reactive oxygen species (ROS) and oxidative stress (Jeng and Swanson, 2006; Xia et al., 2009a). 
Also, the surface properties of nanoparticles are as fundamental as the other key characteristics 
that dictate internalization. For some biomedical applications of ION, high circulation time in the 
body is required for the nanoparticles to recognize their specific target of interest. Biomolecules 
adsorbing to the surface of hydrophobic ION decrease circulation time by initiating the immune 
response cascade which allows phagocytosis of the nanoparticles following recognition as foreign 
objects (Saptarshi et al., 2013). Thus, hydrophobicity may instigate redundant interaction with 
plasma proteins, phagocytic internalization, immune cell stimulation and nanoparticle clearance 
(Park et al., 2014; Easo and Mohanan, 2015). Therefore, minimizing the recognition of 
nanoparticles by the reticuloendothelial system and subsequently by the immune system will 
enhance the probability of uptake by the target cells. Hence, recent research is focused on 
modifying conventional hydrophobic nanoparticle surfaces with a hydrophilic protective layer to 
cause steric repulsive forces against plasma proteins and increase the blood circulation half-life 
of targeted nanocarriers (Loh et al., 2012). 
Surface chemistry consists of a wide variety of properties that conduct the way in which 
ION interact with biomolecules and biological systems through their chemical composition. In 
case of presence of surface modification, results on surface chemical composition reflect the 
effectiveness of coating to avoid nanoparticle core dissolution. Electron spectroscopy for 
chemical analysis, x-ray photoelectron spectroscopy (XPS) and secondary ion mass spectroscopy 
have been extensively used for characterizing the surface chemistry of nanoparticles as well as 
correlating biomaterial surface properties with physiological endpoints (Ratner, 1996). In the 
same way, surface charge of nanoparticles has great importance in the induction of biological 
effects, as it is a major factor in determining the particle dispersion characteristics and also 
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influences the adsorption of ions and biomolecules (biomolecular corona), which may change 
how cells react to the nanoparticles (Powers et al., 2006; Baber et al., 2011).  
The surface charges of particulate systems are approximated through zeta potential 
measurements. Zeta potential (measured by DLS) refers to the function of the surface charge of 
the particle and the nature and composition of the surrounding medium in which the particle is 
dispersed. It is a measure of the total electric potential of all ions and nanoparticles in solution, 
and therefore is affected by changing pH, or ionic strength. Zeta-potential measurements range 
from 0 to ±60mV. High readings (>±30mV) suggest increased stability due to increased 
electrostatic repulsion. Lower readings (<±30mV) indicate a tendency to coagulate (aggregate 
and precipitate) (Teske and Detweiler, 2015). 
Differences in physicochemical properties between nanoparticles and larger particles 
determine their behavior and biodistribution in the body following translocation from the portal 
of entry, their cellular interactions, and their effects (Oberdörster, 2010). Thus, the importance of 
the physicochemical properties of the ION (particle size and size distribution, state of 
agglomeration/aggregation, shape, crystalline structure, chemical composition, surface area, 
surface chemistry and surface charge) is highlighted to understanding the toxic effects on cells 
(Yang et al., 2010). 
2.3. Iron ion release 
Due to iron capacity to switch between ferric (Fe3+) and ferrous (Fe2+) ionic forms by 
easily accepting and donating electrons (reduction-oxidation reactions), it plays a critical role in 
important organic metabolic pathways such as cytochrome P450 function, mitochondrial 
oxidative phosphorylation, oxygen transport, DNA synthesis, and energy production (Shander et 
al., 2009). Once surface coatings degrade, the iron oxide core can be metabolized easily and free 
iron released from ION, which can be transported by proteins like ferritin, transferrin, and 
hemosiderin (Santhosh and Ulrih, 2013) from the endocytic compartment (Soenen and De 
Cuyper, 2010) and incorporated into the body iron pool (Almeida et al., 2011; Lin et al., 2015). 
Nevertheless, as excess of this metal can be very toxic, iron levels in the organism are strictly 
controlled. Thus, ION exposure caused elevated intracellular iron concentrations in a variety of 
cells, dependent on the dose (Geppert et al., 2009, 2011; Rosenberg et al., 2012; Paolini et al., 
2016). Therefore, the normal body capacity to manage iron should be taken into account when 
considering administration of high or frequently repeated doses of ION (Kunzmann et al., 2011). 
Apart from nanoparticle exposure characteristics, also cell features can influence ION 
effects since, depending on cell type, iron ions released from ION can be harmless for cells 
(Geppert et al., 2009, 2011; Rosenberg et al., 2012), induce cytotoxicity (Singh et al., 2010), or 
even be used by cells for their own metabolism, as it was observed for oligodendroglial OLN-93 
Natalia Fernández Bertólez 
14 
 
cells (Hohnholt et al., 2010a, 2011). A possible explanation is that, under normal conditions, iron 
released from ION can be accumulated in cells where it is stored as an iron-ferritin complex to 
annul the high toxicity associated with free iron (Singh et al., 2010; Hohnholt and Dringen, 2013). 
Hence, this storage likely contributes to high cell resistance to iron toxicity and is especially 
relevant in the nervous tissue, since even the prolonged presence of large amounts of accumulated 
ION does not harm these cells. On this regard, a review on ION uptake and metabolism in brain 
astrocytes suggests that the efficient uptake of extracellular iron (released slowly from ION) by 
astrocytes, as well as their strong up-regulation of the synthesis of ferritin contribute to the high 
resistance of these cells to iron toxicity (Hohnholt and Dringen, 2013). So, astrocytes deal well 
with an excess of iron and protect the brain against iron-mediated toxicity. These results are 
supported by recent findings showing that astrocytes, and also neurons, are more resistant against 
acute ION toxicity, likely due to a slow transfer of internalized nanoparticles into the lysosomal 
compartment, required for iron ion release from ION (Petters et al., 2016). However, under 
pathological conditions (such as cancer, atherosclerosis, hypertension or arthritis) iron may 
effectively be released from ferritin leading to increased oxidative damage and causing cellular 
toxicity (Reif, 1992; Valko et al., 2007). 
2.4. Exposure and kinetics 
Growing commercialization of nanomaterials in last years, and particularly ION 
successfully translated to the clinic, substantially increase the potential human exposure to these 
materials. As their toxicity is generally related to their abundance and persistence, the effective 
dose, and the duration of the exposure, a systematic and comprehensive analysis is essential 
(Yoshioka et al., 2014). 
Accidental or intentional exposure routes to nanomaterials may include inhalation (Kwon 
et al., 2014), ingestion (Wang et al., 2010), or dermal uptake (Lorenz et al., 2011). In addition, 
for medical purposes parenteral, systemic or local administration must be considered (Kim et al., 
2006) (Figure I.6). Examples for unintentional exposures to ION include emissions from 
anthropogenic sources into air (power plants, incineration, internal combustion engines, 
occupational settings), water and soil (households, effluents from manufacturing sites) or 
consumer goods (textiles, cosmetics); intentional exposures occur also from biomedical 
applications, food additives, etc. (Oberdörster, 2010). End-product users, occupationally exposed 
subjects, medical patients and the general public may be at risk of adverse effects due to the direct 
contact with the organism (Buzea et al., 2007; Martirosyan and Schneider, 2014; Huang et al., 
2017). Because drugs, cosmetics, and various skin care products contain ION, their contact with 
the skin occurs intentionally as well as accidentally. Furthermore, as the use of nanoparticles in 
food as food additive and in pharmaceuticals is increasing, people in developed countries ingest 
an estimated 1012-1014 manufactured particles per person every day (Mahler et al., 2012). 
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Systemic administration by intravenous injection is the most commonly used approach for 
administration of ION, especially for biomedical uses as magnetic resonance imaging contrast 
agents (Arami et al., 2015). The blood half-life of different types of ION ranges from several 
minutes to several days in rodents, and from 1 hour to 24 hours in humans. Further, blood half-
life values are highly dependent on dose levels of the injected ION (Arami et al., 2015).  
 
Figure I.6. Schematics of human body showing routes of exposure to nanoparticles, 
and potential target organs (modified from Buzea et al., 2007). 
 
One of the most important absorption pathways is the respiratory tract. Inhalation is 
probably the major route for nanoparticles in atmospheric pollutants, combustion-derived 
nanoparticles, and freely dispersible mineral or metal nanoparticles resulting from bulk 
manufacture and handing (Wang et al., 2009). Inhaled nanoparticles are deposited in all regions 
of the respiratory tract; however, larger particles may be filtered out in the upper airways, whereas 
smaller particles reach distal airways (Forbe et al., 2011). After absorption across the lung 
epithelium, they enter the blood and lymph to reach cells in the bone marrow, lymph nodes, 
spleen, heart, brain or any other organ (Basinas et al., 2018). ION can even reach the central 
nervous system and ganglia following translocation via olfactory bulb or sensory nerves existing 
in the nasopharyngeal and tracheobronchial regions of the respiratory tract (Oberdörster et al., 
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2009). Immediately after their administration in vivo, several immunological mechanisms start to 
recognize and collect these foreign particles and direct them to the major elimination pathways 
of the body. Therefore, there is always a competition between the desired distributions of the ION 
in specific target organs and their highly active clearance mechanisms (Arami et al., 2015). 
Knowing the biodistribution and kinetic patterns of administered ION is crucial to enhance they 
the expected functionality in any selected region or organ of the body and to minimize their 
toxicological side effects due to any undesirable kinetic behavior (Veiseh et al., 2010). 
Regardless the absorption pathway, distribution of the nanoparticles in the body is 
strongly dependent on their surface characteristics (Hoet et al., 2004), and varies depending on 
their material, size, presence of coating, and charge. ION are small enough to penetrate very small 
capillaries throughout the body and to translocate across cell barriers. Therefore, they might enter 
cells by various mechanisms and associate with subcellular structures and secondary organs 
(Kettiger et al., 2013). Thus, effects such as inflammation, oxidative stress and molecular cell 
activation are likely to occur not only in the primary organ of entry, but also in secondary target 
organs (Oberdörster et al., 2009). 
2.4.1.  Blood-brain barrier 
Although translocation of nanoparticles to the brain is possible and well-studied in the 
literature under different experimental conditions (Cheng et al., 2010; Shim et al., 2014; Pedram 
et al., 2014; Yemisci et al., 2015; Mc Carthy et al., 2015), the relevance for real-life situations is 
far from clear. Therefore, the evaluation of the potential toxic effects of ION on cells from neural 
origin is required, as specific mechanisms and pathways through which nanoparticles may exert 
their toxic effects remain largely unknown. The brain is probably the best protected organ in the 
human body. Besides the protection against mechanical damage, it is also shielded from possibly 
damaging compounds (circulating pathogens, toxins, and also endogenous signaling substances) 
in the blood by means of structural barriers (Burkhart et al., 2014; Thomsen et al., 2015). The 
blood-brain barrier (BBB) is a structural separation between circulating blood and cerebrospinal 
fluid (CSF) maintained by the choroid plexus in the CNS, which results from the selectivity of 
the tight junctions between endothelial cells in CNS vessels that restrict the passage of solutes 
(Stamatovic et al., 2011). At the interface between blood and brain, endothelial cells and 
associated astrocytes are stitched together by tight junctions (Figure I.7). Endothelial cells restrict 
the diffusion of microscopic objects and large or hydrophilic molecules into the CSF, while 
allowing the diffusion of small hydrophobic molecules (e.g. O2, hormones, CO2). Cells associated 
with the BBB actively transport metabolic products such as glucose across the barrier with 
specific proteins (Yang et al., 2010). Due to their special physicochemical properties, such as size 
or large surface area, ION could cross the BBB and accumulate within the brain, and may cause 
neurotoxicity after reaching the nervous system (Masserini, 2013).  




Figure I.7. Illustration showing the transport of ION though the blood–brain barrier 
and beyond. Step 1: Blood-to-brain endothelium transport: ION are targeted to the 
transferrin receptor on brain capillary endothelial cells. Step 2: Endothelium-to-brain 
transport: Once accumulated inside the brain endothelium, magnetic force is applied 
externally on the cranial surface, which leads to subsequent dragging of the ION 
through the brain endothelial cells, and the basal membrane. This leads to the 
occurrence of the ION inside the brain from where they can meet target neuronal or 
glial cells. BCEC: Brain capillary endothelial cells; N: Neuron; A: Astrocyte; BM: 
Basement membrane; P: Pericyte (modified from Thomsen et al., 2015). 
 
2.5. Toxic effects of iron oxide nanoparticles 
ION have attracted much attention not only because of their superparamagnetic 
properties, which make them suitable for interesting biomedical applications, but also because 
they are thought to have low toxicity to the human body (Jeng and Swanson, 2006; Laurent and 
Mahmoudi, 2011). Thus, in general, ION are classified as biocompatible, mostly due to negative 
results obtained in cytotoxicity studies (Kunzmann et al., 2011). However, absence of cytotoxicity 
does not guarantee that ION pose no risk for use in specific applications, as recent studies report 
different harmful cellular effects including DNA damage, oxidative stress, mitochondrial 
membrane dysfunction, and changes in gene expression as a result of ION exposure in the absence 
of cytotoxicity (reviewed in Singh et al.,, 2010). Hence, criteria to define the toxicity of 
nanoparticles must be clearly defined (Huang et al., 2012), and it has been suggested that terms 
such as “biocompatibility” should be re-evaluated (Singh et al., 2010). Nevertheless, reviews on 
application of magnetic nanoparticles for drug delivery suggested that the possible toxicity of 
ION 
ION 
Natalia Fernández Bertólez 
18 
 
these nanoparticles does not mean that they cannot be applied biomedically, but optimal benefits 
and potential risks need to be identified (Thomsen et al., 2015; Elzoghby et al., 2016).  
2.5.1. Cytotoxicity 
Most studies analyzing ION toxicity are focused on cytotoxic effects of these 
nanoparticles on cell cultures. A number of different cell lines and testing conditions have been 
assessed reporting ION cellular effects at different levels, mainly decrease in viability [by the 
MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay (viability based on 
mitochondrial functionality), and the LDH (lactate dehydrogenase) assay (explained in section 
3.2.1.)], ROS production, and iron ion release, but also apoptosis induction, cell cycle alterations, 
cell membrane disruptions, cytoskeleton modifications, etc. (Figure I.8).  
 
Figure I.8. Reported cellular toxicity induced by ION. ION exposure may lead to 
different cellular toxic effects including impaired mitochondrial function (and, 
consequently, apoptosis), lysosomal damage/dysfunction, cell membrane disruption, 
cytoskeleton disruption, DNA damage and cell cycle alterations. Besides, 
accumulation of high amounts of ION and iron in the cytoplasm leads (in fewer 
cases) to cell death by autophagy. All these effects may be produced by ION not 
only directly, but also indirectly through generation of reactive oxygen species 
(ROS) and iron ion release. Increased ROS levels would lead to enzyme 
depletion/inactivation, protein denaturation, genetic alterations or impacts on cell 
cycle or on cytoskeleton, among others; whereas ion release would cause genomic 
damage, iron imbalance and might eventually result in cell death. ION: iron oxide 
nanoparticles; ROS: reactive oxygen species. 
Magnetite/maghemite combinations have already been approved for clinical use as 
magnetic resonance imaging contrast agents (Gould 2006; Li et al., 2013; Al Faraj et al., 2015). 
Nevertheless, there are some inconsistencies in the literature about the cytotoxicological 
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assessment in different cells and the interpretation of these results. It appears that dose, exposure 
time and cell type are factors affecting the results obtained. For example, iron (II,III) oxide 
nanoparticles induced moderate time- and concentration-dependent cytotoxicity in Vero cells 
after 24h exposure (Szalay et al., 2012), and mild cytotoxicity for either Fe3O4 at mesoporous 
silica composites (Huang et al., 2012) or various ION coated with polyvinyl alcohol on L-929 
fibroblast cells (Mahmoudi et al., 2009a) using the MTT assay. A slight degree of cytotoxicity, 
evaluated by trypan blue exclusion, in human alveolar epithelial A549 cells was also reported for 
Fe2O3 nanoparticles, but not for Fe3O4 nanoparticles (Karlsson et al., 2009). Although in another 
study using L-929 fibroblasts ION modified with different functional groups induced a dose-
dependent reduction in viability (water-soluble tetrazolium salt proliferation assay, WST-8), 
suggesting that ION concentration is more critical for cytotoxicity than any other factor including 
surface modification or size (Han et al., 2011). Nevertheless, ION cytotoxicity was also reported 
to be mainly dependent on nanoparticle size and surface coating (Ying and Hwang, 2010; Rivet 
et al., 2012). Thus, uncoated Fe3O4 nanoparticles were not cytotoxic (trypan blue exclusion 
assay), while oleate-coated Fe3O4 nanoparticles were cytotoxic in a dose-dependent manner, and 
intrinsic properties of sodium oleate were excluded as a cause of the toxic effect (Magdolenova 
et al., 2013). Furthermore, a comparative cytotoxicity study (measuring intracellular enzymatic 
activity with calcein-AM and membrane disruption with ethidium homodimer-1) in a human 
cervical cancer cell line (HeLa) and an immortalized normal human retinal pigment epithelial cell 
line (RPE) indicated that, although uncoated magnetite nanoparticles at a high concentration 
(0.40mg/ml) were toxic to both HeLa and RPE cells, their cytotoxicity at low concentrations was 
cell-type specific (Li et al., 2012).  
Investigations aimed at using ION-labeled stem cells in regenerative therapies did not 
report cytotoxic effects for these nanoparticles (Au et al., 2009). In addition, no significant 
cytotoxicity in stem cells incubated with ferucarbotran (Resovist, clinically approved 
carboxydextran-coated ION, used as a negative magnetic resonance imaging contrast agent) was 
found (Yang et al., 2011; Bigini et al., 2012). However, several reports have stated that these 
particles can in fact exert large effects on cell wellbeing (reviewed in Soenen and De Cuyper, 
2009). Numerous studies showing cytotoxicity following ION exposure (L-glutamic acid-coated 
ION [Fe2O3], nanomagnetite, palladium-coated magnetite, etc.) relate this effect to mitochondrial 
impairment (membrane depolarization), dose- and time-dependent ROS generation, glutathione 
depletion and inactivation of several antioxidant enzymes and oxidative stress (Auffan et al., 
2008; Buyukhatipoglu and Clyne, 2011; Khan et al., 2012; Zhang et al., 2012; Ahamed et al., 
2013; Malvindi et al., 2014; Dwivedi et al., 2014; Patil et al., 2015; Wang et al., 2017). Other 
authors suggested that modification of the surface coating could mediate the cytotoxicity of ION 
(Hildebrand et al., 2010; Naqvi et al., 2010; Könczöl et al., 2011). Other forms of cytotoxicity 
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reported after ION exposure include cell cycle alterations (Wu and Sun, 2011; Lai et al., 2015; 
Augustin et al., 2016; Periasamy et al., 2016), cytoskeleton alterations (Wu et al., 2008, 2010; 
Cromer Berman et al., 2013), disruption of mitochondrial membrane potential (Dwivedi et al., 
2014; Shukla et al., 2015; Sanganeria et al., 2015; Kermanizadeh et al., 2015), plasmatic 
membrane impairment (Watanabe et al., 2013; Rajiv et al., 2015), apoptosis/necrosis (Berry et 
al., 2004; Kim et al., 2015; Ahamed et al., 2016), autophagy (Schütz et al., 2014; Shi et al., 2015; 
Du et al., 2017), and decreases in cell integrity or viability (Astanina et al., 2014; Costa et al., 
2016). 
Studies regarding the potential cytotoxic effects of ION on CNS are scarce and conflicting 
so far (reviewed in Valdiglesias et al., 2014), and their potential risk on human brain cells have 
raised concern (Braeuer et al., 2015). This is, at least in part, due to the great variety of ION, bare 
or with different coatings, tested. Furthermore, results of toxicity assays available are not always 
comparable since they are influenced by several factors such as the cell type tested (Ding et al., 
2010; Kunzmann et al., 2011), experimental conditions assessed (Pisanic et al., 2007), and 
physicochemical properties of ION (Thorek and Tsourkas, 2008). Indeed, general knowledge 
about ION toxic effects indicates that they mainly depend on nanoparticle size and surface coating 
(Rivet et al., 2012). 
2.5.2. Genotoxicity 
A number of in vitro studies have evaluated the effects of ION exposure on the genetic 
material (reviewed in Dissanayake et al., 2015). Different kinds of DNA damage, including strand 
breaks (Hildebrand et al., 2010; Bhattacharya et al., 2011; Han et al., 2011) and micronucleus 
(MN) formation (Singh et al., 2012), induced in cell systems after treatment with ION were 
reported (Figure I.9). Rajiv et al., (2015) observed DNA breaks and chromosome aberrations in 
human lymphocytes exposed to ION (Fe2O3). And Pongrac et al., (2016) observed that ION 
(γFe2O3), uncoated or coated with d-mannose or poly-L-lysine, induced DNA damage (also 
evaluated by comet assay) in murine neural stem cells irrespective of the surface coating. In this 
case, lower doses of any ION induced heavier DNA damage, and the lack of genotoxic effects at 
higher doses was explained by the aggregation behavior of ION at such concentrations. In 
agreement with these studies, Cicha et al., (2015) evaluated the levels of H2AX phosphorylated 
(γH2AX), as indicative of DNA double strand breaks, in human primary tubular epithelial cells 
exposed to lauric acid-coated ION functionalized with mitoxantrone. They observed a significant 
increase in γH2AX foci upon treatment. Other studies describe positive genotoxic effects as well: 
in the comet assay and MN test in A549 alveolar cells treated with bare nanomagnetite (Könczöl 
et al., 2011); in DNA damage in murine L-929 fibroblast cells treated with ION coated with (3-
aminopropyl) trimethoxysilane (APTMS), tetraethyl orthosilicate (TEOS)-APTMS, or citrate 
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(Han et al., 2011); in primary and oxidative DNA damage in human lymphoblastoid TK6 cells 
and primary human leukocytes exposed to oleate-coated nanomagnetite (Magdolenova et al., 
2013); in the comet assay in human IMR-90 lung fibroblasts and human BEAS-2B bronchial 
epithelial cells exposed to hematite (Bhattacharya et al., 2009); and also in DNA damage in both 
skin epithelial A431 and lung epithelial A549 cells treated with smooth nanomagnetite (Ahamed 
et al., 2013). MN induction was also observed in human MCL5 lymphoblastoid cells treated with 
dextran-coated γFe2O3 nanoparticles (Singh et al., 2012). 
Figure I.9. Reported ION-induced genotoxic effects. ION may cause DNA damage 
through direct interaction with the DNA structure or result in the generation of 
oxidative radicals that in turn have the potential to indirectly cause DNA damage, 
mainly through base oxidation (mostly 8-OHdG). Consequently, ION exposure may 
induce genotoxic clastogenic or aneugenic effects. 8-OHdG: 8 
hydroxydeoxyguanosine; ION: iron oxide nanoparticles; ROS: reactive oxygen 
species; DSB: double strand breaks; SSB: single strand breaks. 
 
Opposite to these findings, studies showing negative results for ION genotoxicity are 
more frequent. Couto et al., (2015) demonstrated absence of ION effects on the genetic material 
of human T-lymphocytes, reporting no chromosome aberrations in cells treated with polyacrylic 
acid-coated and uncoated nanomagnetite. Similar absence of genotoxicity was described by 
Magdolenova et al., (2013) in human lymphoblastoid TK6 cells treated with uncoated 
nanomagnetite, and Paolini et al., (2016) reported no genotoxicity or carcinogenicity for 
rhamnose-coated ION (magnetite) on mouse fibroblast Balb/c-3T3 cells. Some other works 
showed negative genotoxicity results (i.e. no induction of primary DNA damage and no increase 
in MN frequency) in many cell types exposed to different ION (Auffan et al., 2006; Karlsson et 
al., 2008, 2009; Guichard et al., 2012; Singh et al., 2012; Zhang et al., 2012). Two independent 
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studies also evaluated the mutagenic potential of ION [AMI-25 ION (Weissleder et al., 1989), 
and ferumoxtran-10 (Bourrinet et al., 2006)] by means of the Ames test with negative results as 
well.  
Short term in vitro genotoxicity tests may be prone to overestimating the in vivo 
genotoxicity of ION. Although in vivo genotoxicity studies are time-consuming, expensive and 
involve ethical issues and complex procedures (e.g., toxicokinetic processes), they have an 
obvious advantage over in vitro tests. Although there are insufficient in vivo studies in literature 
on genotoxic effects of ION, the available ones provide important insight into potential in vivo 
genotoxicity. In particular, (Yang et al., 2012) exposed Kunming mice to Fe3O4 nanoparticles via 
intraperitoneal injection in order to determine the potential safe dose range for medical use. The 
results indicated that ION are easily able to pass across the intestinal barrier and although they 
mainly accumulated in the liver, spleen, kidney, heart and bone marrow, the exposure did not 
induce genotoxicity in leukocytes (evaluated by the comet assay), chromosome aberrations in 
bone marrow cells, or MN in either of these cell types. Contradictory results were also observed 
among studies evaluating MN frequency in bone marrow cells of mice exposed in vivo to ION: 
positive results were obtained by Freitas et al., (2002) and Sadeghiani et al., (2005), while 
negative results were shown by Bourrinet et al., (2006), Estevanato et al., (2011) and Wu et al., 
(2010). 
Hence, given the general lack of consistence in the available results from in vitro and in 
vivo studies of ION genotoxicity, even at similar doses, further investigations are required to 
determine the specific mechanisms underlying the effects on the genetic material induced by these 
nanoparticles. 
2.5.3. Neurotoxicity 
ION have been shown to display the ability to cross the BBB after oral (Wang et al., 
2010), inhalatory (Kwon et al., 2014), and intraperitoneal (Kim et al., 2006) administration, and 
to directly reach the brain through the olfactory nerve after intranasal installation (Wang et al., 
2011). This ability makes them especially eligible for medical purposes on nervous system, such 
as drug delivery and imaging diagnostics, but also potentially harmful for this system. Hence, a 
special attention must be payed to the nervous tissue physiology and behavioral outcomes in 
animal studies. Most studies reported so far on the consequences of in vitro exposure of nervous 
system cells to different uncoated and coated ION have been performed in nervous system cells 
from different origin, particularly PC12 rat cells (Wu and Sun, 2011; Wu et al., 2013b; Deng et 
al., 2014), SH-SY5Y human cells (Imam et al., 2015), mouse c17.2 neural progenitor cells 
(Soenen et al., 2012), chick cortical neurons (Rivet et al., 2012), culture brain microglial cells 
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(Luther et al., 2013; Petters et al., 2016), oligodendroglial OLN-93 cells (Petters et al., 2014a), 
primary rat cerebellar granule neurons (Petters and Dringen, 2015), and endothelial cells 
(Kenzaoui et al., 2012a, b), but scarcely in human neurons or glial cells.  
Nevertheless, unlike the considerable amount of studies addressing in vitro effects of ION 
on nervous system cells, the number of in vivo studies on potential neurotoxicity of these 
nanoparticles is quite restricted. For example, the conjugation of the drug daunorubicin with ION 
(oleic acid-capped Fe3O4) nanocomposites for delivery can reduce the neurotoxicity caused by 
this anticancer drug on rat brains in vivo, suggesting a possible application of these nanoparticles 
to lessen the side effects of cancer therapies (Xu et al., 2012). Most of the in vivo studies on ION 
neurotoxicity employed rats as experimental model. Hence, Kumari et al., (2012) observed 
dullness and irritation in Wistar rats after 28 days of oral daily exposure to ION (Fe2O3). 
Moreover, a significant dose-dependent inhibition of total, Na+-K+, Mg2+ and Ca2+-ATPases in 
brain, as well as acetylcholinesterase in brain and red blood cells, were found in exposed animals, 
suggesting that ION exposure may affect synaptic transmission and nerve conduction. Similarly, 
Bourrinet et al., (2006) observed different physiological responses, including signs of polypnea, 
exophthalmos and mydriasis in Sprague-Dawley rats after intravenous treatment of ION 
(ferumoxtran-10), although no neurobehavioral, neurovegetative, or psychotropic effects were 
detected. More recently, Kim et al., (2013) treated Sprague-Dawley rats with different ION 
[dimercaptosuccinic acid (DMSA)-coated maghemite, and DMSA-, PEG- and PEG-Au-coated 
magnetite] by intraneural injection (sciatic nerve); ION caused immune cell infiltration, neural 
inflammation and apoptosis, and induced neural antioxidant response. Wu et al., (2010) detected 
a regional distribution of ION (magnetite) in brain of rats intranasally instilled for seven days. 
ION induced oxidative damage in striatum but not in hippocampus, despite the presence of 
nanoparticles in both regions resulted particularly high. 
Agreeing with these studies in rats, neurotoxicity of ION has been also reported in mice 
and fish. In mice, intranasal administration of Fe2O3 nanoparticles induced pathological 
alterations in olfactory bulb, hippocampus and striatum; microglial proliferation, activation and 
recruitment were also observed in these areas, especially in the olfactory bulb (Wang et al., 2011). 
In addition, mice treated with magnetite nanoparticles by intragastric administration showed less 
activity and a slight loss of appetite (Wang et al., 2010). In fish, dextran-coated Fe3O4 
nanoparticles intraperitoneally administered to adult zebrafish were found to accumulate in brain 
inducing apoptosis and inhibition of acetylcholinesterase in this tissue. Moreover, although no 
alterations in the expression of genes associated with inflammation were observed, increased 
levels of ferric iron and enhanced mRNA levels of caspase 8, caspase 9 and transcriptional factor 
AP-1 in brain of treated animals were also detected (de Oliveira et al., 2014). 
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3. CELLULAR INTERACTION WITH NANOPARTICLES 
3.1. Cellular uptake 
The actual entry of nanoparticles into the cells should be verified prior to toxicity 
evaluation. As it can be seen in Figure I.10, ION may be actively incorporated by cells mainly via 
passive diffusion, clathrin-mediated endocytosis, caveolae-mediated endocytosis, phagocytosis, 
or macropinocytosis (Sahay et al., 2010; Cores et al., 2015). Particles internalized via active 
uptake are commonly transported in vesicular structures that then fuse to result in phagolysosomes 
or endosomes (Kuhn et al., 2014). Sometimes, they might be endocytosed upon pinocytosis. 
Alternatively, they may also be carried to the cytosol, or transported via caveosomes to the 
endoplasmic reticulum, or cross the cell as part of transcytotic processes. Besides active transport, 
smaller nanoparticles may also enter the cell passively via diffusion through the plasma membrane 
(Sahu, 2009). From the cytoplasm they may then gain access to subcellular compartments such 
as the nucleus and mitochondria (Hart and West, 2009). The speed of these processes seems to be 
strongly dependent on the surface properties of the ION and on their in vivo surface modifications 
(e.g., by endogenous proteins or lipids found in surfactant or plasma) (Oberdörster et al., 2005). 
These observations led to the formulation of the “corona” theory, which states that, in a biological 
environment (e.g., surfactant, blood, mucus), the particle surface is covered by biological 
macromolecules (e.g., proteins, lipids) (Jud et al., 2013). This makes ION uniquely suitable for 
therapeutic and diagnostic uses, but it also may leave target organs, such as the CNS, vulnerable 
to potential adverse effects. 
  
Figure I.10. Summary of possible mechanisms used by nanoparticles to enter cells 
and cellular compartments. From left to right, nanoparticles may actively be taken 
up by cells by passive diffusion, clathrin-mediated endocytosis, caveolae-mediated 
endocytosis, via phagocytosis, or macropinocytosis (from Cores et al., 2015). 
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The method of choice determining ION uptake mainly depends on the research question, 
the available analytical devices as well as on the type of ION of interest. Therefore, it is not 
possible to recommend one specific technique for all cases. As well-known from the convincing 
evidence from the literature, physicochemical properties of nanoparticles, such as size, shape, 
composition of the core and surface coating and/or functionalization, have a key role on 
nanoparticle cellular interaction including uptake, intracellular fate and induction of cell response, 
issues that also may require very different analytical methods (Drasler et al., 2017).  
One sensitive and rapid method to determine cellular uptake is flow cytometry (FCM). In 
FCM, single cells pass in a steady stream in front of a laser detection unit that collects the signals 
from a single cell on appropriate detectors. Forward scattering (FSC) light is useful to determine 
the size or volume of the cell, while side-scattering (SSC) is a measure of cellular complexity 
(Shapiro, 1995). The integrated signal from individual cells as measured by FSC and SSC is 
interpreted as either nanoparticle-containing cell or nanoparticle-free cell (Suzuki et al., 2007) 
(Figure I.11). The signal integration increases the sensitivity compared with fluorescence imaging 
methods, but it is not possible to establish the relative location of the nanoparticle in the cell.  
 
Figure I.11. Flow cytometry analysis of nanoparticle uptake in cells: a) light 
scattering by a cell that is not associated with any nanoparticle; b) nanoparticles 
adhere to the cell surface, leading to an increase in forward scatter (FSC) and side 
scatter (SSC); c) nanoparticle internalization by the cell, leading to an increase in 
SSC only; d) FSC/SSC dot plot from FCM analysis with cells no exposed to ION; 
e) FSC/SSC dot plot from FCM analysis showing a high proportion of cells with 
internalized nanoparticles (R2). 




Electron microscopy (EM) techniques (e.g., scanning EM [SEM], focused ion beam 
[FIB]-SEM, transmission EM [TEM]), are among the analytical methods widely used for 
nanoparticle uptake assessment, which can provide an adequate resolution for the quantification 
of absolute nanoparticle number into the cell. An EM micrograph provides the signal of electron 
dense nanoparticles and the biological context which requires interpretation prior to 
quantification. Therefore, computer-assisted counting is often not an option. With increased 
human intervention in the interpretation, observer expectancy effects may affect the accuracy.   
3.2. Cytotoxicity 
3.2.1. Membrane integrity 
In a cellular context, the membranes, which are bilayers of phospholipids, divide different 
intracellular compartments, each of which has specific functions, and whose integrity determine 
the viability of the cell. They also encapsulate the whole cell. In order to facilitate exchanges 
between compartments and/or cells, membranes have to be permeable. The outer cell membrane 
is the cell interface to its external environment and allows selective transport of ions, molecules 
and also nanoparticles (Vasir and Labhasetwar, 2008). It is the ability of membranes to control 
intracellular homeostasis, through selective permeability and transport mechanisms, which makes 
them a vulnerable target for possible damaging effects of nanoparticles. 
Lactate dehydrogenase (LDH) assay, based on determination of LDH release from the 
cytoplasm, is commonly used to determine membrane integrity. It is a widely recommended 
nonradioactive, rapid, very sensitive and safety assay for cytotoxicity testing of cultured cells as 
well as viability testing. LDH is a ubiquitous enzyme present in cytosol of a wide variety of 
organisms. Since LDH is a fairly stable enzyme, it has been widely used to evaluate the presence 
of damage and toxicity of tissue and cells. LDH is released through the altered cell membrane 
following cell death process. After cell membrane damage, LDH is released and thus dead cells 
can be detected.  
3.2.2. Cell cycle 
The cell cycle is the process by which eukaryotic cells duplicate and divide. The cell cycle 
consists of three specific and distinct phases: G1 (Gap 1) during which the cell grows and 
accumulates the energy necessary for duplication; phase S (synthesis) in which cellular DNA 
replicates; and G2 (Gap 2) where cell prepares to divide. Mitosis (M) phase is divided into two 
differentiated stages: mitosis and cytokinesis. During mitosis a parent cell chromosomes are 
divided between two sister cells. In cytokinesis, division of the cytoplasm occurs, leading to the 
formation of two distinct daughter cells. Each phase of the cell cycle is tightly regulated, and 
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checkpoints exist to detect potential DNA damage and allow it to be repaired before a cell divides. 
If the damage cannot be repaired, a cell becomes targeted for apoptosis. Cells can also reversibly 
stop dividing and temporarily enter a quiescent or senescent state, G0. The first checkpoint is at 
the end of G1, making the decision if a cell should enter S phase and divide, delay division, or 
enter G0. The second checkpoint, at the end of G2, triggers mitosis if a cell has all the necessary 
components (Crosby, 2007). 
The most common method for assessing the cell cycle is using FCM to measure cellular 
DNA content. During this process, a fluorescent dye that binds to DNA is incubated with a single 
cell suspension of permeabilized or fixed cells. Since the dye binds to DNA stoichiometrically, 
the amount of fluorescent signal is directly proportional to the amount of DNA. Because of the 
alterations that occur during the cell cycle, analysis of DNA content allows discrimination 
between G1 (2n), S (2n~4n), G2 (4n) and M phases. Briefly, cells are fixed and permeabilized to 
allow the dye(s) enter the cell and to prevent them of being exported out. Staining with the DNA 
binding dye is carried out after cells have been treated with RNase to ensure only DNA is being 
measured. Several data sets, including forward scatter vs side scatter, pulse area vs pulse width, 
and cell count vs. fluorescence, are collected to ensure only single cells are measured 
(Darzynkiewicz et al., 1980; Nunez, 2001). There are a number of important considerations when 
carrying out analysis of cell cycle with FCM data: (1) the forward scatter/side scatter plots are an 
integral part of the analysis and should not be overlooked, since this is how single cells are 
identified; (2) if doublets (when the DNA content of two cells in G1 are recorded as a single G2/M 
event) are allowed in to the analysis, it can lead to over-representation of G2/M; and (3) cellular 
aggregates and flow rates below 1000 cells/second should also be avoided to allow a low sample 
pressure differential to be used, which leads to an optimal coefficient of variance (Cobb, 2013).  
3.2.3. Cellular death 
Apoptosis is a genetically programmed and well-orchestrated mode of cell death that is 
characterized by a series of morphological and biochemical alterations to the cell architecture that 
package a cell up for removal by phagocytic cells, i.e. activation of initiator and effector caspases, 
cellular shrinkage, chromatin condensation, membrane blebbing, loss of mitochondrial integrity 
and DNA fragmentation (Elmore, 2007). Crucially, apoptotic cells are recognized by phagocytes 
and are engulfed before they leak their contents. Thus, apoptosis ensures that when a cell needs 
to be removed from a tissue, this occurs in an orderly manner that minimizes disruption to 
neighboring cells. The major consideration during apoptosis is that intracellular contents do not 
leak into the extracellular space because this could damage surrounding cells, and trigger 
inflammation through release of molecules with immune-activating activity (Favaloro et al., 
2012; Elmore et al., 2016). Most of the biochemical and morphological changes that typify 
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apoptosis are the consequence of activation of a subset of the caspase family of proteases 
(caspases 3, 6, 7, 8 and 9). The caspases operate similar to a controlled demolition squad, 
coordinating the packaging and disposal of cells in a manner that minimizes damage to neighbors 
and the initiation of inflammation (Galluzzi et al., 2015). There are two different proximal 
pathways leading to caspase activation: (1) the extrinsic pathway initiated by binding of a specific 
subset of ligands, such as Fas ligand, to their corresponding receptors at the cell plasma membrane 
surface, via activated cytokine ‘‘death’’ receptors that process initiator caspase 8; and (2) the 
intrinsic pathway initiated through the death receptor after cytosolic release of mitochondrial 
derived cytochrome c (mediated by members of the B-cell lymphoma-2 (Bcl-2) protein family), 
in which initiator caspase 9 is activated. Both pathways terminate with activation of the effector 
caspase, caspase 3, that lead finally to the cell death (Dorn, 2013). The initiation phase is largely 
dependent on cell type and apoptotic stimulus (e.g., oxidative stress, DNA damage, ion 
fluctuations, and cytokines) (Solier and Pommier, 2009).  
Necrosis, as opposed to apoptosis, is a rather passive, unorganized and generally 
uncontrolled process that is caused by a plethora of external stress factors, including extremely 
high concentrations of xenobiotics, and involves the sudden loss of membrane integrity, release 
of extracellular contents, leading to activation of the immune system and extensive inflammation. 
It usually starts with the loss of ion homeostasis, which eventually evokes cell swelling, loss of 
cell plasma membrane integrity, and cell lysis (Maes et al., 2015). Necrosis of cells is irreversible 
and most often results from acute cellular injury that lead to a metabolic breakdown of the cell 
that coincides with rapid depletion of ATP. In contrast to apoptosis, necrosis has not historically 
been considered to be a genetically controlled process that requires energy (Elmore et al., 2016). 
Necrosis is typically not associated with caspase activation, although the exception to this is when 
cell death follows aggressive activation of the inflammatory subset of caspases (caspases 1, 4 and 
5), a mode of cell death termed pyroptosis. Necrotic cell death bears none of the striking features 
that characterize apoptotic cells, such as extensive membrane blebbing and hypercondensation 
and fragmentation of the nucleus. Instead, necrotic cells undergo extensive organelle and cell 
swelling, leading to decondensation of nuclei. Thus, this mode of cell death is relatively easy to 
distinguish from apoptosis on the basis of morphological criteria (Davidovich et al., 2014).  
Methods for measuring apoptosis typically rely on the detection of caspase-dependent 
events, such as exposure of plasma membrane phosphatidylserine, that precede uptake of vital 
dyes such as trypan blue or propidium iodide (PI). Alternatively, the striking morphological 
features of apoptotic cells (such as compaction and fragmentation of the cell nucleus), which are 
also effected through caspase activation, are still highly relevant for methods detecting this mode 
of cell death (Martin and Henry, 2013). Flow cytometry-based methods for assessing apoptosis 
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based upon DNA fragmentation, caspase activation and phosphatidylserine externalization are 
very well-established methods in the field (Henry et al., 2013). Analysis of annexin V/PI double 
staining by flow cytometry is based on the estimation of cell membrane changes during apoptosis 
and ability of the protein annexin V to bind to phosphatidylserine exposed on the outer membrane 
leaflet in apoptotic cells. In viable cells, phosphatidylserine is located in the inner membrane 
leaflet, but upon induction of apoptosis, it is translocated to the outer membrane leaflet and 
becomes available for annexin V binding. However, phosphatidylserine is also appearing on the 
necrotic cell surface. Using a simultaneous combination of annexin V and PI discriminating 
apoptotic from necrotic cells is feasible (Figure I.12) (Jurisic and Bumbasirevic, 2008). 
 
Figure I.12. In normal cells, phosphatidylserines (purple membrane phospholipids) 
are held on the inner layer of the cell membrane, so annexin V does not attach to the 
cells. During early apoptosis, the phosphatidilserines are exposed on the outer layer, 
where they attach to the FITC-labeled Annexin V and stain the cell surface green. 
During late apoptosis, propidium iodide (PI) enters the cell and stains the contents 
red (from https://www.nacalai.co.jp/global/download/pdf/AnnexinV-FITC.pdf). 
3.3. Genotoxicity 
3.3.1. Comet assay 
The single cell gel electrophoresis assay, commonly known as comet assay, is a simple, 
reliable, sensitive and widely used technique to assess DNA damage in single cells (Singh et al., 
1988). The comet assay protocol was originally proposed by Ostling and Johanson (1984) and 
later modified by Singh et al., (1988).  
Depending on the pH employed, the comet assay allows detection of several types of 
DNA damage, such as single and double strand breaks, incomplete excision repair sites, 
crosslinks, and alkali-labile sites (Collins, 2015). The alkaline version of the comet assay is the 
most commonly used. In brief, after embedding in agarose on a microscope slide, cells are lysed 
employing a solution containing a detergent, to remove the membranes, and high salt 
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concentrations, to eliminate the nuclear proteins, leaving nucleoids (residual DNA structures). 
Afterwards, the nucleoids are incubated in an alkaline solution to facilitate DNA unwinding and 
then electrophoresed in alkali. During the electrophoresis, the DNA loops containing breaks relax 
and move away from the nucleoid to the anode due to their negative charge, forming a comet 
shape which is observed by fluorescence microscopy using a suitable fluorescent stain (Figure 
I.13). The more damaged the DNA, the farther migration to the anode. Length and intensity of 
the comet tail is proportional to the number of breaks in the DNA. Not damaged cells will not 
show a tail (Singh et al., 1988). 
Figure I.13. Fluorescence microscopy image of cell nucleoids after comet assay: A) 
not damaged nucleoid, B) mildly damaged nucleoid, C) highly damaged nucleoid. 
 
The comet assay is widely employed to evaluate primary DNA damage. It is used in (i) 
both in vivo and in vitro genotoxicity testing, to screen novel drugs, cosmetics, or chemicals for 
potential carcinogenic properties, (ii) in human biomonitoring, to evaluate the effects of toxic 
agents at DNA level, and its involvement in diseases or individual variations, for instance in DNA 
repair capacity, (iii) in environmental monitoring, as a marker of genetic damage by pollutants, 
and (iv) in basic research into mechanisms of DNA damage and repair (Azqueta and Collins, 
2013; Azqueta et al., 2014). Moreover, some of the most recent applications of the comet assay 
are in the assessment of genotoxic effects of nanomaterials (Collins, 2015). 
Since nanoparticles exhibit unique physicochemical properties, evaluation of their 
potential genotoxic effect is crucial. Genotoxic activities of nanoparticles may be due to direct 
interaction with the DNA, or by secondary damage induced through ROS production (Bowman 
et al., 2012). In the past few years, the comet assay has been extensively used to study genotoxic 
effects of nanoparticles; automated image analysis softwares are commercially available, making 
the use of comet assay simple and effective (Tice et al., 2000). 
3.3.2. γH2AX assay 
Genotoxic insults such as ultraviolet light (UV) exposure, drugs, chemicals, and 
endogenous DNA processes can lead to double strand breaks (DSB) (Mah et al., 2010). When a 
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DSB is produced, a very early cell response occurs. The H2AX variant histones flanking the DSB 
sites are rapidly phosphorylated at the serine 139 residue, leading to the formation of the so-called 
γ-H2AX (Ivashkevich et al., 2012) (Figure I.14). γ-H2AX serves as a platform for the recruitment 
of other DNA repair proteins but also increases DNA accessibility, recruits cohesins that maintain 
the proximity between DNA strands during the repair process, and modulates the checkpoint 
response (Rogakou et al., 1998; Dickey et al., 2009; Carriere et al., 2017). Under normal 
conditions, γH2AX appear within few minutes after the lesion, reach maximum levels after about 
30min and then decline and disappear after approximately 24h (Rogakou and Sekeri-Pataryas, 
1999; Bourton et al., 2012). Therefore, H2AX phosphorylation represents an early event in the 
DNA damage response against DSB and plays a central role in sensing and repairing these lesions 
(Matsuzaki et al., 2010; Scarpato et al., 2013). Due to the severity of this kind of DNA damage, 
cells respond rapidly and massively to nascent breaks in order to locate them in the chromatin and 
repair the damage as quickly and accurately as possible, since erroneously repaired breaks can 
lead to cancer and cell death.  
 
Figure I.14. Representation of H2AX phosphorylation as a response to double 
strand breaks (DSB). ATM, ataxia telangiectasia mutated (modified from Hoeller 
and Dikic, 2009). 
 
Although the use of γH2AX as a genotoxic marker is a good way to identify the genotoxic 
potential of nanoparticles, its use in this field is extremely novel and scarce. The alteration in the 
expression profile of γH2AX induced by nanoparticles may be detected by different techniques 
such as immunohistochemistry, flow cytometry, and western blot. Analysis of 
immunofluorescence γ-H2AX staining by FCM provides an automated high-throughput platform 
that is fast, practical, reliable way to analyze the DSB formation (Toduka et al., 2012), and the 
correlated potential genotoxicity due to nanoparticle exposure (Kumar and Dhawan, 2013; 
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Dissanayake et al., 2015). Besides, FCM evaluation provide tools to take into consideration 
variations due to cell-cycle effects (Watters et al., 2009), and increases considerably the number 
of cells evaluated, diminishing the variability and enhancing the statistical power of the results 
(Sánchez-Flores et al., 2015). 
3.3.3. Micronucleus test 
The study of DNA damage at the chromosome level is an essential part of genetic 
toxicology because chromosomal mutation is an important event in carcinogenesis (Fenech, 
2008). It is known that chromosome aberrations are a direct consequence and manifestation of 
DNA damage, e.g., chromosome breaks due to unrepaired DSB and/or chromosome 
rearrangements from misrepair of strand breaks in DNA (Fenech, 2000). Micronuclei (MN) result 
from acentric chromatids or chromosome fragments, i.e. those lacking a centromere (clastogenic 
events), or whole lagging chromosomes (aneugenic events) that are unable to migrate to the 
mitotic spindle poles and subsequently are not incorporated into either of the daughter nuclei 
(Figure I.15). Therefore, MN can only arise in cells that have undergone cell division (Avlasevich 
et al., 2011; Lukamowicz et al., 2011). MN are nuclear entities independent of the main nucleus, 
numbering anywhere between 1 and 6 per cell, with diameter between 1/3 and 1/16 of the diameter 
of the main nucleus (Botta and Benameur, 2011). 
 
Figure I.15. Representation of MN formation in cells undergoing nuclear division 
(from Fenech et al., 2011). 
 
MN test have emerged as a widespread method for assessing chromosome damage 
because it enables both chromosome loss and chromosome breakage to be measured reliably, and 
hence is a well-established assay for detecting clastogenic and aneugenic compounds 
(Lukamowicz et al., 2011). As an alternative to the traditional MN scoring by microscopy 
(subjective, tedious and time consuming), a first automatic measurement of MN by flow 
cytometry was developed by Nüsse and Kramer (1984) and Nüsse et al., (1994). However, the 
same two technical problems were consistently encountered: (i) the need to remove background 
‘‘noise’’, and (ii) the fact that some subcellular particles were mistakenly scored as MN. Since 
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Nüsse and Kramer (1984) developed a two-step method to improve the separation of small MN 
from the main nuclei, a number of groups attempted to improve the staining or analysis 
techniques, where the exclusion of necrotic and late apoptotic DNA is possible (Avlasevich et al., 
2006; Bryce et al., 2007). Thus, FCM method is also used in genetic toxicology testing, as it adds 
the benefits of automated scoring and low time-consuming measurements (Laingam et al., 2008). 
For nanoparticles as a whole, as well as ION in particular, MN test appear to be one of 
the most popular genotoxicity tests based on the numbers of corresponding reports (Magdolenova 
et al., 2014; Golbamaki et al., 2015). Although the number of studies on ION genotoxicity is 
increasing, some results for the same core chemical composition are inconsistent. They need to 
be confirmed by additional experiments, determining whether they reflect genuine differences 
due to differences in nanoparticle characteristics, such as size, coating, functionalization, etc. 
Another consideration about the in vitro MN assay when applied to nanomaterial hazard 
assessment is that it is highly advisable to use fluorescent DNA dyes for staining the cells, in 
order to avoid falsely identifying nanoparticle agglomerates as MN (Magdolenova et al., 2014). 
3.3.4. DNA repair competence assay 
DNA repair mechanisms are the cell defense system to protect and maintain the genome 
integrity. DNA repair involves three main mechanisms: (i) direct reversal of the damage, (ii) 
excision repair – which according to the type of DNA damage induced could involve three 
pathways: base excision repair, nucleotide excision repair and mismatch repair – and (iii) DSB 
repair, which may be conducted by two routes, depending on the cell cycle phase: homologous 
recombination and non-homologous end joining. Deficiencies in these systems can often promote 
genome instability and directly lead to various human diseases, particularly cancer, neurological 
abnormalities, immunodeficiency and premature aging (Iyama and Wilson, 2013). 
The DNA repair competence assay, or challenge assay, is a cytogenetic method to 
evaluate the effects on the cellular ability to repair the DNA damage induced by different physical 
or chemical agents. Exposure to mutagenic agents can lead to potential genotoxic effects, 
important DNA alterations, as well as cause impairment or interference with the cellular repair 
machinery, increasing the risk of certain diseases such as cancer (Au et al., 2010). Consequently, 
these alterations could reduce the capacity of cells to repair damaged DNA and trigger 
pathological processes. The basis of this in vitro test is that exposure of cells to a certain 
challenging agent can deteriorate their DNA repair machinery, thus decreasing the repair capacity 
of damage induced. Cells are treated in vitro with a known mutagen (e.g. X-rays, bleomycin, 
H2O2) and a subsequent time for repair of the damage induced is allowed. The genetic damage 
induced can be then analyzed through several common genotoxicity tests, such as chromosomal 
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aberrations test, MN test, comet assay, etc. The difference between the damage evaluated before 
and after that incubation time will show the repair capacity of the study cells (Au et al., 2010). 
The use of comet assay to measure DNA damage in the DNA repair competence assay 
provides a powerful tool to detect repair ability. Besides, it offers the advantage of quantifying 
the repair as progress of the DNA damage levels since, in contrast with other cytogenetic 
techniques such as chromosome aberrations, it allows evaluating the damage in different time 
points (i.e., after damage induction and after the incubation period in fresh medium) (Schmezer 
et al., 2001). 
While numerous studies addressed the DNA damage induced by nanoparticles, their 
impact on DNA repair processes has never been specifically approached. Hence, comprehensive 
studies describing the DNA repair processes that could be affected by NP exposure, at the level 
of protein function, gene induction and post-transcriptional modifications, are needed. As well, it 
is quite important filling this gap of knowledge and taking into account the advantages and 
limitations of the different experimental approaches, to finally understand the nanoparticle 
interactions with the genome in an integral manner (Carriere et al., 2017). 
On the basis of what was explained in this memory so far, ION have a number of 
interesting current and potential future applications, especially in the biomedical field. All these 
medical applications require internalization of ION for efficient diagnosis or treatment, leading 
to potential risks associated with exposure. Concretely, development of ION employed in the 
study of CNS pathologies is especially increasing nowadays; however, data on possible 
consequences of exposure of human nervous system cells to ION are still scarce. ION toxicity 
has been demonstrated to vary considerably and also to depend on cell type and physicochemical 
characteristics such as size, shape, presence/type of coating, and stability in biological media. The 
analysis of all data collected in the bibliography so far highlights the lack of consensus in 
establishing the toxicity mechanism associated with ION exposure, mainly due to the high 





















Due to their particular physicochemical properties, iron oxide nanoparticles (ION) have 
great potential for an increasing number of biomedical applications, particularly those focused on 
nervous system. For such applications, ION must be introduced in the human body and be in 
contact with cells and tissues, making the necessity of knowing the potential risk associated to 
nervous system exposure imperative. In this context, the main objective of this work was to assess 
the potential cytotoxicity and genotoxicity induced in neuronal and glial cells by exposure to 
differently coated ION. 
This overall goal will be achieved through the following specific objectives: 
1. To determine the release of iron ions from the ION surface, and to assess the ability of the 
ION to enter the neuronal and glial cells. 
2. To analyse the cytotoxicity associated to ION exposure, in terms of alterations in membrane 
integrity or cell cycle, and induction of cell death. 
3. To examine genotoxic effects related to treatment with ION, determining induction of 
primary DNA damage, double strand breaks, and chromosome aberrations. 
4. To evaluate modifications in DNA repair ability caused by ION in neuronal and glial cells. 
Each one of these objectives will be conducted in SH-SY5Y neuronal cells and A172 glial 
cells (astrocytes), testing two types of ION – coated with silica (S-ION) and with oleic acid (O-
ION) – under a range of experimental conditions including doses, treatment times and 
















III. MATERIALS AND METHODS

III. Materials and Methods  
41 
 
III. MATERIALS AND METHODS 
1. NANOPARTICLES: PREPARATION AND CHARACTERIZATION 
Silica-coated magnetite nanoparticles (S-ION) were synthesized and prepared as stable 
water suspensions (5mg/ml) as described by Yi et al., (2006). Oleic acid coated ION (O-ION) 
were synthesized and prepared as stable water stock suspensions (19mg/ml) as described by Maity 
and Agrawal (2007). 
Particle size and morphology were previously studied by transmission electron microscopy, 
surface chemistry was analysed by photoelectron spectroscopy, while average hydrodynamic size 
and zeta potential of nanoparticles in suspension were determined by dynamic light scattering in 
deionized water, complete and serum-free SH-SY5Y and A172 culture medium (see composition 
below) (Costa et al., 2016). 
Prior to each treatment, a stock suspension (1mg/ml) of each ION was prepared in complete 
or serum-free SH-SY5Y and A172 culture media (see composition below) and ultrasonicated in 
a water bath (Branson Sonifier, USA) for 5min. Serial dilutions were carried out to obtain the 
different test concentrations, and ultrasonicated in water bath for an additional 5min period. 
 2. DISSOLVED IRON CONCENTRATIONS IN THE CELL CULTURE MEDIUM 
In order to determine the iron ions released from ION, nanoparticle suspensions were 
prepared in complete or serum-free SH-SY5Y and A172 cell culture media and incubated for 3h 
and 24h at 37°C in a humidified 5% CO2 environment. After centrifugation at 14,000rpm for 
30min, the liquid medium over the ION solid phase was collected. Flame atomic absorption 
spectroscopy (FAAS) (Thermoelemental Solaar S4 v.10.02) was used to quantify the iron content 
in the supernatant. Complete or serum-free cell culture media without nanoparticles subjected to 
the same experimental conditions were used as negative controls. 
3. CELL CULTURES AND TREATMENTS 
Human neuroblastoma SH-SY5Y cell line was purchased from the European Collection of 
Cell Cultures. These cells were cultured in nutrient mixture EMEM/F12 (1:1) medium 
supplemented with 10% heat-inactivated foetal bovine serum (FBS), 1% antibiotic and 
antimycotic solution, with 1% non-essential amino acids. Human glioblastoma A172 cells were 
obtained from the European Collection of Cell Cultures and grown in a nutrient mixture composed 
of DMEM with 1% L-glutamine, 1% antibiotic and antimycotic solution, supplemented with 10% 
heat inactivated FBS. All ingredients were obtained from Invitrogen. Cells were incubated in a 
humidified atmosphere with 5% CO2 and 37ºC. 
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To carry out the experiments, cells were seeded in 96-well plates (5–6 x104 cells/well) and 
allowed to adhere for 24h at 37°C prior to the experiments. For each experiment, these cells were 
incubated with ION and controls. Concentrations tested were 10, 50, 100 and 200µg/ml when 
treating SH-SY5Y cells, and 5, 25, 50 and 100µg/ml when treating A172 cells, and treatment 
times were 3 and 24h. Previous results from cell viability assays (Costa et al., 2016) were used to 
establish these concentrations and exposure times. The decrease in viability was lower than 30% 
in all cases. Cell culture media were used as negative controls in all experiments. The following 
chemicals were employed as positive controls: camptothecin (Campt) 10μM for apoptosis; Triton 
X-100 1% for lactate dehydrogenase (LDH) assay; mitomycin C (MMC) 1.5μM for cell cycle 
analysis in both cell lines and micronucleus (MN) test in neuronal cells, and 15μM for MN test 
in glial cells; bleomycin (BLM) 1μg/ml for γH2AX analysis, and H2O2 100µM for comet assay 
in both cell types and DNA repair competence assay in SH-SY5Y cells, and 200µM for DNA 
repair competence assay in A172 cells. 
4. CELLULAR UPTAKE 
The potential of the ION to enter the SH-SY5Y neuronal cells was evaluated by following 
the protocol described by Suzuki et al., (2007). Cells were seeded in 96-well cell culture plates. 
After 24h of seeding, the cells were exposed to ION for 3 and 24h. After exposure, the culture 
medium containing nanoparticles was removed and cells were harvested using 0.025% trypsin. 
They were then centrifuged at 250xg for 5min. The supernatant was discarded, and the pellet was 
re-suspended in 0.5ml phosphate buffered saline solution (PBS). The rate of cells containing 
nanoparticles was determined using a FACSCalibur flow cytometer (Becton Dickinson). The 
analysis was carried out based on the size and the intracellular complexity of the cells by 
measuring the forward scatter (FSC) and the side scatter (SSC), respectively. Data were acquired 
from a minimum of 104events per sample using CellQuest Pro software (Becton Dickinson). 
The uptake and intracellular localization of ION in A172 cells were assessed by 
transmission electron microscopy (TEM) coupled with energy-dispersive X-ray spectroscopy 
(EDX) as previously described (Fernández-Bertólez et al., 2018b). Cells were seeded in T25 
flasks and exposed to 25μg/ml and 100μg/ml of ION dispersed in complete and serum-free media 
for 3 and 24h. Negative controls (cells with no exposure to nanoparticles) and positive controls 
(cells exposed to 150µg/ml of TiO2 nanoparticles, Sigma reference 637254) were also included 
in this experiment. After exposure, cells were washed twice with PBS, harvested by trypsinization 
and centrifuged. The pellets were then fixed in 2.5% glutaraldehyde in 0.2M sodium cacodylate 
pH 7.2–7.4 for 2h, post-fixed with 2% osmium tetroxide, dehydrated through graded alcohol 
solutions and embedded in Epon. Ultrathin sections of 100nm were mounted on copper grids and 
contrasted with uranyl acetate and lead citrate and examined with Jeol JEM 1400 transmission 
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electron microscope, equipped with an energy dispersive X-ray (EDX) spectrometer (Oxford 
Instruments). Digital images were captured by using a CCD digital camera Orious 1100W. 
5. CYTOTOXICITY 
5.1. Membrane integrity 
A commercial kit (Roche Diagnostics Corp) was used to measure the LDH release in cell 
culture media, according to the manufacturer’s instructions. After exposure, cell culture medium 
was collected for LDH measurement. Absorption was measured at 490 nm with a reference 
wavelength of 655 nm using a Cambrex ELx808 microplate reader (Biotek, KC4). Positive 
control experiments were performed with 1% Triton X-100 and set as 100% cytotoxicity. LDH 














where [A]sample, [A]medium, [A]positive control denote the absorbance of the sample, 
medium negative control and Triton X-100 positive control, respectively. 
 5.2. Cell cycle 
 In order to examine the cell distribution along the different phases of the cell cycle, the 
relative cellular DNA content was evaluated by means of flow cytometry as previously described 
by Valdiglesias et al., (2011). Specifically, after treatments with each ION or positive control 
(MMC), cells were trypsinized and suspended in PBS. Then cells were centrifuged, washed with 
PBS and fixed with cold (-20ºC) 70% (V/V) ethanol. Then, fixed cells were stored overnight at 
4ºC. Next, for analysis, cells were centrifuged, re-suspended in PBS containing 0.1μg/ml RNase 
A and 40μg/ml propidium iodide (PI) and incubated at 37ºC in the dark for 30min. 
Samples were kept in ice prior to analysis. The analysis was performed using a 
FACSCalibur flow cytometer (Becton Dickinson). A minimum of 104 events were acquired, and 
the DNA content was assessed from the PI signal detected by the FL2 detector. In order to obtain 
information on the percentage of cells at G0/G1, S and G2/M regions, cell cycle histograms were 
evaluated using Cell Quest Pro software (Becton Dickinson). Complementarily, subG1 region of 
the cell cycle distribution was also evaluated, as indicative of the late stages of apoptosis. 
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 5.3. Apoptosis and necrosis 
BD Pharmingen™ Annexin V-FITC apoptosis detection kit was used to measure apoptosis 
cell death that may be potentially induced by ION treatment, by means of flow cytometry. 
Additionally, late apoptosis/necrosis was determined as the percentage of annexin V+/PI+ cells. 
Annexin V-fluorescein isothiocyanate (FITC)/PI double staining was carried out with BD 
Pharmingen™ Annexin V-FITC apoptosis detection kit I (Becton Dickinson), following the 
manufacturer’s protocol using flow cytometry. Contents of the kit are as follows: (i) annexin V-
FITC conjugate: 50µg/ml in 50mM Tris-HCl, pH 7.5, containing 100mM NaCl; (ii) PI solution: 
100µg/ml in 10mM potassium phosphate buffer, pH 7.4, containing 150mM NaCl; (iii) 10X 
binding buffer: 100mM HEPES/NaOH, pH 7.5, containing 1.4M NaCl.  
After treatments with ION or Campt as positive control, cells were harvested with 0.025% 
trypsin, suspended in PBS and centrifuged at 300xg for 5min at room temperature. After 
centrifugation, supernatant was removed, and pellet was re-suspended in 200µl of 1X binding 
buffer, and 5μl of annexin V-FITC and 5μl of PI were added to each sample; then the samples 
were incubated at room temperature in the dark for 15min. Analysis was done immediately using 
a FASCalibur flow cytometer (Becton Dickinson). Events for annexin V-FITC were recorded 
from FL1, and events for PI were taken from FL2. Data were acquired from a minimum of 104 
events per sample using Cell Quest Pro software (Becton Dickinson). Early apoptosis was 
expressed as percentage of annexin V+/PI− cells. 
6. GENOTOXICITY 
6.1. Micronucleus test 
Micronucleus (MN) frequency was evaluated by flow cytometry following the protocols 
reported by Nüsse et al., (1994) and Roman et al., (1998), with some modifications (Valdiglesias 
et al., 2011). After the predetermined exposure of cells to each type of ION and positive control 
(MMC), cell culture medium was removed, and cells were cultured for an additional period of 
24h for SH-SY5Y cells and 48h for A172 cells in fresh medium, time determined on the basis of 
cell cycle duration. Then, cells were trypsinized at 0.025% and suspended in PBS. After 
centrifugation, the supernatant was removed and 0.25ml cold solution (4ºC) containing NaCl 
(10mM), trisodium citrate (1g/l), and nonidet P40 (0.3mg/l) was added to each tube alongside 5µl 
of 50μg/ml PI and 1.25µl of 0.05mg/ml RNase A. After the incubation of samples in the dark at 
room temperature for 15 min, a second solution consisting of citric acid (1.5mg/l) and sucrose 
(0.25M) was added and incubated for 30min. Subsequently, a suspension of nuclei and MN was 
prepared by filtering through a 50μm nylon mesh. The final suspension of nuclei and MN was 
analysed with a FACSCalibur flow cytometer (Becton Dickinson). PI-associated fluorescence 
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emission was collected in the FL2 channel. The frequency of MN was calculated using Cell Quest 
Pro software (Becton Dickinson), based on the acquisition of at least 5x104 events. 
 6.2. γH2AX assay  
The evaluation of H2AX histone phosphorylation was performed following the general 
protocol proposed by Tanaka et al., (2009). After the exposure to each type of ION and positive 
control (BLM), cells were trypsinized at 0.025% and suspended in PBS. After centrifugation and 
removal of supernatant, cells were incubated with 1% p-formaldehyde for 15min at 4ºC. Then, 
the samples were centrifuged, and the supernatant was removed. Next, samples were incubated 
overnight at 4ºC with 1ml of cold (-20ºC) ethanol 70% (V/V). The following day, samples were 
washed with PBS and 100µl anti-γH2AX antibody labelled with Alexa Fluor® 488 [1:20, 1% 
bovine serum albumin in PBS] was added and incubated for 15min at room temperature. Next, 
samples were washed in PBS, supernatant was removed, and 500µl PBS containing PI (40µg/ml) 
and RNase A (0.1μg/ml) were added and incubated for 30min at room temperature. Finally, a 
minimum of 104 events were acquired with a FACSCalibur flow cytometer (Becton Dickinson). 
Data obtained from Alexa Fluor 488 (FL1) and PI (FL2) were analysed using Cell Quest Pro 
software (Becton Dickinson). 
6.3. Comet assay  
After treatments with both ION and the positive control (H2O2), the alkaline comet assay 
was performed following the general protocol proposed by Singh et al., (1988). Briefly, after 
collecting cells by trypsinization at 0.025%, they were suspended in 100µl of 0.7% low-melting-
point agarose (LMA) in PBS (pH 7.4). Then cells were dropped as two drops onto a slide that was 
previously pre-coated with a 1% layer of normal melting point agarose and covered with 
coverslips. Slides were placed on ice for 15min and, after the second layer of agarose solidified, 
coverslips were removed, and slides were immersed in freshly prepared lysis solution (2.5M 
NaCl, 100mM Na2EDTA, 10mM Tris-HCl, 250mM NaOH, pH 10, and 1% triton X-100 added 
just before use) for at least 1h at 4°C in the dark. 
After the lysis step, slides were placed on a horizontal electrophoresis tank 
(420x300x90mm) in an ice bath. Then, the tank was filled with freshly made alkaline 
electrophoresis solution (1mM Na2EDTA, 300mM NaOH, pH 13) and left in the dark for 40min 
to allow DNA unwinding. Later, electrophoresis was carried out for 30min at 25V and 300mA 
(0.83V/cm). Slides were then washed three times for 5min with neutralizing solution (0.4M Tris–
HCl, pH 7.5). Following neutralization, slides were left to air-dry in the dark, and stained with 
60μl of 4,6-diamidino-2-fenilindol (DAPI), The preparations were kept in a humidified sealed 
box to prevent drying of the gel and analysed within six days. 
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Image capture and analysis were performed using the comet IV software (Perceptive 
Instruments). In all cases, 50 cells were scored from each replicate drop (i.e. 100 cells in total), 
and percentage of DNA in the comet tail (%tDNA) was used as DNA damage parameter.  
Before carrying out the comet assay experiments, possible interference between ION and 
the comet assay protocol was evaluated, according to the procedure described by Magdolenova 
et al., (2012). Briefly, untreated cells were centrifuged at 200xg for 5min at 4°C. Supernatant was 
removed and 40μl of ION were added directly to the cells just before mixing them with 40μl of 
1.4% low-melting point agarose, so that the final concentration of ION was 200μg/ml in SH-
SY5Y cells and 100μg/ml in A172 cells, the highest doses to be tested for genotoxicity. Then the 
alkaline comet assay was carried out following the general protocol described above. Since the 
O-ION concentration used in SH-SY5Y cells showed significant interference with the comet 
assay methodology, lower doses were then tested (10, 50, and 100μg/ml). 
7. DNA REPAIR COMPETENCE ASSAY 
The experimental design described by Laffon et al., (2010) was followed to evaluate the 
effects of S-ION on DNA damage repair. It consisted of three consecutive phases: (i) in phase A 
(pre-treatment) cells were incubated for 3 or 24h in the presence or absence of ION (50µg/ml) at 
37°C; (ii) in phase B (DNA damage induction) cells were challenged with H2O2 (100µM for SH-
SY5Y cells and 200 µM for A172 cells) for 5min at 37°C in the presence or absence of ION 
(50µg/ml); and (iii) in phase C (repair) cells were washed in fresh medium to remove treatment, 
and incubated with or without ION (50 µg/ml) for 30min at 37°C to allow DNA repair. Alkaline 
comet assay was carried out just after treatment with H2O2 (data labelled as “before repair”) and 
after the repair period (data labelled as “after repair”) as described previously in section III.6.3. 
Additionally, cells were treated with ION (50µg/ml) for 30min and the comet assay was 
performed immediately after. This was done to test whether 30min incubation with ION (as occurs 
in phase C) might induce significant damage to DNA. 
8. STATISTICAL ANALYSIS 
Statistical analyses were performed using SPSS for Windows statistical package (version 
21.0). A minimum of three independent experiments were performed for each experimental 
condition tested, and each condition was always run in duplicate and under blind conditions. 
Experimental data were expressed as mean ± standard error. Distribution of the response variables 
departed significantly from normality (Kolmogorov-Smirnov test) and therefore non-parametric 
tests were considered adequate for the statistical analysis of these data. Differences among groups 
were tested with Kruskal-Wallis test and Mann-Whitney U-test. The associations between two 
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The physicochemical characterization of both ION employed in the present study was 
previously carried out by our group (Costa et al., 2016) and is shown in Table IV.1. Briefly, S-
ION used are spherical particles with an average diameter of 20.2 nm, including core and silica 
coating; less than 2% of the S-ION surface presents iron, confirming an effective silica coating. 
O-ION are spherical particles with a magnetite core average diameter of 10.9nm; less than 7% of 
the nanoparticle surface presents iron. The mean hydrodynamic sizes and zeta potential values 
demonstrated the colloidal dispersion stability and low tendency to agglomeration, except for O-
ION dispersed in both serum-free media. 
1. SH-SY5Y CELLS EXPOSED TO S-ION 
1.1. Iron ion release from the nanoparticles 
The release of iron ions from the S-ION was studied in serum-free and complete cell culture 
media. It was found to be very low in serum-free medium at the three times tested (3, 6 and 24h) 
(Figure IV.1). Nevertheless, important concentrations of dissolved iron were observed when S-
ION were suspended in complete media, generally increasing with exposure time and 
nanoparticle dose. 
 
Figure IV.1: Analysis of iron ions released from S-ION in (A) complete cell culture 
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1.2. Cellular uptake 
Results obtained from testing the ability of S-ION to enter the human neuroblastoma cells 
are shown in Figure IV.2. The nanoparticles were effectively internalized by the cells at all 
conditions tested in a dose-dependent manner (serum-free medium: r=0.824, P<0.01 for 3h 
treatment and r=0.877, P<0.01 for 24h treatment; complete medium: r=0.737, P<0.01 for 3h 
treatment and r=0.692, P<0.01 for 24h treatment). However, uptake was slightly higher in serum-
free medium than in complete medium, and for the highest dose tested it was more prominent at 
3h than at 24h treatment.  
 
Figure IV.2: Neuronal cell uptake of S-ION prepared in complete and serum-free 
medium. Bars represent the mean ± standard error. **P<0.01, significant difference 
with regard to the corresponding negative control. 
1.3. Cytotoxicity 
1.3.1. Membrane integrity 
The potential alterations in the neuronal cell membrane integrity caused by S-ION exposure 
were assessed by measuring LDH activity in extracellular medium, since LDH is released when 
the cell membrane is damaged. Results obtained in this test are collected in Figure IV.3. No 
significant alteration in the percentage of LDH activity was observed at any medium, 
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Figure IV.3: Results of membrane integrity assessment in SH-SY5Y cells exposed 
to S-ION in complete and serum-free medium. Bars represent the mean ± standard 
error. PC: positive control (1% Triton X-100). **P<0.01, significant difference 
regarding the corresponding negative control. 
1.3.2. Cell cycle analysis 
Figure IV.4 shows the cell distribution during the various phases of the cell cycle after 
exposing the neuronal cells to S-ION. The 3 h treatments, regardless of the medium employed, 
did not modify the cell cycle, and significant alterations at 24h treatments were only observed for 
the 200µg/ml concentration (decrease in G2/M phase and notable although not significant increase 
in S phase for treatment in serum-free medium, and increase in S phase for treatment in complete 
medium). 
 
Figure IV.4: Analysis of SH-SY5Y cell cycle after 3 and 24h of treatment with S-
ION prepared in complete and serum-free medium. Bars represent the mean ± 
standard error. PC: positive control (1.5μM MMC). **P<0.01, significant difference 
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Besides, the subG1 region of the cell cycle distribution was also evaluated, since DNA 
fragmentation, indicative of the late stages of apoptosis, results in the appearance of PI-stained 
events containing subG1 levels (Fracker et al., 1995); results are gathered in Figure IV.5. No 
significant increase in the subG1 fraction was observed excepting for the cells exposed in serum-
free medium to the highest S-ION dose for 24h. 
 
Figure IV.5: Apoptosis (% of cells in the subG1 region of cell cycle distribution) in 
neuronal cells treated with S-ION prepared in complete and serum-free medium. 
Bars represent the mean ± standard error. PC: positive control (1.5μM MMC). 
*P<0.05, significant difference with regard to the corresponding negative control. 
1.3.3. Apoptosis and necrosis detection 
To further investigate whether treatments with S-ION were able to induce cell death by 
apoptosis or necrosis, a double stain with annexin V and PI was carried out. Results obtained from 
the analyses showed that S-ION did not induce early apoptosis (events positive for annexin V but 
negative for PI) at any concentration after 3h of exposure regardless of the medium used (Figure 
IV.6). After 24h of treatment significant increases in apoptosis rate could only be observed for 
the highest doses assayed (200µg/ml in serum-free medium and 100 and 200µg/ml in complete 
medium). No significant induction of necrosis/late apoptosis (events positive for both annexin V 
and PI) was obtained at any experimental condition tested (Figure IV.7).  
1.4. Genotoxicity 
1.4.1. γH2AX assay 
The genotoxic potential of the S-ION was examined using different approaches. As a rapid 
screening method for genotoxicity, we first analysed H2AX phosphorylation, an early cellular 
response to the induction of DNA double-strand breaks (DSB). As it can be clearly seen in Figure 
















































Figure IV.6: Apoptosis cell rates (%) after exposure of neuronal cells to S-ION for 
3 and 24h prepared in complete and serum-free medium. Bars represent the mean ± 
standard error. PC: positive control (10μM Campt). *P<0.05, **P<0.01, significant 
difference regarding the corresponding negative control. 
 
Figure IV.7: Necrosis cell rates (%) after exposure of neuronal cells to S-ION for 3 
and 24h prepared in complete and serum-free medium. Bars represent the mean ± 
standard error. PC: positive control (10μM Campt). *P<0.05, **P<0.01, significant 
difference regarding the corresponding negative control. 
 
Figure IV.8: Phosphorylation of H2AX histone after treatment of neuronal cells 
with S-ION prepared in complete and serum-free medium. Bars represent the mean 
± standard error. PC: positive control (1μg/ml BLM). **P<0.01, significant 
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1.4.2. MN test 
Next, we applied a relatively less specific approach, the MN test scored by flow cytometry, 
in order to quantify chromosome alterations. The results of MN evaluation showed that no 
significant changes were produced in the MN ratio after treatment of the neuronal cells with the 
S-ION (Figure IV.9).  
 
Figure IV.9: MN induction in neuronal cells after treatment with S-ION prepared in 
complete and serum-free medium. Bars represent the mean ± standard error. PC: 
positive control (1.5μM MMC). *P<0.05, significant difference with regard to the 
corresponding negative control. 
1.4.3. Comet assay 
The comet assay was used for measuring primary DNA damage in SH-SY5Y cells caused 
by exposure to S-ION. Due to the especial physicochemical characteristics of nanomaterials, 
several possible interferences may occur with the comet assay methodology (Karlsson et al., 
2015). Thus, a comprehensive test for detecting these interferences was carried out before starting 
DNA damage evaluation, following Magdolenova et al., (2012). As it can be appreciated from 
Figure IV.10, addition of S-ION to the cells just before the lysis step was not found to interfere 
with the subsequent steps of the experimental protocol, since no differences were found between 

































Figure IV.10: Results of interference testing between S-ION (200µg/ml) and comet 
assay methodology in complete and serum-free medium. Bars represent the mean 
standard error. 
When the comet assay was applied to neuronal cells treated with S-ION in serum-free 
medium, no significant alteration in %tDNA was detected (Figure IV.11). Nevertheless, dose-
dependent induction of DNA damage was observed in complete medium (r=0.948, P<0.05 for 3h 
treatment, and r=0.842, P<0.05 for 24h treatment). 
 
Figure IV.11: DNA damage induction in neuronal cells after treatment with S-ION 
prepared in complete and serum-free medium. Bars represent the mean ± standard 
error. PC: positive control (100μM H2O2). *P<0.05, **P<0.01, significant difference 
with regard to the corresponding negative control. 
1.5. DNA repair 
Results obtained in the DNA repair competence assay are shown in Figure IV.12. When 
cells were challenged with H2O2 and no exposure to S-ION was carried out, there was a significant 
decrease in the level of DNA damage after the 30min repair period in both media tested. When 
incubation with S-ION was carried out before damage induction by H2O2 (phase A, either 3 or 
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complete medium, more pronounced in incubation for 24h than for 3h. Similar results were 
obtained when S-ION were applied only during the 30min repair period (phase C), although 
treatment of cells for 30min with only S-ION increased significantly the DNA damage over the 
control level in both cell culture media. However, the opposite occurred for experiments where 
treatment with H2O2 and S-ION were performed simultaneously (phase B), i.e., significant repair 
observed in serum-free medium and no repair in complete medium. 
 
Figure IV.12: Effects of S-ION on repair of H2O2-induced DNA damage in neuronal 
cells. Incubation with S-ION (50μg/ml) was carried out either before H2O2 
(100μg/ml) treatment (phase A), simultaneously (phase B), or during the repair 
period (phase C). Bars represent the mean ± standard error. *P<0.05, **P<0.01, 
significant difference with regard to the same treatment before repair, #P<0.05, 
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2. SH-SY5Y CELLS EXPOSED TO O-ION 
2.1. Iron ion release from the nanoparticles 
Quantification of iron ion concentration in both cell culture media assessed by FAAS 
showed ion release from O-ION limited to the treatments in complete medium, particularly 
marked after 3h of exposure (Figure IV.13). 
 
Figure IV.13: Analysis of iron ion release from O-ION in complete and serum-free 
cell culture medium. Bars represent mean ± standard error. 
2.2. Cellular uptake 
Flow cytometry analysis of O-ION internalization by SH-SY5Y cells revealed a similar 
dose- and time-dependent nanoparticle uptake in complete and serum-free media. Indeed, 
significant correlations were obtained at both exposure times in complete (r=0.929, P<0.01, and 
r=0.827, P<0.01, for 3 and 24h, respectively) and serum-free (r=0.964, P<0.01, and r=0.730, 
P<0.01, for 3 and 24h, respectively) media (Figure IV.14). 
 
Figure IV.14: SH-SY5Y cellular uptake of O-ION in complete and serum-free 
medium. Bars represent mean ± standard error. **P<0.01, significant differences 




































































































2.3.1. Membrane integrity 
Results of cell membrane integrity evaluation are shown in Figure IV.15. A significant 
release of LDH was observed after treating SH-SY5Y cells with the highest O-ION concentrations 
in both media, but limited to 24h in the case of serum-free medium. 
 
Figure IV.15: Results of membrane integrity assessment (LDH assay) in neuronal 
cells exposed to O-ION in complete and serum-free medium. Bars represent mean ± 
standard error. PC: positive control (1% Triton X-100). *P<0.05, **P<0.01, 
significant differences compared to the corresponding negative control. 
2.3.2. Cell cycle analysis 
The analysis of the different phases of the cell cycle (G0/G1, S, G2/M) by flow cytometry 
after exposure to O-ION revealed that the normal progression of SH-SY5Y cycle was generally 
altered (Figure IV.16). After 3h treatments these significant alterations were only observed in 
serum-free medium at concentrations from 50µg/ml on. More marked effects were found after 
24h of treatment, with statistically significant dose-dependent increases in both media in G0/G1 
phase (r=0.512, P<0.01, and r=0.531, P<0.01, in complete and serum-free medium, respectively), 
and decreases in G2/M phase (r=-0.858, P<0.01, and r=-0.863, P<0.01, in complete and serum-












































Figure IV.16: Analysis of SH-SY5Y cell cycle after treatment with O-ION for 3h 
in complete (upper left) and serum-free medium (upper right), or for 24h in complete 
(lower left) and serum-free medium (lower right). Bars represent mean ± standard 
error. PC: positive control (1.5μM MMC). *P<0.05, **P<0.01, significant 
differences with regard to the corresponding negative control. 
Additionally, analysis of subG1 region of cell cycle histogram, as indicative of late stages 
of apoptosis, was carried out (Figure IV.17). O-ION exposure induced noticeable dose-dependent 
increases in apoptosis in both complete (3h: r=0.871, P<0.01; 24h: r=0.831, P<0.01) and serum-
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Figure IV.17: Late apoptosis (cells in the subG1 region of cell cycle distribution) 
assessment in neural cells treated with O-ION in complete and serum-free medium. 
Bars represent mean ± standard error. *P<0.05, **P<0.01, significant differences 
compared to the corresponding negative control. 
2.3.3. Apoptosis and necrosis detection 
Analysis of annexin V/PI double staining by flow cytometry was carried out to assess the 
early apoptosis and necrosis rates induced in cells by exposure to O-ION. Results obtained 
showed significant increases in the percentage of apoptotic cells after 24h treatments, with a slight 
dose-dependent effect in the serum-free medium (r=0.580, P<0.01) (Figure IV.18). However, 
necrosis rates showed no significant changes at any of the conditions tested (Figure IV19). 
 
Figure IV.18: Apoptosis induction by exposure of SH-SY5Y cells to O-ION in 
complete and serum-free medium. Bars represent the mean ± standard error. PC: 
positive control (10μM Campt). *P<0.05, **P<0.01, significant difference with 





























































































Figure IV.19: Necrosis induction after exposure of SH-SY5Y neurons to O-ION in 
complete and serum-free medium. Bars represent mean ± standard error. PC: positive 
control (10μM Campt). **P<0.01, significant difference with regard to the 
corresponding negative control. 
2.4. Genotoxicity 
2.4.1. γH2AX assay 
Figure IV.20 shows the results obtained from analysis of H2AX phosphorylation. Exposure 
of SH-SY5Y cells to O-ION did not induce significant changes in %γH2AX at any time, dose or 
medium tested. 
 
Figure IV.20: H2AX histone phosphorylation after treatment of neuronal cells with 
O-ION in complete and serum-free medium. Bars represent mean ± standard error. 
PC: positive control (1μg/ml BLM). **P<0.01, significantly different from the 
corresponding negative control. 
2.4.2. MN test 
According to MN test results, no MN induction was found in serum-free medium at 3h 
exposure or in complete medium at any time or dose tested. Significant increases in MN frequency 
were only observed in SH-SY5Y cells treated with the highest O-ION concentrations for 24h in 







































































Figure IV.21: Micronuclei rates in SH-SY5Y neurons exposed to O-ION in 
complete and serum-free medium. Bars represent mean ± standard error. PC: positive 
control (1.5μM MMC). *P<0.05, **P<0.01, significant differences with respect to 
the corresponding negative control. 
2.4.3. Comet assay 
Results obtained from comet assay are displayed in Figures IV.22 and IV.23. Prior to 
performing the experiments, the possible interference of O-ION with comet methodology was 
addressed (Figure IV.22). This test was initially performed with only the highest concentration to 
be tested for genotoxicity (200µg/ml). Since significant differences were observed between the 
results obtained in the presence and in the absence of O-ION in serum-free medium, indicating 
that nanoparticles could interfere with some step of the assay, testing was further carried out with 
all other concentrations in both media, but none of them showed signs of interference. Afterwards, 
alkaline comet assay was carried out showing general increases in primary DNA damage 
(%tDNA) with respect to the negative control in O-ION treated SH-SY5Y cells, regardless of 
serum presence in the medium (Figure IV.23). Significant dose–response relationships were only 
found in serum-free medium (3h: r=0.526, P<0.01; 24h: r=0.460, P<0.05). 
 
Figure IV.22: Results of interference testing between O-ION (10-200μg/ml) and 
comet assay methodology in complete and serum-free cell culture medium. Bars 








































control 10ug/ml 50 ug/ml 100 ug/ml 200 ug/ml




Figure IV.23: Primary DNA damage in SH-SY5Y cells treated with O-ION in 
complete and serum-free medium. Data corresponding to treatment with 200μg/ml 
in serum-free medium are not shown due to interference of the nanoparticles with 
the comet methodology. Bars represent mean ± standard error. PC: positive control 
(100μM H2O2). *P<0.05, **P<0.01, significant differences with regard to the 
corresponding negative control. 
2.5. DNA repair 
Results obtained from the DNA repair competence assay are shown in Figure IV.24. When 
cells were challenged with H2O2 and no exposure to O-ION was carried out, a significant decrease 
in the level of primary DNA damage after the 30min repair period was observed in both media, 
confirming a proper repair ability of the cells in absence of nanoparticles. Nevertheless, 
ineffectiveness of cells in repairing the H2O2-induced DNA damage was revealed after incubation 
with O-ION before (phase A, both media) or during (phase B, serum-free medium) damage 
induction with H2O2. Despite significant increases in DNA damage were induced by cell treatment 
with the nanoparticles for only 30min in both media, no alterations in DNA repair were observed 
when O-ION treatments were conducted during the repair period (phase C, 30 min). 


































Figure IV.24: Effects of O-ION on repair of H2O2-induced DNA damage in neurons 
in complete and serum-free medium. Incubation with 50µg/ml O-ION was 
conducted independently prior to exposure to 100µM H2O2 (for 3 or 24h, phase A), 
simultaneously with H2O2 (phase B), or during the repair period (phase C). Bars 
represent mean ± standard error. *P<0.05, **P<0.01, significant differences with 
regard to the same treatment before repair. ##P<0.01, significant differences with 
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3. A172 CELLS EXPOSED TO S-ION 
3.1. Iron ion release from the nanoparticles 
Determination of iron ions in the culture media assessed by FAAS revealed scarce release 
of ions from the S-ION in serum-free medium regardless exposure time and after 3h incubation 
in complete medium (Figure IV.25). Nevertheless, notable time and concentration-dependent 
release was observed in complete medium after 6 and 24h incubations. 
 
Figure IV.25: Analysis of iron ion release from S-ION in complete and serum-free 
cell culture medium. Bars represent mean ± standard error. 
3.2. Cellular uptake 
Nanoparticle internalization was analysed by TEM coupled with EDX in order to confirm 
nanoparticle composition. Results obtained show that glial cells are able to internalize S-ION at 
the conditions here tested. Electron-dense deposits were observed within endosomes after 24h of 
exposure to S-ION 25 and 100µg/ml and also after 3h of exposure to the highest concentration, 
both in complete and serum-free media (Figure IV.26). These agglomerates were also detected in 





















































Figure IV.26: Transmission electron micrographs of A172 cells incubated with 
100µg/ml of S-ION for 3h in complete (a) and serum-free (b) medium and after 24h 
of exposure in complete (c) medium showing nanoparticle internalization (arrows 
indicate S-ION agglomerates) in opposition to control cells (d). All bars (down left 
side) are 0.5μm long. 
3.3. Cytotoxicity 
3.3.1. Membrane integrity 
The possible effect of S-ION on glial cell membrane integrity was analysed by measuring 
LDH enzyme release (Figure IV.27). It was observed that S-ION, regardless of the medium 
composition, did not produce significant alterations in membrane integrity, i.e. increases in LDH 
release, at any condition tested. 
 
Figure IV.27: Results of membrane integrity assessment (LDH assay) in A172 cells 
exposed to S-ION in complete and serum-free medium. Bars represent mean ± 
standard error. PC: positive control (1% Triton X-100). **P<0.01, significant 
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3.3.2. Cell cycle analysis 
Results obtained in the analysis of the different phases of the cell cycle (G0/G1, S, G2/M) 
revealed that, in general, S-ION exposure altered the normal progression of A172 cell cycle 
(Figure IV.28). Although no significant differences in the cell distribution in each phase were 
obtained in the 3h treatments in complete medium when compared with the control, there was a 
statistically significant dose-dependent increase in the S-phase (r=0.406, P<0.05) with a 
simultaneous dose-dependent decrease in the G0/G1 phase (r=-0.443, P<0.05). After 3h treatments 
in serum-free medium, significant alterations were observed, mainly in G0/G1 (r=-0.594, P<0.01) 
and S phases (r=0.681; P<0.01). Exposure of glial cells to S-ION for 24h induced significant cell 
cycle alterations at all concentrations tested, regardless of the medium used. Consequently, 
positive dose-response relationships were obtained in all phases in complete medium (G0/G1: r=-
0.864, P<0.01; S: r=0.900, P<0.01; G2/M: r=0.481, P<0.05), and in G0/G1 and S phases in serum-
free medium (G0/G1: r=-0.733, P<0.01; S: r=0.899, P<0.01). 
 
Figure IV.28: Analysis of A172 cell cycle after treatment with S-ION for 3h in 
complete (upper left) and serum-free medium (upper right), or for 24h in complete 
(lower left) and serum-free medium (lower right). Bars represent mean ± standard 
error. PC: positive control (1.5μM MMC). *P<0.05, **P<0.01, significant 
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In addition, analysis of subG1 region of the cell cycle distribution was conducted as 
indicative of late stages of apoptosis (Figure IV.29). S-ION treatment in complete medium 
induced apoptosis only at the highest concentration and longest exposure time tested. However, 
a strong dose-dependent cell death generation was observed from 25µg/ml on in serum-free 
medium (3h: r=0.822, P<0.01; 24h: r= 0.880, P<0.01). 
 
Figure IV.29: Late apoptosis (cells in the subG1 region of cell cycle distribution) 
assessment in glial cells treated with S-ION in complete and serum-free medium. 
Bars represent mean ± standard error. *P<0.05, **P<0.01, significant differences 
compared to the negative control. 
3.3.3. Apoptosis and necrosis detection 
Early apoptosis was assessed by means of annexin V/PI double staining by flow cytometry. 
Results obtained in complete medium showed significant increases in the percentage of apoptotic 
cells after treatment with S-ION at the highest concentrations tested, particularly evident at 24h 
exposure but with significant dose-response relationships in both cases (3h: r=0.426, P<0.05, 24 
h: r=0.673, P<0.01) (Figure IV.30). An even more notable apoptosis induction was observed in 
serum-free medium, with significant differences with regard to the negative control from 25µg/ml 
on and also significant dose-response relationships in both cases (r=0.860, P<0.01 for 3h; r=0.908, 
P<0.01 for 24h).  
Furthermore, although necrosis rates obtained in the same analyses were much lower than 
apoptosis rates, they showed significant dose-dependent increases at the highest concentrations 
tested (50 and 100µg/ml) (r=0.558; P<0.01) only for the longest exposure time in complete 
medium (Figure IV.31). In contrast, in serum-free conditions, a dose-dependent relationship was 
observed at 3h, with statistically significant increases in the necrosis production from 25µg/ml on 




















































Figure IV.30: Apoptosis induction by exposure of A172 cells to S-ION for 3 and 
24h in complete and serum-free medium. Bars represent the mean ± standard error. 
PC: positive control (10μM Campt). *P<0.05, **P<0.01, significant difference 
with regard to the negative control. 
 
Figure IV.31: Necrosis induction after exposure of A172 astrocytes to S-ION for 3 
and 24 h in complete and serum-free medium. Bars represent mean ± standard error. 
PC: positive control (10μM Campt). *P<0.05, **P<0.01, significant difference with 
regard to the negative control. 
3.4. Genotoxicity 
3.4.1. γH2AX assay 
Results obtained from analysis of H2AX phosphorylation by flow cytometry are shown in 
(Figure IV.32). Significant increases in %γH2AX were only observed in A172 cells treated with 
50 and 100µg/ml S-ION for 24h in complete medium. No effects were observed in complete 
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3.4.2. MN test 
According to MN assay results, no MN induction was observed in glial cells by S-ION 
treatment at any concentration or exposure time, either in complete or in serum-free medium 
(Figure IV.33). 
 
Figure IV.32: H2AX histone phosphorylation after treatment of glial cells with S-
ION in complete and serum-free medium. Bars represent mean ± standard error. PC: 
positive control (1μg/ml BLM). *P<0.05, **P<0.01, significantly different from the 
negative control. 
 
Figure IV.33: Micronuclei rates in A172 astrocytes after treatment with S-ION in 
complete and serum-free medium. Bars represent mean ± standard error. PC: positive 
control (15μM MMC). **P<0.01, significant differences with respect to the negative 
control. 
3.4.3. Comet assay 
When the possible interference between the nanoparticles and the comet methodology was 
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in the absence of S-ION (100μg/ml) (Figure IV.34), indicating no nanoparticle interference with 
any step of the assay, both in complete and serum-free media.  
Subsequently, increases in primary DNA damage with respect to the controls were 
observed in S-ION treated cells, at the highest concentration after 3h treatment and from 25μg/ml 
on after 24h, regardless of serum presence in the medium (Figure IV.35). Positive dose-response 
relationships were also found in all cases (r=0.493, P<0.01 and r=0.564, P<0.01 for 3h, in 
complete and serum-free medium, respectively, and r=0.741, P<0.01 for 24h in both complete 
and serum-free medium). 
 
Figure IV.34: Results of interference testing between S-ION (100μg/ml) and comet 
assay methodology in complete and serum-free cell culture medium. Bars represent 
mean ± standard error. 
 
Figure IV.35: Primary DNA damage in A172 cells after treatment with S-ION in 
complete and serum-free medium. Bars represent mean ± standard error. PC: positive 
control (100μM H2O2). *P<0.05, **P<0.01, significant differences with regard to 
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3.5. DNA repair 
As shown in Figure IV.36, results obtained from the DNA repair competence assay showed 
a significant decrease in H2O2-induced damage after the repair period in all cases, independently 
of the assay phase in which glial cells were exposed to S-ION. In addition, the absence of damage 
induction by S-ION when cells were incubated for only 30min discards any additional DNA 
damage produced when cells were exposed during the repair phase. 
 
Figure IV.36: Effects of S-ION on repair of H2O2-induced DNA damage in 
astrocytes in complete and serum-free medium. Incubation with 50µg/ml S-ION was 
performed independently prior to exposure to 200µM H2O2 (phase A, for 3 or 24h), 
simultaneously with H2O2 (phase B), or during the repair period (phase C). Bars 
represent mean ± standard error. *P<0.05, **P<0.01, significant difference with 
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4. A172 CELLS EXPOSED TO O-ION 
4.1. Iron ion release from the nanoparticles 
Quantification of iron concentration in both cell culture media showed a dose- and time-
dependent ion release from O-ION in complete medium, but only a slight increase in iron 
concentration at 24h treatments in serum-free medium (Figure IV.37). 
 
Figure IV37: Analysis of iron ion release from O-ION in complete and serum-free 
cell culture medium. Bars represent mean ± standard error. 
4.2. Cellular uptake 
The uptake and intracellular localization of O-ION in A172 cells were assessed by 
transmission electron microscopy (TEM) coupled with energy-dispersive X-ray spectroscopy 
(EDX). The presence of nanoparticles was confirmed within endosomes in all tested conditions 
(25 and 100µg/ml after 3 and 24h of exposure), both in complete and serum-free medium, as 
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Figure IV.38: Transmission electron micrographs of A172 cells incubated with 
100µg/ml of O-ION in complete medium for 3h (a) and 24h (b), and in serum-free 
medium for 3h (c) and 24h (d), showing nanoparticle internalization. Bar sizes are 
0.2μm in (a) and (b), and 1μm in (c) and (d). 
4.3. Cytotoxicity 
4.3.1. Membrane integrity 
Figure IV.39 shows LDH release to the cell culture media. No significant increase in 
enzyme leakage was detected at any condition tested. 
 
Figure IV.39: Results of membrane integrity assessment (LDH assay) in A172 cells 
exposed to O-ION in complete and serum-free medium. Bars represent mean ± 
standard error. PC: positive control (1% Triton X-100). *P<0.05, significant 
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4.3.2. Cell cycle analysis 
The flow cytometry analysis of the DNA content in the different phases of the cell cycle 
(G0/G1, S, G2/M) revealed that O-ION treatments altered significantly the normal progression of 
A172 cell cycle (Figure IV.40). A marked S phase arrest from 25 µg/ml on was observed at the 
two times tested, regardless of the presence of serum in the culture medium. Accordingly, strongly 
significant dose-dependent increases in S phase in complete (3 h: r=0.945, P<0.01; 24 h: r=0.931, 
P<0.01) and serum-free (3h: r=0.934, P<0.01; 24 h: r=0.654, P<0.01) media were observed, 
together with decreases in G0/G1 and G2/M phases.  
Additionally, evaluation of subG1 region of the cell cycle histogram was performed as 
indicative of late stages of apoptosis. Results showed noticeable dose- and time-dependent 
increases in late apoptosis rates in astrocytes exposed to O-ION, in both complete (3h: r=0.931, 
P<0.01; 24h: r=0.942, P<0.01) and serum-free (3h: r=0.923, P<0.01; 24h: r=0.926, P<0.01) 
media (Figure IV.41). 
 
Figure IV.40: Analysis of A172 cell cycle after treatment with O-ION for 3h in 
complete (upper left) and serum-free medium (upper right), or for 24h in complete 
(lower left) and serum-free medium (lower right). Bars represent mean ± standard 
error. PC: positive control (1.5μM MMC). *P<0.05, **P<0.01, significant 
differences with regard to the corresponding negative control. 
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Figure IV.41: Late apoptosis (cells in the subG1 region of cell cycle distribution) 
assessment in A172 cells treated with O-ION in complete and serum-free medium. 
Bars represent mean ± standard error. **P<0.01, significant differences compared to 
the corresponding negative control. 
4.3.3. Apoptosis and necrosis detection 
In line with subG1 region analysis, evaluation of annexin V/PI double staining also 
exhibited significant dose-dependent increases in the percentage of apoptotic cells after O-ION 
treatments in complete (3h: r=0.852, P<0.01; 24h: r=0.931, P<0.01) and serum-free (3h: r=0.912, 
P<0.01; 24h: r=0.942, P<0.01) media (Figure IV.42). Moreover, slight increases in necrosis rates, 
particularly in complete medium, were observed, although rate values were always below 5% 
(Figure IV.43). 
 
Figure IV.42: Apoptosis induction by exposure of A172 cells to O-ION in complete 
and serum-free medium. Bars represent the mean ± standard error. PC: positive 
control (10μM Campt). *P<0.05, **P<0.01, significant difference with regard to the 










































































































Figure IV.43: Necrosis induction after exposure of A172 astrocytes to O-ION in 
complete and serum-free medium. Bars represent mean ± standard error. PC: positive 
control (10μM Campt). *P<0.05, **P<0.01, significant difference with regard to the 
corresponding negative control. 
4.4. Genotoxicity 
4.4.1. γH2AX assay 
Results obtained from analysis of H2AX phosphorylation are shown in Figure IV.44. Only 
slight increases were observed in the percentage of γH2AX at certain experimental conditions. 
 
 
Figure IV.44: H2AX histone phosphorylation after treatment of A172 cells with O-
ION in complete and serum-free medium. Bars represent mean ± standard error. PC: 
positive control (1µg/ml BLM). *P<0.05, **P<0.01, significantly different from the 
corresponding negative control. 
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4.4.2. MN test 
As it can be seen in Figure IV.45, no significant MN induction was found in A172 cells 
exposed to O-ION at any dose, time, or culture medium tested. 
 
Figure IV.45: Micronuclei rates in A172 cells exposed to O-ION in complete and 
serum-free medium. Bars represent mean ± standard error. PC: positive control 
(15µM MMC). **P<0.01, significant differences with respect to the corresponding 
negative control. 
4.4.3. Comet assay 
Prior to conducting the comet assay experiments, the possible interference of O-ION with 
any step of its methodology was discarded since very similar results were obtained when 
performing the assay in the presence and in the absence of O-ION (Figure IV.46). Subsequently, 
alkaline comet assay was carried out, and results showed general increases in primary DNA 
damage (%tDNA) with respect to the negative control in astrocytes exposed to the highest O-ION 
concentrations, at both exposure times for complete medium but limited to 24h in serum-free 
medium (Figure IV.47). Significant dose-response relationships were found in complete (3h: 
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Figure IV.46: Results of interference testing between O-ION (100μg/ml) and comet 
assay methodology in complete and serum-free cell culture medium. Bars represent 
mean ± standard error. 
 
Figure IV.47: Primary DNA damage in A172 cells treated with O-ION in complete 
and serum-free medium. Bars represent mean ± standard error. PC: positive control 
(100μM H2O2). *P<0.05, **P<0.01, significant differences with regard to the 
corresponding negative control. 
4.5. DNA repair 
Figure IV.48 shows the results from the DNA repair competence assay. No alteration in 
DNA repair ability caused by O-ION exposure was observed at any condition, since significant 
decreases in H2O2-induced damage were registered after the repair period, similar to those 
exhibited in the presence of H2O2 alone. Similar results were obtained for all phases tested and 




































Figure IV.48: Effects of O-ION on repair of H2O2-induced DNA damage in A172 
cells in complete and serum-free medium. Incubation with 50µg/ml O-ION was 
conducted independently prior to exposure to 200µM H2O2 (for 3 or 24h, phase A), 
simultaneously with H2O2 (phase B), or during the repair period (phase C). Bars 
represent mean ± standard error. *P<0.05, **P<0.01, significant differences with 

































































Magnetic nanoparticles are one of the first nanomaterials to be approved for clinical use 
(Gould, 2006). Among the different types of magnetic nanoparticles, iron oxide nanoparticles 
(ION) awaken a particular interest due to their unique properties, including superparamagnetism 
and high biocompatibility (Elsaesser and Howard, 2012). Iron oxide can exist in different 
chemical compositions, including magnetite (Fe3O4) or maghemite (γ-Fe2O3). Both oxides have 
very similar physical properties due to their nearly identical crystalline structure (Estelrich et al., 
2015), whereas magnetization is higher for magnetite than for maghemite (Turcheniuk et al., 
2013). This is one of the main reasons why magnetite is the most commonly ION used in 
biomedicine. 
ION features make them very suitable for a broad variety of uses, mostly in biomedical 
applications, namely magnetic resonance imaging, targeted drug delivery, tumour location and 
magnetic hyperthermia, among others (reviewed in Revia and Zhang, 2016). In particular, over 
the last decade, ION are being used for diagnosis and therapy of several central nervous system 
(CNS) pathologies, such as Alzheimer´s, Parkinson´s, multiple sclerosis, and primary brain 
tumours (Kanwar et al., 2012). This is mainly because the reduction in particle size gives ION 
the ability to cross the blood-brain barrier (BBB) and get access to brain, commonly difficult to 
reach (Monopoli et al., 2012; Kenzaoui et al., 2013; Petters et al., 2014b). Besides, because of 
their ability to overcome the restraints of the BBB (Thomsen et al., 2013), they have been used 
as carriers for the transport of drugs, siRNA, or DNA into the brain. ION size, combined with 
high surface area and reactivity, makes the nervous system extremely vulnerable to their potential 
toxicity. Indeed, recent investigations indicated that ION can not only reach the brain (Liu et al., 
2013), but also cause a certain degree of neurotoxicity (Migliore et al., 2015). 
However, studies regarding the potential toxic effects of ION on CNS are scarce and 
conflicting so far (reviewed in Valdiglesias et al., 2014), and their potential risk on human brain 
cells have raised concern (Braeuer et al., 2015). Still, the lack of robust toxicological screenings, 
and poor comprehension of predictive paradigms of nanoneurotoxicity are the major obstacles in 
translating the advancing nanoparticle designs into viable biomedical platforms system (Kim et 
al., 2013). This is, at least in part, due to the great variety of ION, bare or with different coatings, 
tested. Besides, most studies were focused on addressing cytotoxic effects, e.g., decrease in 
viability, cytoskeleton alterations, iron ion release or reactive oxygen species (ROS) generation 
(Suh et al., 2009; Soenen and De Cuyper, 2010). However, their possible effects on other different 
cellular functions, on the genetic material, or on the DNA repair ability have been hardly 
addressed on human nervous cell types (reviewed in Valdiglesias et al., 2016). Furthermore, 
results of toxicity assays available are not always comparable since they are influenced by several 
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factors such as the cell type tested (Ding et al., 2010; Kunzmann et al., 2011), experimental 
conditions assessed (Pisanic et al., 2007), and physicochemical properties of ION (Thorek and 
Tsourkas, 2008). Indeed, general knowledge about ION toxic effects indicates that they mainly 
depend on nanoparticle size and surface coating (Rivet et al., 2012). 
On this basis, the present study was designed to elucidate the potential adverse effects of 
S-ION and O-ION on human neuronal and glial cells (astrocytes) by evaluating a dose range and 
short- and long-term exposure times (3 and 24 h, respectively), in complete and serum-free media 
conditions. In particular, after cellular uptake assessment of ION, the measurement of membrane 
integrity, cell cycle progression and apoptosis/necrosis rates were evaluated as indicators of 
cytotoxicity, whereas histone H2AX phosphorylation, MN frequency and primary DNA damage 
were determined as genotoxicity parameters. Complementarily, possible effects on DNA repair 
ability and iron ion release capacity were also assessed. 
ION have high chemical activity and oxidation capacity, resulting in loss of magnetism and 
dispersibility. In order to avoid this and to improve their properties, ION surface can be coated 
with different natural or synthetic polymers and/or numerous biological molecules (Mahdavi et 
al., 2013). For in vivo purposes, nanoparticles are required to be biocompatible, water-dispersible, 
stable in biological media, and uniform in size to maintain the suitable magnetic properties (Chang 
et al., 2012; Lee et al., 2015). Surface coatings are known generally to influence advantageously 
nanoparticle features. Nevertheless, as mentioned before, surface modifications may also alter 
their biocompatibility, stability, aggregation state, size, and toxicity (Mahmoudi et al., 2011a,c). 
The type of coating employed usually depends on the functionalization needed for each particular 
ION application.  
In this study ION with two different coatings were tested: silica and oleic acid. Silica 
coating has several advantages that make it very suitable for biomedical applications, including 
negative charge at blood pH or transparent matrix (Alwi et al., 2012). Silica can increase ION 
biocompatibility without affecting magnetic properties, may convert hydrophobic nanoparticles 
into hydrophilic water-soluble particles, helps to prevent aggregation by improving the 
nanoparticle chemical stability, and the silanol-terminated surface groups may be modified with 
various coupling agents to covalently bind to specific ligands, reviewed in Andrade et al., (2009). 
All these properties make silica one of the most commonly used agents for ION coating, 
particularly for bioimaging and biosensing purposes (Alwi et al., 2012). Still, the possible 
neurotoxicity of silica-coated ION (S-ION), particularly on nervous cells different from neurons, 
has not been discarded yet. 
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ION coated with an oleic acid bilayer (O-ION) are also a good option for biomedical 
purposes since oleic acid coating stabilizes the nanoparticles in organic solvents (Sahoo et al., 
2001). This mono-unsaturated fatty acid is commonly used as high affinity surfactant agent to 
modify the surface of ION through the formation of strong chemical bonds between the carboxylic 
acid and ION, resulting in highly uniform, monodispersed and biocompatible nanoparticles 
(Soares et al., 2016). Moreover, the lipid-soluble and non-ionic oleic acid coating improves the 
nanoparticle ability to cross the blood-brain barrier and reach the brain, being particularly useful 
in specific applications directed to this organ, as targeted drug delivery or hyperthermia (Dilnawaz 
and Sahoo, 2015). 
In vitro studies are essential to initially evaluate the potential risk for the different CNS 
cells, from neurons to glial cells, associated with the use of ION (Dwane et al., 2013; Migliore et 
al., 2015). However, studies on the potential toxic effects of ION in the CNS are still scant and 
their possible toxic effects on human brain cells have not been ruled out (Braeuer et al., 2015). 
The use of primary human cell culture models, although more representative, are limited, since 
differentiated nervous cells are difficult to obtain, have a limited proliferating capacity in culture, 
and present associated ethical constraints. The use of standardized stocks of cell lines have the 
advantage of the proliferative potential of an immortal cancer cell line and its high throughput in 
culture, combined with ability to be differentiated cells that can then be used in functional assays. 
Thus, in the present work, we have sought a balance between advantages such as performance in 
cell culture or toxic sensitivity of the nervous cell lines employed, with disadvantages such as the 
absence of some morphological and functional characteristics due to differentiation. 
Among all glial cells, astrocytes are especially interesting since they are the most 
abundant brain cell type. The astrocytic end-feet cover the majority of the BBB which makes 
them the first cellular obstacle ION interact with (Yang et al., 2010). Moreover, astrocytes are 
strategically distributed between the blood vessels and neurons (Geppert et al., 2011). Besides, 
they seem to play a key role in the etiology of neurodegenerative disorders and, consequently, 
have been proposed as new targets for the treatment of important neuropathologies such as 
Alzheimer’s disease, amyotrophic lateral sclerosis, and Parkinson’s disease (Barker and Cicchetti, 
2014; Phatnani and Maniatis, 2015; Finsterwald et al., 2015). At the beginning of glial research, 
astrocytes were thought to give only structural support. However, nowadays a number of new 
important astrocytic functions have been known, and due to their morphological and 
physiological heterogeneity it is quite difficult to define what an astrocyte is (Sofroniew and 
Vinters, 2010; Kimelberg and Nedergaard, 2010; Verkhratsky et al., 2015). They not only provide 
other neural cells with energy substrates and nutrients, but they also play a key role in the 
homeostasis of ions, pH and water, regulate the vasopressure in brain, recycle neurotransmitters, 
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as well as fulfill a wide range of other homeostasis maintaining functions in the brain (Sofroniew 
and Vinters, 2010; Pekny and Pekna, 2014). During the past two decades, astrocytes emerged also 
as increasingly important regulators of neuronal functions including the generation of new nerve 
cells and structural as well as functional synapse remodeling. Moreover, they interact with 
neurons and modulate their signal transmission (De Bock et al., 2014; Howarth, 2014). The A172 
cell line employed in this Thesis is an astrocytoma non-tumorigenic and p53 wild-type cell line 
derived from a human glioblastoma that has been commonly used in in vitro studies to elucidate 
basic neurobiological principles and as a glial model in neurotoxicity testing (Wolff et al., 1999; 
Qiang et al., 2009; Sato et al., 2009). 
Neurons are the core constituent of the brain and are crucial for the maintenance of its 
function. In general, neurons have the specific function to transmit electrochemical signals, and 
can differ regarding their morphology, location, type of neurotransmitter produced, function 
(motor, sensory) or effect (excitatory, inhibitory) (Zeng and Sanes, 2017). The damage of 
neurons, such as loss of structure or function, was considered to play a key role in the etiology of 
certain neurodegenerative diseases as well (Wu et al., 2011). The human neuroblastoma SH-
SY5Y neuronal cell line employed in this work is a dopaminergic cell line which express tyrosine 
hydroxylase and dopamine-beta-hydroxylase, as well as the dopamine transporter, and can be 
differentiated into a functionally mature neuronal phenotype in the presence of various agents. It 
is one of the more frequently and extensively used cell lines as an in vitro model in 
neurobiological, neurochemical, and neurotoxicological studies (Xie et al., 2010; Kovalevich and 
Langford, 2013), due to their ability to differentiate and proliferate in culture for long periods, 
and they also possess many biochemical and functional features of primary neurons (Xie et al., 
2010). 
Recent studies have demonstrated that nanoparticles exposed to biological fluids interact 
with a variety of biomolecules (mainly serum proteins, although lipids, sugars, etc. may adhere 
with), which lead to formation of a functional layer or "corona" on their surfaces (Monopoli et 
al., 2012). The corona formation is in turn dependent on the physicochemical properties of the 
nanoparticles (e.g., surface chemical composition and surface charges, presence/absence of 
coating) (Mahmoudi et al., 2011a; Sakulkhu et al., 2014; Arami et al., 2015), the type of 
biomolecules and their concentration, and incubating temperature, among others (Zanganeh et al., 
2016). It is evident that the functionality and effectiveness of nanoparticles exposed to living 
organisms (e.g., cells) depend more on the nature and amount of the proteins present in the corona 
than on their bare surface (Mahmoudi et al., 2015). The protein corona plays an important 
biological role; it can change the way nanoparticles interact with cells, because it can modify their 
physicochemical characteristics, leading to structural and functional changes, such as 
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internalization ability, enzymatic function, and toxic effects (Nel et al., 2009; Lesniak et al., 2010; 
Mahmoudi et al., 2011b, 2012; Bertrand and Leroux, 2012; Monopoli et al., 2012). Hence, protein 
corona makes it challenging to distinguish the relationship between chemical functionality of 
nanoparticles and their biological effects (Zanganeh et al., 2016). Investigation on the possible 
formation and composition of this protein corona is crucial to understanding their correspondence 
with the ION toxicological profile, and attempt to mimic their behavior in vivo (Mahmoudi et al., 
2012). The protein corona has been found to provide multiple protective effects to biological 
systems. However, interpretations of these beneficial effects can often be unclear due to the 
variation in conditions and reported outcomes. Conflicting reports on cytotoxicity and biological 
fates, even when identical nanoparticles were studied, have been reported (Mahmoudi et al., 
2011a; Mao et al., 2013; Sakulkhu et al., 2014; Behzadi et al., 2014; Sharifi et al., 2015). In order 
to assess the potential influence of this protein corona on ION effects investigated in the present 
study, all experiments were carried out in the presence and absence of serum in the media 
(complete and serum-free media, respectively). 
Concentrations and exposure times employed in the present study were chosen based on 
previous cell viability results, obtained from 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), neutral red uptake (NRU), and alamar blue (AB) assays 
(Costa et al., 2016). Experimental conditions selected to be tested were those producing a 
maximum decrease in SH-SY5Y or A172 cell viability of 30%, thus avoiding the possible 
influence of excessive decline in viability on the results of the different parameters tested. As for 
the physiological meaning of the ION concentrations chosen, the dose range recommended for 
carboxydextran coated-ION (ferucarbotran, Resovist®) to be used in clinical magnetic resonance 
imaging (0.2–0.8mg Fe/kg body weight) (Reimer and Balzer, 2003) is roughly equivalent to the 
lower doses tested in this study (2.5-10μg/ml). 
1. SH-SY5Y CELLS EXPOSED TO S-ION 
Analysis of iron ion release from the S-ION suspensions showed a different behaviour of 
the nanoparticles depending on the media composition. Low concentrations of iron were detected 
in serum-free medium, whereas the release of ions was notable in the presence of serum (complete 
medium), in general increasing with time and S-ION concentration. Release of iron ions from 
ION was previously described in a number of studies (Soenen and De Cuyper, 2009). However, 
this release can vary depending on the suspension conditions and the nanoparticle surface coating 
(Malvindi et al., 2014). Results obtained here suggest that degradation of the studied S-ION is 
not dependent on particle size, since similar hydrodynamic diameters obtained in different media 
showed very different dissolution rates. 
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The chemical synthesis, as well as the presence of coating, which surrounds and isolates 
the magnetic material from the environment, and its physicochemical properties, may influence 
the degradation rate of the particles and so the release of iron ions (Lévy et al., 2010; Mahon et 
al., 2012). This would explain the differences found in our study, since ION suspended in 
complete medium may externally interact with serum proteins, thus favouring the silica coating 
degradation and causing a higher iron release from the nanoparticle core. In fact, proteins may 
increase the dissolution rates of iron oxides through both aqueous complexation and ligand-
enhanced dissolution (Nel et al., 2009).  
The evaluation of cellular uptake of nanoparticles by flow cytometry using side scatter 
parameter (indicative of cell granularity/complexity) is suitable for initial screening of 
nanotoxicity (Ibuki and Toyooka, 2012). Experimental data confirmed that the S-ION were 
effectively taken up by neuroblastoma cells, and the uptake was higher when exposure was 
performed in the absence of serum. These findings agree with previous studies in other cell types 
showing that S-ION are quickly internalized by macrophages (Kunzmann et al., 2011), and by 
A549 and HeLa cells (Malvindi et al., 2014). Differences in nanoparticle uptake were previously 
reported by Krais et al., (2014), who studied the role of serum proteins on ION uptake, and 
observed that the presence of a protein corona may indeed influence the cellular uptake of folic 
acid-functionalized ION. Agreeing with our results, Salvati et al., (2013) speculated that 
excessive binding of serum proteins may prevent selective, ligand-mediated uptake of 
nanoparticles. Besides, our in vitro studies revealed a remarkable lower degree of internalization 
for the highest S-ION concentration at 24h when compared to the one obtained at 3h. This is 
likely due to the progressive nanoparticle agglomeration at this high concentration, which causes 
a more noticeable interference with the uptake process at the longest exposure period. 
Cell cycle machinery corresponds to series of events which lead the cell to its division and 
duplication (Crosby, 2007). Results obtained from analysis of cell cycle showed that exposure for 
3h to S-ION did not alter it at any concentration, which agrees with previous findings from some 
other studies using bare or differently coated ION (Mahmoudi et al., 2011c). However, significant 
mitotic arrest (increase in the rate of cells in S phase and/or decrease in the rate of cells in G2/M 
phase) was observed for 24h treatments in both culture media at the highest dose tested. Similar 
alterations in the cell cycle were observed by Namvar et al., (2014) after exposing Jurkat cells to 
bare magnetite nanoparticles prepared by green biosynthesis (using a brown seaweed), but the 
dose used was much lower (6.4µg/ml, corresponding to the inhibitory concentration 50 [IC50], 
calculated by MTT assay). In the previous cell viability assays with the current S-ION (Costa et 
al.,, 2016), viabilities obtained for treatments up to 200µg/ml were always higher than or equal 
to 70% as calculated by MTT, neutral red uptake and alamar blue assays; therefore cytotoxicity 
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of these nanoparticles, at least to SH-SY5Y cells, was much lower than cytotoxicity of the ION 
used by Namvar et al., (2014) in Jurkat cells. These observations agree with the general 
assumption that ION coated with silica are indeed less toxic that bare ION. Besides, in a recently 
published study, Couto et al., (2015) were unable to find any alteration on cell cycle when testing 
polyacrylic acid (PAA)-coated and non-coated ION on human T lymphocytes (48h treatments). 
In order to evaluate apoptosis, which is critical in many physiological and pathological 
processes, we used two alternative strategies: analysis of the subG1 region of the cell cycle 
distribution, indicative of DNA fragmentation at the late stages of apoptosis, and Annexin V/PI 
staining for sensitive detection of early stage apoptosis. Results obtained with the two strategies 
were quite similar. The only significant increase in apoptosis rate observed was for the highest S-
ION concentrations after 24h treatments in both media tested. The exception was the subG1 region 
in complete medium, which did not show any significant alteration. This difference may be 
explained on the basis of the methodological differences between the two techniques used. 
Annexin V/PI staining and measurement is carried out just after the treatments, and reflects early 
stage apoptosis, meanwhile subG1 region analysis is performed after an additional 24h incubation 
period following the treatments, and is indicative of late stage apoptosis. Hence, probably the 
cells undergoing early apoptosis detected by Annexin V/PI staining have already been mostly 
removed when subG1 region was analysed. Similar apoptosis results were reported by Jeng and 
Swanson (2006), who found that ION only induce apoptosis in mouse Neuro-2A neuroblastoma 
cells after exposure to concentrations higher than 100µg/ml. Contrarily, Namvar et al., (2014) 
described time-dependent (from 12 to 48h) increases in the apoptosis rates in Jurkat cells treated 
with bare magnetite nanoparticles (6.4µg/ml), evaluated by the two same methodologies used in 
the current work. Likewise, significant apoptosis induction (evaluated by means of mitochondrial 
membrane potential, JC-1 assay) in cervical and lung cells exposed to 2.5nM S-ION (magnetite) 
for 48h was reported (Malvindi et al., 2014). This concentration is equivalent to approximately 
30µg/ml of the current S-ION, dose which produced negative results at all conditions tested in 
this study. 
Cell death by necrosis (and/or late apoptosis) was also determined by annexin V/PI 
staining, and no alterations in this rate were found in SH-SY5Y cells exposed to S-ION at any of 
the conditions assayed. Namvar et al., (2014) obtained again contrary results: time-dependent 
increase in the necrosis/late apoptosis rate in Jurkat cells treated with ION but, as mentioned 
above, toxicity of these nanoparticles (in terms of cell viability decrease) was much higher. 
Possible effects of S-ION exposure on cell membrane integrity of neurons were evaluated 
by LDH leakage assay. Negative results were obtained for all experimental conditions evaluated, 
which is essentially in agreement with most results obtained for cell cycle and apoptosis or 
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necrosis induction, and also with previous results from the same nanoparticles, doses and cell line 
using MTT and alamar blue viability assays (Costa et al., 2016). Nevertheless, positive LDH 
leakage results were obtained by Malvindi et al., (2014) after treatment of A549 and HeLa cells 
for 48 and 96 h with 2.5nM S-ION (as already mentioned, equivalent to 30µg/ml of the current 
S-ION), according to their apoptosis assessment results and confirming the lower cytotoxicity of 
the present silica-coated nanoparticles. 
Taking all cytotoxicity results together, S-ION tested showed low cytotoxic potential; data 
from serum-free medium indicate a slightly larger harmful potential [viability reduction (Costa et 
al., 2016), cell cycle alterations and apoptosis induction (present study)], agreeing with the faintly 
higher entrance of the nanoparticles into the cells. 
For testing the potential of S-ION to induce damage on genetic material, we used a battery 
of genotoxicity tests, i.e., γH2AX assay, MN test, and comet assay. As response to the formation 
of DNA double strand break (DSB), H2AX flanking the DSB sites are rapidly phosphorylated at 
the serine 139 residue to become γH2AX. Reliability and specificity of the γH2AX assay as a 
biomarker of DNA damage have already been proved (Garcia-Canton et al., 2012; Nikolova et 
al., 2014). We used the γH2AX assay evaluated by flow cytometry since it provides an automated, 
fast, practical, and reproducible high-throughput platform that increases considerably the number 
of cells evaluated, diminishing the variability and enhancing the statistical power of the results 
(Sánchez-Flores et al., 2015). No significant increase in the γH2AX levels was observed in SH-
SY5Y cells after exposure to S-ION. No other study employing γH2AX assay for testing 
genotoxicity caused by any type of ION could be found in the literature; however, this cell line 
showed significant H2AX phosphorylation activity when treated with ZnO nanoparticles 
(Valdiglesias et al., 2013a) but not when exposed to different types of TiO2 nanoparticles 
(Valdiglesias et al., 2013b). 
The purpose of MN test is to identify chromosome aberrations, since MN may contain 
lagging chromosome fragments or whole chromosomes; therefore, it detects both clastogenic and 
aneugenic events. After S-ION treatment no effects were observed in the neuronal cells in terms 
of MN formation. To our knowledge no studies have been reported on MN induction by S-ION 
in any type of cells so far, but passiveness of other types of ION on MN formation have been 
documented in cells from different origin in in vitro (Li et al., 2011; Zhang et al., 2012; Shah et 
al., 2013) and in vivo studies (Wu et al., 2010; Li et al., 2011; Fang et al., 2012). 
The comet assay is one of the most frequently used methods for genotoxicity testing. It is 
a sensitive, user-friendly, and rapid technique to detect primary DNA damage, including single 
strand breaks (SSB) and DSB, abasic and alkali-labile sites, and incomplete excision repair sites. 
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Due to its simplicity, versatility and ability to detect different DNA lesions, it has been claimed 
to be the most promising assay to measure potential genotoxicity of nanomaterials (Magdolenova 
et al., 2014). Thus, we applied the alkaline comet assay to examine primary DNA damage induced 
by S-ION. But before that, we confirmed that these nanoparticles do not interfere with the assay 
methodology, since interference of different nanomaterials had been previously reported (Stone 
et al., 2009; Karlsson, 2010; Magdolenova et al., 2012). When treatments were carried out in 
serum-free medium no significant induction of DNA damage was observed. However, in 
complete medium S-ION induced dose- and time-dependent increase in the comet parameter, in 
agreement with the iron ion dissolution determination, which showed important amounts of ions 
released from the nanoparticles in complete medium. Although the human body contains 
relatively high concentrations of iron, the presence of this metal at concentrations higher than 
physiological can lead to deleterious effects. Iron ions are able to interact with DNA in-between 
the bases, thereby unwinding the double-helix (Eichhorn and Shin, 1968) and causing single 
strand breaks (SSB) and oxidative base modification (Toyokuni and Sagripanti, 1999). This kind 
of damage, especially SSB, is detected by the standard alkaline comet assay but is not related to 
phosphorylation of H2AX or MN production. Therefore, this may help to explain the positive 
results obtained in the comet assay and the negative ones from γH2AX assay and MN test. 
According to the current results, the type of DNA damage induced by S-ION on neuronal cells is 
likely not related to DSB but mostly to repairable DNA lesions (alkali labile sites and SSB), 
indicating recent damage (Azqueta and Collins, 2013). Similar increases in comet assay 
parameters (tail length and tail DNA intensity) were reported by Malvindi et al., (2014) in A549 
and HeLa cells treated with S-ION, by Hong et al., (2011) in murine L-929 fibroblast cells 
exposed to ION coated with (3-aminopropyl) trimethoxysilane (APTMS), tetraethyl-orthosilicate 
(TEOS)-APTMS, or citrate, and by Bhattacharya et al., (2009) in human lung IMR-90 fibroblasts 
and bronchial epithelial BEAS-2B cells treated with bare hematite. Moreover, no induction of 
chromosome aberrations (which require DSB production) was observed in human T lymphocytes 
treated with PAA-coated and non-coated ION (Couto et al., 2015), what further supports our 
results. 
Possible effects of S-ION on DNA repair processes were tested by DNA repair competence 
assay using H2O2 as challenging agent. H2O2 causes damage to DNA by generating hydroxyl-free 
radicals (OH·) (Jaruga and Dizdaroglu, 1996). These radicals attack DNA at the sugar residue of 
the DNA backbone, leading to SSB (Benhusein et al., 2010). Rejoining of SSB induced by H2O2 
is a simple cellular process; thousands of breaks per cell can be repaired in a matter of half an 
hour in typical cultured mammalian cells (Azqueta and Collins, 2013). In the current study, repair 
of approximately one-third of the DNA damage observed after H2O2 treatment was obtained 
during a 30min period, both in serum-free and in complete media. Incubations with the 
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nanoparticles were carried out at three different stages of the assay: before inducing DNA damage 
(pre-treatment or phase A, for 3 or 24h), during DNA damage induction (phase B), or during the 
repair period (phase C). Results obtained were different depending on the presence of serum in 
the medium. In serum-free medium no significant decrease in the DNA damage during the repair 
phase was observed when S-ION incubation was carried out before DNA damage induction, or 
during the repair phase. Since incubation only with S-ION for 30min caused a significant increase 
in the comet parameter, maybe the negative repair result obtained for phase C is related to DNA 
damage induced directly by the S-ION instead of (or in addition) to actual disturbance on the 
repair machinery. When treatment with H2O2 and the nanoparticles was performed 
simultaneously the repair process occurred normally; a possible explaining reason is the short 
time for this incubation (only 5 min), insufficient to cause any alteration in the repair systems. 
The results observed in complete medium suggested scarce effects on DNA repair, since 
significant decreases in the DNA damage were observed after the repair period at all conditions 
tested, excepting for phase B. As indicated before, a notable release of iron ions from the S-ION 
took place in complete medium. The deleterious effects of transition metal ions, such as iron, to 
DNA are greatly enhanced by the presence of oxygen and related species; thus, iron ions readily 
associate with DNA and, in the presence of hydrogen peroxide, a high ratio of DSB to SSB are 
generated (Lloyd and Phillips, 1999). Since the repair of DSB can take hours (Frankenberg-
Schwager, 1989), the result obtained for phase B in complete medium is probably related to the 
type of DNA damage induced, for which a 30min repair period is not long enough, more than to 
alterations in the repair process. To the best of our knowledge, this is the first study addressing 
the potential effects of ION on cellular repair systems. Therefore, further investigations are 
required to go into detail about all these findings. 
In conclusion, despite being effectively internalized by the neuronal cells, S-ION presented 
general low cytotoxicity; positive results were only obtained in some assays at the highest 
concentrations and/or longest exposure time tested. Genotoxicity evaluations in serum-free 
medium were negative for all conditions assayed; in complete medium dose and time-dependent 
increase in DNA damage, not related to the production of DSB or chromosome loss (according 
to the results of γH2AX assay and MN test), was obtained. Differences in the three genotoxicity 
assays applied, regarding their sensitivity to detect different types of genetic damage, confirm the 
need for using them in combination, since they complement one another. 
Medium composition (presence or absence of serum) influenced the behaviour of S-ION, 
although not in a great extent. Uptake of the nanoparticles by the cells, cytotoxicity, and effects 
on DNA repair were more pronounced in the absence of serum. On the contrary, iron ion release 
and primary DNA damage were only observed in complete medium. Formation of a protein 
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corona in the presence of serum has probably an important role in these differences. Further 
studies are needed to determine the protein corona formation and to elucidate the possible role of 
redox imbalance in the generation of harmful effects, particularly those related to DNA damage.  
2. SH-SY5Y CELLS EXPOSED TO O-ION 
In the study of exposure of neuronal cells to O-ION, prior to evaluating toxicity, 
internalization of these nanoparticles into SH-SY5Y cells was analysed by flow cytometry. 
Results obtained show that SH-SY5Y cells are able to efficiently internalize these nanoparticles 
at all experimental conditions tested, regardless the medium composition. Accordingly, in the 
previous section of this work, cultured SH-SY5Y cells were also reported to efficiently uptake 
silica-coated ION at the same dose and time conditions.  
The lack of a significant LDH release from neuroblastoma cells after O-ION treatment 
suggests that these nanoparticles do not generally disturb the cellular membrane integrity at low 
and medium concentrations, as previously shown in rat astrocytes treated with 10µg/ml of Fe3O4 
or γ-Fe2O3 for 6h (Au et al., 2007), or in oligodendroglial OLN-93 cells exposed to 1mM 
dimercaptosuccinate-coated ION for 4h (Petters et al., 2014a). These results support other studies 
reporting membrane damage in A549 cells exposed to magnetite only at high concentration 
(100µg/ml) for 24h (Watanabe et al., 2013), or human peripheral lymphocytes treated with 
maghemite (50-100µg/ml) for 24h (Rajiv et al., 2015). 
Cell cycle machinery is managed by a highly ordered set of events that lead to the proper 
division and duplication of the cell (Crosby, 2007). Results from the flow cytometry analysis of 
the relative DNA content of neuronal cells exposed to O-ION showed that the normal progression 
of SH-SY5Y cell cycle was impaired after nanoparticle exposure, and this was particularly 
notable after 24h treatment in serum-free medium. Cell cycle arrest was mainly observed as a 
significant dose-dependent increase in G0/G1 phase together with a clear decrease in G2/M region, 
indicating a possible mitotic arrest. These results agree with the induction of mitotic arrest in S 
and G2/M phases observed after 24h treatment of SH-SY5Y cells with 200µg/ml S-ION, recently 
discussed in this Thesis. Similar effects of ION on cell cycle of other different neuronal cells were 
also reported (Mahmoudi et al., 2009a, 2012; Wu et al., 2013a).  
Results from analysis of cell death showed significant increases in the rates of early 
apoptosis (evaluated by annexin V/PI staining) and late apoptosis (determined as subG1 phase of 
cell cycle analysis) in both complete and serum-free media. Previously reported data on apoptosis 
induction by ION confirm our results. Imam et al., (2015) found increases in apoptosis rate in 
SH-SY5Y cells after exposure to 2.5-40μg/ml of 10nm, but not 30nm, uncoated ION for 24h. Wu 
et al., (2013b) demonstrated that high doses of bare magnetite nanoparticles (>50µg/ml) increased 
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phosphorylation of P53 (protein involved in the G2/M DNA damage checkpoint) and promoted 
apoptosis in PC12 cells after 24h of exposure.  
The potential of O-ION to induce necrosis, passive and energy-independent mode of death, 
was also evaluated in this study. Unlike the results obtained in the Wu et al., (2013b) study, in 
which necrosis induction was described after PC12 cells treatment with bare ION (>50 µg/ml) for 
24h, O-ION did not produce necrosis in the SH-SY5Y cells at any of the conditions evaluated. 
Similarly, as previously described, the same cell line did not show increase in the necrosis rates 
after being exposed to S-ION (10 to 200µg/ml) for 3 or 24h. Taking together, results obtained in 
the present study from apoptosis and necrosis analyses, suggest that O-ION seem to induce cell 
death mainly via the apoptotic pathway.  
Besides, in order to evaluate the potential genotoxic effects of O-ION three different 
methodological approaches were carried out, i.e. comet assay, γH2AX assay and MN test. Since 
several previous works reported interference of different nanoparticles with comet assay 
methodology (Stone et al., 2009; Karlsson, 2010; Magdolenova et al., 2012), a comprehensive 
test for detecting potential ION interferences with the alkaline comet assay protocol was carried 
out prior to DNA damage evaluation. A significant additional DNA damage at 200µg/ml O-ION 
concentration in serum-free conditions was found, indicating residual nanoparticle interference 
limited to these specific conditions. This may be due to the high tendency to aggregation of O-
ION dispersed in serum-free medium (Costa et al., 2016), particularly exacerbated at elevated 
concentrations. Results from standard alkaline comet assay showed that O-ION induced primary 
DNA damage in the exposed cells. Similarly, Magdolenova et al., (2013) found significant 
genotoxic effects (by comet assay) in human TK6 cells and lymphocytes treated with oleate-
coated magnetite (lowest observed adverse effect level at 0.5h treatment: 144µg/ml and 
56.4µg/ml, respectively, and at 24h treatment: 2.9µg/ml and 1.13µg/ml, respectively), and 
Kenzaoui et al., (2012b) reported DNA damage induction in human brain-derived endothelial 
cells treated with uncoated ION and O-ION (0.4-235µg/ml) for 24 and 48h. Results from all these 
studies indicate a different sensitivity to O-ION exposure depending on cell type and experimental 
conditions.  
In the present work, treatment with O-ION did not induce H2AX phosphorylation at any 
condition tested. The same negative results were found in this Thesis in SH-SY5Y cells treated 
with S-ION under the same experimental conditions. Given its novelty, application of γH2AX 
assay in nanogenotoxicity evaluation is still extremely unusual. However, according to the present 
results, Harris et al., (2015) reported no DSB detection (phosphorylated H2AX) in Balb/3T3 cells 
treated with uncoated and O-ION. Hence, considering together the results obtained from γH2AX 
analysis and comet assay, it seems that primary DNA damage detected in the comet assay was 
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likely due to other kind of genetic damage (i.e. SSB, alkali-labile sites, abasic sites), which 
involves consequences much less relevant for the cell. 
In order to identify possible chromosome alterations in SH-SY5Y cells due to exposure to 
O-ION, MN test was carried out. MN analysis may reveal both clastogenic and aneugenic events 
(Fenech, 2008). In our study, significant increases in MN frequencies were only detected in SH-
SY5Y cells after 24h of exposure to O-ION highest doses in serum-free medium, suggesting that 
primary DNA damage detected in the comet assay was only fixed as chromosome alterations at 
these high O-ION concentrations and long exposure time in the absence of serum. Nevertheless, 
cytotoxicity observed at these same conditions, namely high apoptosis rates and cell cycle arrest 
at S phase, may have also influenced MN test results by generating artefacts, for instance due to 
the nuclear fragmentation into smaller nuclear bodies occurring during apoptosis cell death, which 
can be considered as MN in the flow cytometry analysis. Significant induction of MN had been 
already observed in other human cell types (Könczöl et al., 2011; Singh et al., 2012; Rajiv et al., 
2015). 
DNA repair systems are recognized as one of the most important cellular defence 
mechanisms responsible for DNA integrity. In order to evaluate whether O-ION exposure has 
some impact on the DNA repair capacity of SH-SY5Y cells, which would lead to increased DNA 
damage in response to other internal or external insults, DNA repair competence assay was carried 
out with O-ION treatment in different phases. Results obtained showed a similar effect of O-ION 
on the cell repair ability regardless of media composition, although slightly higher in serum-free 
medium. In particular, alterations in repair ability were observed when cells where treated before 
or during the challenge with H2O2. Still, the presence of nanoparticles during the repair period did 
not cause any alteration in the repair capacity at any condition tested, even though exposure to O-
ION for the duration of the repair period (30 min) induced a significant increase in DNA damage. 
To our knowledge, the only study available in the literature addressing the potential effects of 
ION on cellular repair mechanisms reported that silica-coated magnetite nanoparticles 
significantly altered the repair ability of SH-SY5Y cells, being the effect more pronounced in the 
absence of serum proteins.  
Results of quantification of iron ion release from the O-ION surface was markedly 
dependent on the medium composition. Suspensions of O-ION in complete medium displayed an 
increased ion release in a concentration-dependent manner, while O-ION suspended in serum-
free medium were very stable at all conditions tested. Similar differences were previously found 
by other authors (Geppert et al., 2012; Malvindi et al., 2014; Hanot et al., 2015). Iron ions released 
into the cytosol, directly from the nanoparticle surface or due to lysosomal enzymatic degradation, 
can participate in the Fenton reaction producing reactive oxygen species (ROS) (Valko et al., 
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2007; Klein et al., 2012), resulting in oxidative stress which would eventually lead to disruption 
of iron homeostasis, antioxidant defence system depletion, cytotoxic effects and DNA damage 
(Soenen and De Cuyper, 2009, 2010; Singh et al., 2010; Malvindi et al., 2014). Since the lower 
iron ion levels released in the absence of serum are not associated with the higher O-ION induced 
cytotoxicity observed in serum-free medium, further investigation is needed, e.g. exploring 
oxidative stress related pathways, to figure out the mechanism behind cytotoxicity produced by 
these nanoparticles.  
The decrease in iron ions with incubation time in complete medium may be explained by 
the presence of transferrin, a major constituent of FBS (Young and Garner, 1990). This protein 
may bind iron ions released from the nanoparticles, with the quantity of iron bound increasing 
with time. If transferrin takes part in the protein corona, iron bound to this protein will not be 
detected in the analysis of iron ions in the supernatant medium. 
When comparing complete and serum-free media results showed that, in general, the 
presence of serum had a slight influence on the O-ION induced genotoxicity and effects on repair 
capacity. As for cytotoxicity, data obtained suggested that serum proteins interact with oleic acid 
coating slightly preventing cytotoxicity production, i.e. membrane impairment, cell cycle 
alterations and cell death induction. These results are in line with our previous findings describing 
higher decreases in SH-SY5Y viability induced by O-ION in serum-free medium (Costa et al., 
2016). Also supporting our results, previous works reported a possible protective effect of the 
protein corona on ION toxicity (Nel et al., 2009; Mahmoudi et al., 2011a; Mahmoudi et al., 2012). 
In conclusion, results obtained showed that O-ION exhibit a moderate cytotoxicity related 
to cell membrane impairment, cell cycle disruption and cell death induction, especially marked 
in serum-free medium. On the contrary, iron ion release was only observed in complete medium, 
indicating that cytotoxicity observed was not related to the presence of iron ions in the medium. 
However, O-ION genotoxic effects were limited to the induction of primary DNA damage, not 
related to DSB and easily repairable, and this damage did not become fixed in cells in most 
conditions.  
3. A172 CELLS EXPOSED TO S-ION 
Before testing the possible harmful effects of S-ION on A172 cells, the actual entry of 
nanoparticles into astrocytes was verified. Results obtained from TEM revealed the presence of 
S-ION internalized in A172 astrocytes in all the conditions tested, regardless medium 
composition or exposure time, demonstrating that these cells may efficiently uptake these 
nanoparticles. Moreover, S-ION were found to be accumulated in intracellular vesicles, 
suggesting that endocytic processes are involved in S-ION uptake into astrocytes. Similarly, 
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cultured astrocytes were reported to efficiently accumulate ION with different types of coatings 
in a time-, concentration- and temperature-dependent manner (Hohnholt et al., 2013).  
S-ION did not impair plasmatic membrane integrity at the conditions tested in this study, 
as demonstrated by the negative results revealed in the assessment of LDH release. As already 
mentioned, no significant LDH leakage was either observed in SH-SY5Y neuronal cells treated 
with the same S-ION. Previous studies in other cell lines reported membrane damage only at high 
ION (magnetite) concentration (100μg/ml) (Watanabe et al., 2013) or long exposure time 
(maghemite, 24h) (Rajiv et al., 2015). As none of these conditions led to membrane impairment 
in the current study, results obtained suggest that silica coating prevents membrane damage, 
and/or that astrocytes are less sensitive to this effect.   
The cell cycle machinery is managed by a highly ordered set of events that lead to the 
division and duplication of the cell (Crosby, 2007). In the presence of DNA damage or cellular 
stress, cell cycle checkpoint protein P53 triggers cell cycle arrest to provide time for the damage 
to be repaired or for self-mediated apoptosis (Alarifi et al., 2013). Results obtained from the cell 
cycle analysis showed important dose-dependent cell cycle alterations induced by S-ION, 
particularly marked in the 24h treatments, in which cell cycle of A172 cells resulted altered in all 
conditions tested, regardless the dose or the medium composition. Still, these effects, included 
mainly alterations in G0/G1 and S phases reflecting a possible mitotic arrest, and were more 
pronounced in serum-free medium. These results support the previous work of Mahmoudi et al., 
(2012) who also observed similar cell cycle effects in BE(2)-C neurons and A172 astrocytes 
treated with S-ION (2-32mM) for 24h. Similarly, uncoated magnetite nanoparticles induced a 
concentration-dependent accumulation of cells in G2/M phase and of p53 gene expression in 
neuronal PC12 cells treated for 24h (100 and 200µg/ml) (Wu and Sun, 2011). And Mahmoudi et 
al., (2009a) observed that uncoated and polyvinyl alcohol-coated ION caused cell cycle arrest in 
G0/G1 phase at 200-400mM in mouse fibroblast cell line (L929), possibly due to the irreversible 
DNA damage and repair of oxidative DNA lesions.  
Evaluation of apoptosis induced by S-ION exposure was carried out by two approaches; 
on one hand the analysis of the subG1 region of the cell cycle as an indicator of DNA 
fragmentation at the late stages of apoptosis, and on the other hand, by annexin V/PI staining flow 
cytometric analysis, as a sensitive measure of apoptosis early stages. Results obtained by both 
methodologies resulted quite similar, with apoptosis induction limited to the highest S-ION doses 
and longest exposure time in complete medium, but important dose-dependent increases of 
apoptosis rates observed at both exposure times in serum-free medium. In agreement with our 
results, Mahmoudi et al., (2012) also observed increases in the apoptotic rate (subG1 stage of cell 
cycle) in BE(2)-C neurons and A172 astrocytes exposed to S-ION for 24h, and Jeng and Swanson 
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(2006) reported a time-dependent increase of apoptotic Neuro-2A cells after 48h treatment with 
carboxyethylsilanetriol-coated ION (50µg/ml). In general, ION-induced apoptosis was previously 
described not only in nervous system cells but also in other different cell types, including human 
A549 lung cells (Watanabe et al.,, 2013), human Jurkat T lymphocytes (Namvar et al., 2014), or 
rat lung epithelial cells (Ramesh et al., 2012).  
Evaluation of cell death by annexin V/PI allowed also to quantify the rate of cells 
undergoing necrosis together with late apoptosis. In complete medium, S-ION only induced 
necrosis at the highest doses and longest exposure time; whereas in serum-free medium significant 
dose-dependent increases were obtained only in the 3h treatment. Since results from annexin V/PI 
analysis and subG1 region are similar, and considering that percentage of annexin V binding +/PI− 
cells includes not only necrotic but also late apoptotic cells, S-ION seem to induce cell death 
mainly via the apoptotic pathway. Accordingly, apoptosis but not necrosis induction was observed 
in this Thesis in SH-SY5Y neurons exposed to the same S-ION (100 and 200µg/ml) for 24h. 
The potential genotoxic effects of S-ION were evaluated by means of three different 
genotoxicity approaches, namely γH2AX assay, comet assay and MN test. Moreover, DNA repair 
competence assay was applied to assess possible alterations in the astrocyte DNA repair capacity 
in the presence of S-ION. 
As already mentioned, and given its novelty, application of γH2AX assay to ION 
genotoxicity studies is extremely scarce. According to the results previously described for SH-
SY5Y cells, S-ION did not induce DSB, either in complete or in serum-free medium. In the 
present work S-ION did not induce H2AX phosphorylation in A172 astrocytes either, except at 
the highest concentrations after 24 h treatment. Considering the results obtained in the iron ion 
release from the nanoparticles, the increase detected seems to be more likely due to the indirect 
effect of iron ions, than to the genotoxic S-ION properties themselves. Presence of iron ions would 
lead to an imbalance in the Fenton reaction and, consequently, to an increase in oxidative damage, 
eventually causing breaks in the DNA strands (Luther et al., 2013). 
Comet assay was carried out in order to evaluate the possible induction of primary genetic 
damage by S-ION exposure. As several reports previously described the interference of different 
nanoparticles with the comet assay methodology (Stone et al., 2009; Karlsson, 2010; 
Magdolenova et al., 2012), the possible interference by S-ION at the highest concentration to be 
tested was discarded prior to performing the analysis. Subsequently, results from comet assay 
showed that S-ION induced DNA primary damage in astrocytes only at the highest concentrations 
after a short exposure period, but from 25µg/ml on, in a dose-dependent manner, after 24h 
treatment. This concentration-dependent increased DNA damage was previously observed in 
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A549 and Hela cells treated with both S-ION (Malvindi et al., 2014) or ION with other different 
coatings (Bhattacharya et al., 2009; Han et al., 2011; Seo et al., 2017). However, since the results 
obtained from γH2AX analysis in this study were mainly negative, this primary DNA damage 
observed in comet assay seems not be related to DSB but to other kind of DNA damage (e.g. SSB, 
abasic sites, alkali-labile sites) more easily repairable.   
Micronucleus test was performed to identify possible chromosome alterations induced by 
exposure to S-ION, coming from clastogenic or aneugenic events. No induction of MN was found 
in astrocytes exposed to S-ION at any condition tested, indicating on the one hand that S-ION did 
not induce aneugenic effects on astrocytes. On the other hand, it seems that these cells were able 
to repair the primary DNA damage initially produced by S-ION exposure, revealed by positive 
response of comet assay, thus avoiding its fixation as chromosome alterations. A lack of MN 
production after nanoparticle exposure was obtained in several studies employing different cell 
lines and ION, as human lymphoblastoid cells treated with uncoated maghemite or with uncoated 
and dextran-coated magnetite (Singh et al., 2012), Syrian hamster embryo cells treated with naked 
maghemite and magnetite nanoparticles (Guichard et al., 2012), Chinese hamster lung cells 
exposed to glutamic acid-coated (Zhang et al., 2012) and to poly ethylene imine- or poly ethylene 
glycol-coated ION (Liu et al., 2014). 
In order to evaluate whether S-ION exposure has some impact on the DNA repair ability 
of astrocytes, which would lead to increased DNA damage in response to internal or external 
insults, DNA repair competence assay was carried out with S-ION treatment in different phases. 
Results obtained showed that S-ION did not interfere with the repair capacity of A172 astrocytes, 
at any condition tested, since significant decreases in H2O2-induced DNA damage, indicative of 
efficient repair, were observed in the presence of S-ION. These decreases were consistently 
obtained regardless the moment the incubation with nanoparticles was conducted (before, during 
or after treatment with the challenging agent H2O2) and were also similar to the decrease detected 
in the absence of S-ION. Studies addressing the potential effects of ION on cellular repair 
mechanisms are practically inexistent. In this Thesis S-ION effects on SH-SY5Y cells repair 
ability was described by employing the same approach. In that case, S-ION exposure did alter the 
repair of H2O2-induced DNA damage in these cells, with considerably more pronounced effects 
when serum-free medium was employed. This dissimilar response to S-ION exposure of the two 
types of nervous system cells indicates, as previously reported, that glioma cells have a more 
efficient repair capability of induced DNA damage than neurons (Laffon et al., 2017). 
All genotoxicity results together indicate that S-ION present a low genotoxic activity, 
limited to easily repairable DNA damage as demonstrated by the positive results obtained in 
comet assay together with the negative results from γH2AX and MN assays. In any case, the DNA 
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damage induced by S-ION seems to be repaired, since the repair capacity resulted not altered, 
and, consequently, it was not fixed in the cells as proved by the lack of MN production. Besides, 
all these effects were not dependent on the presence/absence of serum in the medium.   
Nevertheless, the quantity of iron ions released from the S-ION depended markedly on the 
medium composition. While S-ION suspended in serum-free medium were very stable at all 
conditions tested, suspensions of nanoparticles in complete medium showed a concentration-
dependent increase in ion release, particularly noticeable at the longest exposure time. This iron 
excess may lead to an imbalance in its homeostasis and cause elevated ROS generation through 
the Fenton reaction, resulting in oxidative stress which would lead to cytotoxic effects and DNA-
damage (Soenen and De Cuyper, 2009, 2010; Singh et al., 2010; Malvindi et al., 2014).  
Therefore, the iron ion release could help to explain the cytotoxic effects induced by S-ION when 
complete medium was employed. Since no ion release but cytotoxicity was observed in serum-
free medium experiments, other different action mechanisms, for instance those linked to 
oxidative damage production, should be investigated. Differences in ion release found in our study 
depending on the medium composition were previously described (Geppert et al., 2012; Malvindi 
et al., 2014; Hanot et al., 2015). In fact, protein presence has been associated with an increase in 
dissolution rates of ION through both aqueous complexation and ligand-enhanced dissolution 
(Nel et al., 2009). Hence, it is possible that the serum proteins favour the silica coating 
degradation, thus causing a higher iron release from the nanoparticle core. Nevertheless, different 
issues such as cell type, intracellular medium pH or composition, nanoparticle composition or 
physical-chemical characteristics such as size, coating or aggregation capacity have been 
previously suggested to be other main factors influencing the iron release from ION (Geppert et 
al., 2009, 2011; Singh et al., 2012; Rosenberg et al., 2012; Paolini et al., 2016). 
Generally speaking, current results showed that the absence of serum in the medium had 
some influence on cytotoxicity of S-ION, resulting in more pronounced cellular effects (cell cycle, 
apoptosis and necrosis). These findings are in accordance with our previous observations of 
higher decreases in viability induced by S-ION in both A172 and SH-SY5Y cells in serum-free 
medium (Costa et al., 2016) and support a possible protective effect of the protein corona on the 
cytotoxicity induced by nanoparticles previously suggested by other authors (Nel et al., 2009; 
Mahmoudi et al., 2011a, 2012). Nevertheless, in general no notable differences in genotoxicity 
induction or DNA repair alterations were found between complete and serum-free medium. 
In conclusion, in the present study genotoxicity and cytotoxicity associated with S-ION 
exposure were evaluated in glial cells by a battery of assays. Results obtained showed that S-ION 
exhibit certain cytotoxicity, especially in serum-free medium, related to cell cycle disruption and 
cell death induction. However, S-ION presented scarce genotoxic effects, not dependent on 
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medium composition and easily repairable. Moreover, the primary DNA damage was only related 
to DSB at the highest concentrations and longest time tested, probably associated with the increase 
in iron release in complete medium. Negative results in MN test indicate (i) no aneugenic effects 
and (ii) that the previously mentioned DNA strand breaks were not fixed upon cell division. No 
effects on the DNA repair systems were observed.  
4. A172 CELLS EXPOSED TO O-ION 
Before addressing the toxicological profile of O-ION, the uptake of nanoparticles by the 
cells was determined. Results of TEM demonstrated the presence of O-ION inside A172 cells at 
all conditions tested, regardless medium composition or exposure time. According with our 
results, significant ION uptake was previously reported in rat primary astrocytes (Geppert et al., 
2009, 2011, Hohnholt et al., 2010b, 2013; Hohnholt and Dringen, 2013), and in human (Kiliç et 
al., 2015; Fernández-Bertólez et al., 2018a) and rat (Marcus et al., 2016) neurons under different 
experimental conditions. 
LDH release analysis indicated that exposure to O-ION do not compromise the membrane 
integrity of A172 cells. In line with these results, previous studies reported either no effect on rat 
primary astrocytes (Au et al., 2007) and oligodendroglial OLN-93 cells (Petters et al., 2014a) 
exposed to different ION, or slight membrane damage, commonly limited at high concentrations 
or long exposure times, in cell types not derived from CNS (Watanabe et al., 2013; Rajiv et al., 
2015). 
Results obtained in the analysis of cell-cycle distribution show significant dose-dependent 
arrest of the cell cycle in the S-phase at all conditions tested, indicating that O-ION clearly alter 
the normal cell cycle progression of these cells. Similarly, studies in other nerve cell types showed 
a dose-dependent S-phase arrest in human BE(2)-C (Mahmoudi et al., 2012) and SH-SY5Y 
neuronal cells exposed silica-coated ION (Kiliç et al., 2015), and in PC12 rat cells after treatment 
with uncoated ION (Wu et al., 2013b). Cell cycle arrest induced by these nanoparticles is probably 
caused by alterations in the expression of regulatory genes involved in cell cycle, cell death, 
oxidative stress pathways, and/or DNA-damage repair (Periasamy et al., 2014). Further research 
in this direction is required to confirm this hypothesis. 
Together with significant modifications in the cell cycle progression, the proportion of 
A172 astrocytes in the sub-G1 region, indicative of late apoptosis, also increased in a dose- and 
time-dependent manner, in both complete and serum-free media. Accordingly, results from 
analysis of annexin V/PI staining showed significant increases in the rates of early apoptosis after 
O-ION exposure as well. Previously reported data on apoptosis induction by ION confirm our 
results. Periasamy et al., (2014) observed increased levels of early apoptosis in human 
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mesenchymal stem cells treated with uncoated magnetite, and Naqvi et al., (2010) in murine 
macrophage (J774) cells exposed to Tween 80-coated ION. Besides, several studies conducted in 
neuronal cells also support our findings. In particular, high doses of bare magnetite nanoparticles 
were found to promote P53 phosphorylation and apoptosis in PC12 cells (Wu et al., 2013b); 
exposure to uncoated ION increased apoptosis rate in SH-SY5Y cells (Imam et al., 2015); 
Mahmoudi et al., (2012) also observed raises in late apoptotic cells (subG1 stage of cell cycle) in 
BE(2)-C neurons treated with silica-coated ION; and Jeng and Swanson (2006) reported a time-
dependent increase of apoptotic Neuro-2A cells after exposure to carboxyethylsilanetriol-coated 
ION. Furthermore, O-ION produced a slight but significant increase in necrosis rates when 
treatments were performed in complete medium, but not in serum-free medium. Previous results 
obtained by Wu et al., (2013b) exhibited induction of necrosis in PC12 cells by bare ION. Taking 
together all results regarding cell death assessment obtained from the present and previous studies, 
they suggest that ION are able to induce cell death, mainly via the apoptotic pathway.  
In order to address the potential effects of O-ION on the genetic material of A172 cells, 
three different genotoxicity approaches were carried out, namely comet assay, γH2AX assay and 
MN test. A comprehensive test for detecting interferences of O-ION with the comet assay 
methodology was carried out prior to performing the analysis. After ruling out possible 
interferences, results from comet assay showed that nanoparticle treatment induced primary DNA 
damage in astrocytes in a dose-dependent manner, particularly in the presence of serum in the 
medium. Employing the same technique, Kenzaoui et al., (2012b) also reported positive results 
in human brain-derived endothelial cells exposed to uncoated ION and O-ION, not observing 
differences between the two nanoparticles, and Magdolenova et al., (2013) in human TK6 cells 
and lymphocytes treated with oleate-coated magnetite, with TK6 cells being less sensitive. 
H2AX histone is quickly phosphorylated at serine 139 (γH2AX) to repair double strand 
breaks (DSB) produced by genetic insults or replication errors. Thus, quantification of γH2AX is 
widely used as a very sensitive and specific biomarker for DSB (Sánchez-Flores et al., 2015). In 
the present study, slight significant increases in the γH2AX levels of A172 cells exposed to O-
ION were detected. These results could reflect a part of the primary DNA damage observed in 
the comet assay (which detects not only DSB but also other types of primary DNA damage) or, 
most likely, be the result of the high early apoptosis rate observed after O-ION exposure, 
associated with the DNA fragmentation typical of this type of cell death. Indeed, Kiliç et al., 
(2015) did not found increases in γH2AX levels, together with absence of apoptosis induction, in 
SH-SY5Y cells treated with silica-coated ION under the same experimental conditions. Also, no 
increase in DSB (γH2AX) was reported in Balb/3T3 fibroblasts treated with uncoated ION and 
O-ION (Harris et al., 2015), in SH-SY5Y cells exposed to O-ION (Fernández-Bertólez et al., 
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2018a), and in other non-neural cell types treated with different ION (Schütz et al., 2014; Pöttler 
et al., 2015).  
The potential chromosome alterations induced by O-ION exposure in astrocytes was 
addressed by the MN test. The lack of MN induction observed after ION exposure was previously 
reported in other several studies employing different cell systems. In particular, in Syrian hamster 
embryo cells treated with naked maghemite and magnetite nanoparticles (Guichard et al., 2012), 
in Chinese hamster lung cells exposed to glutamic acid-coated ION (Zhang et al., 2012), in human 
lymphoblastoid cells treated with uncoated maghemite or with uncoated and dextran-coated 
magnetite (Singh et al., 2012), and in human SH-SY5Y neurons exposed to silica-coated ION 
(Kiliç et al., 2015), among others. MN are considered fixed genetic damage resulting from 
chromosome fragments or whole chromosomes lagged during anaphase that remain into daughter 
cells when the nucleus divides (Fenech, 2008). Accordingly, and considering all results obtained 
in this study from genotoxicity tests, O-ION exposure induced primary DNA damage, as revealed 
by γH2AX analysis and, particularly, comet assay, but A172 cells were able to repair this damage 
avoiding its fixation as chromosome alterations (MN). 
DNA repair systems play a key role in cellular defence mechanisms responsible for DNA 
integrity. In order to evaluate whether O-ION exposure has some impact on DNA repair ability, 
DNA repair competence assay was performed exposing A172 cells to O-ION in three different 
phases. Results obtained showed that O-ION did not interfere with the DNA repair capacity at 
any condition tested. Studies addressing the potential effects of ION on cellular repair 
mechanisms are extremely scarce. Silica-coated ION effects on repair capacity of SH-SY5Y and 
A172 cells were previously assessed by our group by employing the same approach (Kiliç et al., 
2015; Fernández-Bertólez et al., 2018b). In SH-SY5Y cells, the presence of nanoparticles altered 
the repair of H2O2-induced DNA damage, with considerably more pronounced effects when 
serum-free medium was employed (Kiliç et al., 2015). However, results obtained from A172 cells 
were in accordance with the ones found in the present study, with no alteration in repair ability 
found at any condition tested (Fernández-Bertólez et al., 2018b). This different response between 
the two types of nervous system cells are in line with the well-accepted idea that glial cells may 
have a more efficient repair ability in order to protect neuronal tissue from external insults (Saeed 
et al., 2015). However, it may be also due to the less sensitivity of glial cells to this type of induced 
DNA damage when compared to neurons, as previously demonstrated (Laffon et al., 2017). 
Results of quantification of iron ions released from the O-ION surface was markedly 
dependent on the media composition. Suspensions of O-ION in complete medium displayed an 
increased ion release in a dose- and time-dependent manner, whereas O-ION suspended in serum-
free medium resulted very stable. Other authors described similar differences agreeing with these 
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observations (Geppert et al., 2012; Malvindi et al., 2014; Hanot et al., 2015). The higher iron 
release in complete medium may be related to the smaller particle size, and consequently larger 
surface area, since hydrodynamic size of these O-ION in complete medium was reported as 251.5 
± 4.9nm, while in serum-free medium it was 2,587.7 ± 382.2nm (Costa et al., 2016). Other 
possible explanation may be that the interaction with the serum proteins present in the complete 
medium favours the oleic acid coating degradation and consequently the iron ion release. In spite 
of this, current cytotoxicity and genotoxicity results were quite similar in both media, suggesting 
that free iron ions are not responsible for the effects observed and that presence of serum proteins 
do not influence O-ION toxicity. 
In conclusion, results obtained in the present study showed that O-ION exhibit moderate 
cytotoxicity, related to proliferation arrest and cell death induction (principally by apoptotic 
pathway), and cause genotoxic effects, mainly primary DNA damage, which is not fixed as 
chromosome alterations. These effects were not influenced by the presence of serum in the 
medium. Conversely, notable iron ion release was observed only in complete medium, indicating 
that cyto- and genotoxicity results were not entirely caused by iron ion homeostasis disruption. 
Besides, no alterations in the DNA repair processes were obtained. 
5. COMPARATIVE ANALYSIS OF COATINGS AND CELL TYPES 
Based on the results explained above, we can conclude that silica coating seems to be less 
toxic and more biocompatible than oleic acid for the nervous cell lines employed in the present 
study. In general, S-ION showed less cytotoxicity than O-ION. Moreover, S-ION exhibited 
slightly lower genotoxic effects than O-ION in both cell lines, not related to the induction of DSB 
and not fixed in either SH-SY5Y or A172 cells upon cell division. Previous studies stated that 
ION are stored in lysosomal compartment where they decompose to free iron ions (Laurent et al., 
2011; Laskar et al., 2012). Free iron ions can affect mitochondria and/or increase free radical 
concentration (Fröhlich et al., 2012). Given that the FCM analysis of SH-SY5Y uptake of both 
ION indicate similar cell internalization regardless of the coating composition, differences in 
cyto- and genotoxic effects may be explained by differences in the surface chemistry between O-
ION and S-ION. Hence, faster transfer of internalized O-ION to the lysosomal compartment, and 
more intense dissolution rates of oleic acid coating at the acid lysosome pH (Malvindi et al., 
2014), could likely generate larger amounts of ferric iron, which may cause higher cell damage 
(Petters et al., 2016). Indeed, the different dissolution kinetics of ION has been observed to 
depend on the surface coating and its physicochemical properties (Lévy et al., 2010; Colombo et 
al., 2012; Mahon et al., 2012; Hanot et al., 2015). Furthermore, ION with various surface 
modifications and different hydrodynamic size may induce slight, but possibly meaningful, 
changes in cell cytotoxicity and genotoxicity (Hong et al., 2011; Magdolenova et al., 2013). In 
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some conditions of this study, O-ION as micro-sized agglomerates were observed, specifically in 
serum-free media, probably due to the absence of interactions of oleic acid coat with serum 
proteins of the biological medium (protein corona), which modified their hydrodynamic size and 
stability. This fact could greatly influence the biological interaction with O-ION and the higher 
observed toxic effect regarding silica coating.  
Furthermore, from the point of view of biomedical applications of ION on CNS, A172 
astrocytes demonstrated to be more vulnerable than neurons to the toxic effect of S-ION and O-
ION. Although cytotoxic effects have been observed in SH-SY5Y and A172 cell lines after 
exposure to both ION, these effects were broadly higher in astrocytes than in neurons. In addition, 
it was found that astrocytes and neurons exhibit primary DNA damage after ION exposure, but 
only in the case of A172 cells it was related to DSB, a more severe type of genetic damage. 
However, in both cases this damage was repaired, since it did not lead to chromosome alterations 
(detected by MN test). Other studies on chemical toxicity suggest that glial cells (i.e. astrocytes) 
are more sensitive than neuronal cells (Stockmann-Juvala et al., 2006), as it was observed in this 
work. A possible bias for this comparison is the cell cycle state at the moment of treatment, since 
cells in diverse states of the cell cycle express different biomolecules and could have different 
responses to exogenous stimuli, such as xenobiotic exposures and specifically ION exposure 
(Bregoli et al., 2013). Moreover, different features of the cell types involved in nervous system 
physiology may determine diverse response against toxic insults (Laffon et al., 2017). Another 
possible explanation for this difference in sensitivity may be due to different internalization rates 
of ION in astrocytes and neurons, which may lead to variations in the mobilization of ION to the 
lysosomal compartment and, therefore, to the production of iron ions responsible for the cellular 
damage. However, it is not possible to contrast such a difference in the uptake of ION between 


























From the results obtained in this study, we may draw the following conclusions: 
SH-SY5Y cells treated with S-ION 
1. Despite being effectively internalized by the SH-SY5Y neuronal cells, S-ION present 
general low cytotoxicity, only manifested at the highest concentrations and/or longest 
exposure time tested.  
2. While S-ION do not exhibit genotoxicity in serum-free medium, they induce dose and time-
dependent increase in DNA damage, not related to the production of DSB or chromosome 
loss, in complete medium. Exposure to S-ION influence differently the DNA repair process 
in complete and serum-free media, with more pronounced effects in the latter. 
SH-SY5Y cells treated with O-ION 
3. SH-SY5Y cells are able to take up O-ION in a dose and time-dependent manner. O-ION 
exhibit a restrained cytotoxicity related to cell membrane impairment, cell cycle disruption 
and cell death induction, especially marked in serum-free medium. Cytotoxicity is not 
related to the presence of iron ions in the medium. 
4. O-ION genotoxic effects are limited to the induction of primary DNA damage, not related 
to DSB and easily repairable, and this damage do not become fixed in cells in most 
conditions. These nanoparticles cause alterations in DNA repair ability when cells are 
treated before or during the challenge with H2O2, regardless of the presence of serum 
proteins. 
A172 cells treated with S-ION 
5. S-ION may enter A172 glial cells, and induce a certain cytotoxicity, especially in serum-
free medium, related to cell cycle disruption and cell death induction. 
6. S-ION cause scarce genotoxic effects in glial cells, not dependent on medium composition 
and easily repairable. Primary DNA damage induced was only related to DSB at the highest 
concentrations and longest time tested. It is probably associated with the increase in iron 
release in complete medium and not fixed upon cell division. DNA repair systems are not 
altered by exposure to S-ION. 
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A172 cells treated with O-ION 
7. O-ION are efficiently internalized in the A172 glial cells. They exhibit moderate 
cytotoxicity, related to proliferation arrest and cell death induction (principally by apoptotic 
pathway), and cause genotoxic effects, mainly primary DNA damage, which is not fixed 
as chromosome alterations. Nevertheless, they do not produce alterations in the DNA repair 
processes. 
8. These effects are not influenced by the presence of serum in the medium and are not 
dependent on iron ion release from the nanoparticle surface.  
Comparative analysis of coatings and cell types 
9. Silica coating seems to be less toxic and more biocompatible than oleic acid for the nervous 
system cell lines employed in the present study. 
10. A172 astrocytes demonstrated to be more sensitive than SH-SY5Y neurons to the toxic 
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